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ABSTRACT 
Cardiovascular disease (CVD) is the world’s biggest killer, globally accounting 
for over 17,5 million deaths annually. Almost half of these deaths are caused by 
acute myocardial infarction. It is an umbrella term that encompasses several 
medical conditions associated with the heart and the circulatory system. It is 
important to detect patients with high risk of acute myocardial infarction quickly. 
This can help in cutting costs by screening the hospital admissions process and 
focusing resources to those that are specifically at risk. Biomarkers and 
biosensors are playing a crucial role in the diagnostic revolution of 
cardiovascular disease. Although significant studies have been done on 
electrochemically transduced biosensors for detecting CVDs, of late they have 
had limited commercial success. However, advances in interrelated research 
areas have made it possible for faster, accurate, portable and environmentally 
friendly electrochemical diagnostic devices to be made. This project aims to: 
• Develop Immunoassays for two cardiac biomarkers which are CRP and 
cardiac troponin T 
• Integrate the immunoassays on to screen-printed gold electrodes 
(SPGE) to make electrochemical immunosensors. 
• Optimise the immunosensors to produce rapid, sensitive and specific 
devices  
• Evaluate the performance of the optimised immunosensors compared to 
other alternative detection devices.  
Some aspects of the fabrication process of screen-printed gold electrodes were 
investigated particularly ink compositions and curing techniques. It was found 
that the quality of the carbon ink affects the performance of the electrodes and 
that curing electrodes with conventional oven drying gave better performance to 
high throughput infra-red drying. Initially a plate based ELISA assay for CRP 
was developed before the assay was transferred onto screen-printed gold 
electrodes.  
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Antibodies were immobilised using passive adsorption and after optimisation of 
the screen-printed immunosensor, it managed to detect CRP with a limit of 
detection of 0.52 µg mL-1 with a linear range up to 20 µg mL-1 in spiked serum. 
This was within diagnostically relevant range. Comparison of the assay with a 
commercial alternative gave good correlation (R2 value of 0.99). A second 
immunosensor was developed for cardiac Troponin T (cTnT) using similar 
screen-printed gold electrodes. In this immunosensor, the use of self-
assembled monolayers (SAMs) was employed to assist in covalent 
immobilisation, orientation and preservation of the capture antibody. A method 
for depositing the 11-mercaptoundecanoic acid (11-MUA) SAMs on the gold 
working electrode without compromising functionality of the other electrodes 
was developed. It was found that the use of self-assembled monolayers 
increased the sensitivity of the assay enabling it to decrease the limit of 
detection on the immunosensor from 2.12 ng mL-1 (passive adsorption) to 1.14 
ng mL-1 (SAM assisted covalent immobilisation). It was also found that the use 
of SAMs enhanced the shelf life of the immobilised antibody compared to those 
passively adsorbed. 
The use of gold nanoparticles to amplify the immunosensor signal was explored 
.This further improved the sensitivity of the cTnT assay. The final 
immunosensor setup comprising the use of 11-MUA self-assembled 
monolayers and 60 nm conjugated gold nanoparticles enabled the detection of 
cTnT with a limit of detection of 0.51ng mL-1 in buffer and 0.58 ng mL-1 in 75% 
serum samples. This assay was benchmarked against a hospital analyser and a 
quartz crystal microbalance biosensor (QCM-1). It gave comparable results with 
correlation values of 0.99 and 0.95. The two developed immunosensors for 
CRP and cTnT can easily be integrated onto an electrochemical analyser to 
make a multi-marker electrochemical immunosensor for detecting 
cardiovascular diseases. 
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1 Introduction and Literature Review 
The origin of this thesis was to develop an electrochemical biosensor platform 
for the detection of cardiac makers that will aide in the diagnosis and or 
prognosis of cardiovascular disease. This chapter will explain the background of 
the project and the need for such a biosensor. It will then show the current 
methods used in detecting and diagnosing cardiovascular disease, the 
pathophysiology of cardiovascular disease and its link to the biomarkers 
associated with the disease. It will also list the current biomarkers that are used 
in the diagnosis of cardiovascular disease and the objectives of this thesis are 
then described. 
 
1.1 An Overview of Cardiovascular Disease  
1.1.1 Statistics  
The World Health Organization (W.H.O) lists cardio-vascular disease (CVD) as 
the premier cause of death globally accounting for more than 17.3 million 
deaths in 2008 which equates to 30 % of all deaths that year (W.H.O, 2011b). In 
the United Kingdom for every 1000 people, 11 are affected by some form of 
CVD which in turn is directly responsible for 200,000 deaths annually, slightly 
more than 1 in 3 deaths (W.H.O, 2011c). According to the British Heart 
Foundation (BHF) there are two main forms of CVD which are Coronary Heart 
Disease (CHD) and stroke. About half of all CVD deaths (48%) are from CHD 
and more than a quarter (28%) are from stroke (Allender et al., 2008a). CHD 
causes around 94,000 deaths in the UK each year (Allender et al., 2008b). 
Figure 1.1 shows the global distribution of the problem, although many 
advances have been made in the prevention, early detection and treatment of 
these diseases, they still remain the leading causes of death worldwide 
(Gerszten and Wang, 2008).  
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Figure 1.1: A map of the world showing numbers of deaths from coronary heart 
disease (W.H.O, 2011c) 
 
There are indications that these figures will keep on rising and by 2030 it is 
estimated that almost 23.6 million people will die from CVDs, mainly from heart 
disease and stroke (W.H.O, 2011b) Figure 1.2 shows the current global number 
of deaths due to different cardiovascular diseases and the incidence at different 
age groups. It is clear then that cardiovascular disease prevention is an 
important social and clinical issue, but it is also an economic one. The CVD cost 
the health care system in the UK £14.4 billion in 2006 (Allender et al., 2008a). 
 
Figure 1.2: Global number of deaths per year due to different types of 
cardiovascular diseases and their age distribution (Open University, 2010). 
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1.1.2 Types of Cardiovascular Disease 
Cardiovascular disease is an umbrella term that encompasses several medical 
disorders of the heart and blood vessels and includes coronary heart disease 
(CHD) which is a disease of the blood vessels supplying the heart muscle. It is 
the condition, which results when the heart's blood supply is blocked or 
interrupted by a build-up of fatty substances in the coronary arteries. The walls 
of the arteries can become clogged up with fatty deposits called atheroma in a 
process known as atherosclerosis (W.H.O, 2011b). Cerebrovascular Disease 
(CeVD) is also classified under cardiovascular diseases and it is a condition that 
affects the blood vessels supplying the brain. Unlike CHD that is caused mainly 
by atherosclerosis, it is hypertension in the case of CeVD. It damages the blood 
vessel lining including the endothelium and thus exposes the collagen inducing 
platelets to aggregate and initiate a repairing process that may be incomplete 
and sometimes have imperfections. In the long term the sustained hypertension 
may permanently change the structure of the blood vessels transforming them 
into stiffened, deformed, narrow, and uneven which in turn makes them more 
vulnerable to blood pressure fluctuations. Another cardiovascular disease is 
peripheral arterial disease, which is a disease of blood vessels supplying the 
arms and legs. Other cardiovascular conditions are rheumatic heart disease, 
which is caused by streptococcal bacteria damage to the heart valves and 
muscle through rheumatic fever, congenital heart disease caused by birth 
defects and malformations of heart. Deep vein thrombosis and pulmonary 
embolism are delocalised blood clots from the leg veins, which can dislodge 
and move to the heart and lungs. Heart failure is the ultimate result of most 
unattended cardiovascular diseases. Heart failure can be classified into two 
types. If heart failure occurs suddenly, it is known as acute heart failure. Chronic 
heart failure is when heart failure happens gradually over a long period. A 
summary of the different types of cardiovascular diseases and their origin is 
highlighted in Figure 1.3  
   Introduction and Literature Review 
 
5 
W.M.Fakanya-Cranfield University-PhD Thesis 
Figure 1.3: Different types of cardiovascular diseases and their origin (W.H.O, 
2011a). 
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1.1.3  General Symptoms and Risk Factors for Cardiovascular 
Disease 
The evaluation of risk factors for cardiac diseases is complicated and is different 
to that of some diseases with clear-cut causes like infections where a single 
common pathogen can manifest clinically observed symptoms. This is because 
cardiovascular diseases do not have clear cut risk factors (Huether and 
McCance, 2004). There is a complex interplay involved at molecular and 
cellular level in the development of atherosclerosis. There are two major 
categories of risk factors for CVD, which are those that can be avoided called 
modifiable risk factors and those that cannot be changed which are called non-
modifiable risk factors. It is important to highlight the fact that risk factors do not 
necessarily have a definitive causal role, but are justified by being statistically 
linked to CVD (Huether and McCance, 2004).Symptoms for coronary heart 
disease (CHD) are known to be both very noticeable and discrete. Several 
variations of CHD present different symptoms and clinical manifestations 
(Ahmed et al., 2007). 
 
1.1.4  Modifiable Risk Factors 
Cardiovascular disease is casually linked to the lifestyle of the individual and 
modifiable behaviours such as smoking, a sedentary lifestyle, a poor diet which 
are all strongly correlated to high incidence (Cotran R, 1999). In more 
developed and modernized economies the behaviour patterns are easily 
influenced by the growth of towns and cities. This has an effect of promoting a 
sedentary type of life as there is easy availability of transport. There have been 
significant levels of mechanisation and many processes are being done more 
efficiently with machines done instead of the traditional manual methods. 
People have more amenities and easy access to unhealthy diets, technology 
has made it possible to order fast food on the internet and have it delivered on 
the door step (Cotran et al., 1999). These factors coupled with lack of exercise 
are significant factors in the pandemic of obesity in the developed world, which 
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is linked to CVD. The World Health Organisation estimates that 60% of the 
world’s population is not sufficiently physically active.  
Although this trend is more prevalent in the developed world, CVD is also a 
major growing problem in the developing world (Murray and Lopez, 1997). In 
the developing world the ever improving medical treatment and increasing 
modernisation has resulted in less malnutrition and communicable disease and 
thus increasing the average life span (Murray and Lopez, 1997). This has made 
more people in the developing countries to be more likely to die of chronic 
degenerative diseases associated with older age (Yusuf et al., 2001). In 
developing countries, where increasingly Westernised lifestyles, jobs, smoking 
and unhealthy diets has brought about the emergence of cardiovascular 
disease as the major cause of morbidity and mortality after a lag period of one 
or two decades (Novak, 1998).  
 
1.1.5  Non-Modifiable Risk Factors 
Non-modifiable risk factors include age, family history, sex and ethnicity. There 
is a general misconception that the cardiovascular disease is a mature onset 
condition that only appears later in life. This is because statistics show more 
victims aged above 75 to be at risk of having more chances of an attack. Some 
authors argue that that there are strong chances that the condition could have 
started earlier in life taking decades to progress. According to Cotran (1999) 
with every decade in life there is a slightly more than a doubling in risk of 
developing complications like CVD. It is however difficult to define and 
distinguish the actual mechanism for this as old age is associated with a lot of 
conditions like diabetes and hypertension which are also risk factors for CVD 
(Ahmed et al., 2007). On average men are twice as likely to have an AMI when 
compared to age matched pre-menopausal women. However, post-menopausal 
AMI statistics rise sharply; this is attributed to the absence of endogenous 
oestrogen which is thought to have protective effect in pre-menopausal women 
(Gray, 2002a). 
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However, this advantage is not present in stroke patients. Menopause is 
associated with a progressive increase in total cholesterol, with, in particular, an 
increase in LDL and decrease in HDL. Total cholesterol levels peak in women 
aged between 55-65 years; a 10 years delay compared to the peak in men 
(Murray and Lopez, 1997). 
 
1.1.6 Chest Pain Symptoms for CVD 
There are two main types of chest pains; these can be classified as typical and 
atypical chest pains. Atypical chest pains are those that are often sharp and 
which come and go. They are normally felt on the left side of the chest, the 
abdominal area, back, or the arm. Atypical chest pains are more common in 
women (Ahmed et al., 2007). On the other hand typical chest pain usually feels 
heavy or like someone being squeezed. It is felt under the breastbone and the 
pain usually occurs with strong activity or emotion, and goes away with rest or a 
medication like nitroglycerin. Adults with typical chest pain have a higher risk of 
CHD than those with atypical chest pain (Gray, 2002a). Angina pectoris is a 
main symptom of coronary heart disease characterised by a painful heavy 
feeling in the centre of the chest that is capable of expanding to the stomach, 
back, jaw, neck and arms. Symptoms of stable angina are triggered at times of 
increased physical or emotional activity. However, in unstable angina, these 
symptoms can manifest at any time. For the less fortunate, the first signs of a 
heart disease may be a heart attack or myocardial infarction (Ahmed et al., 
2007). 
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1.1.7 Other Symptoms for CVD 
In patients suffering from coronary heart disease, it is common to experience 
irregular and unusually fast heart palpitations caused by unbalanced beating of 
the heart. The heartbeats can be observed to beat at an irregular rhythm, 
usually more rapid. Each heartbeat can also be felt to beat much harder and 
forcefully than normal. This symptom can last for several hours and reoccur 
over several days while the patient can also experience unusual 
breathlessness, dizziness or even chest pains (Gray, 2002b). It is also worth 
mentioning that heart palpitations may not necessarily be a direct consequence 
of coronary heart disease but also a variety of other conditions. Frequent 
fainting also indicates that there is an insufficient supply of oxygen to the brain 
and could be linked to the narrowing of blood vessels (Ahmed, 2007). Fluid 
retention is also known as oedema in medical terms and is another risk factor 
linked to cardiovascular disease and heart failure. Other symptoms of CHD can 
include: nausea, dizziness, excessive sweating, shortness of breath, fatigue 
with activity (exertion), and heart attack (Ahmed, 2007). Heart attacks and 
strokes are usually acute events, which means that they are usually severe and 
immediate action need to be taken upon onset of the symptoms to avoid 
fatalities. Atherosclerosis is the major factor in the development of most acute 
cardiovascular diseases like acute Myocardial Infarction (AMI) (Laing et al., 
1991).  
 
1.2 Pathophysiology of Cardiovascular Disease 
1.2.1 Atherosclerosis and Cardiovascular Disease 
Research into the pathogenesis of atherosclerosis has been fuelled by its link to 
cardiovascular diseases and the socioeconomic impact of CVDs. An 
understanding of the relationship between atherosclerosis and cardiovascular 
disease is essential to this project as diagnostic markers are usually embedded 
as part of the fabric that constitutes the pathophysiology of the diseases. It has 
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been discovered that the risk factors responsible for cardiovascular diseases 
trigger physiological changes that result in a chronic inflammatory condition of 
the tissue. This condition will then trigger a cascade of reactions and complex 
interactions between homeostatic molecules, responsible for innate and 
adaptive immunity resulting in a proatherogenic activity (Hanson, 2008). The 
presence of atherosclerotic lesions within the vasculature is virtually a pre-
requisite for most cardiovascular diseases. Advanced lesions within the 
coronary arteries can cause luminal occlusion leading to stable and unstable 
angina pectoris. Erosion or rupture of vulnerable lesions can lead to the 
atherothrombotic complications of myocardial infarction (MI): stroke, renal 
failure, heart failure, sudden death, and peripheral vascular disease (Hanson, 
2008). 
Atherosclerosis is a generalised process and there is evidence that it starts 
postnatal. Although patients may later present problems with arterial pathology, 
the disease is not localised, almost invariably everywhere, and it is the root 
cause of associated morbidity and mortality (Laing et al., 1991). The high 
prevalence of atherosclerosis in the developed or westernised population and 
its scattered distribution in the vasculature, has made it desirable to fully 
understand the cellular and molecular relationships involved in the development 
of atherosclerosis. This will help individuals at risk of progressing to a cardiac 
event to be identified to facilitate possible pathways of therapeutic intervention 
(Mackay et al., 2004). Traditionally atherosclerosis has been considered a lipid 
storage disease where lesion swelling and stenosis were thought to be the 
primary cause of ischaemic heart disease and stroke (Ross and Harker, 1976).  
This generalisation was proven to be inadequate in the late 1970s and historical 
and current evidence supports the role of plasma lipids for example cholesterol 
and triglycerides. Lipoproteins like low-density lipoprotein (LDL) and very low 
density lipoprotein (VLDL) in atherogenesis were subsequently considered to be 
early markers (Kannel et al., 1979; Martin et al., 1986). Although 
hyperlipidaemia has traditionally been attributed to be the major cause of the 
development of atherosclerosis, it has since been shown not to be the case as 
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the extent of atherosclerosis is not always proportional to sustained blood lipid 
concentration. In reality almost half of all coronary events occur in individuals 
without clinical hyperlipidaemia (Braunwald, 1997). Some studies have gone all 
the way to show that hyperlipidaemia is only weakly related to ischaemic stroke 
(Shahar et al., 2003). Attempts to develop an atherosclerotic lesion in vivo have 
proved to be complex, requiring persistent lipid presence, endothelial 
dysfunction and inflammation (Hanson, 2008). Inflammatory cells and cytokines 
are alleged to play a pivotal role in the development of the lesion and as such 
are a source of known and potential biomarkers for CVDs (Apple, 2007). 
 
1.2.2 Inflammation and Cardiovascular Disease 
The pathophysiology of inflammation is a minefield for potential biomarkers for 
cardiovascular disease. This is because of the direct relationship between 
inflammation and cardiovascular disease mentioned earlier (Apple, 2007). A 
cascade of events result in inflammation, according to Alderman et al (2002) the 
process starts with the vasculature being exposed to LDL cholesterol in severe 
hyperlipaemic plasma. Upon exposure, the LDL penetrates the endothelial cell 
layers into the intimae favouring areas of low shear stress. When conditions 
become favourable for oxidation for example in the presence reactive oxygen 
species (ROS) the LDL will transforms to oxidised LDL (oxLDL). This triggers 
the expression of leukocyte adhesion molecules (LAM) on the surface of arterial 
endothelial cells (Hansson, 2005). Endothelial cells located overlying nascent 
atheroma have been observed to particularly show an increase in the 
production of vascular cell adhesion molecules-1 (VCAM-1) (Li et al., 1993). 
The modified lipoprotein oxLDL has the ability to attach and bind to the 
endothelium resulting in endothelial activation (Cominacini et al., 2001). 
Activation of the endothelium begins the process of localised inflammation, 
allowing leukocyte extravasation through production of cell adhesions proteins 
like selectins and integrins. There is a rapid externalisation of some Weibel-
Palade bodies and these results in the endothelial surface to exhibit P-selectin 
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and E-selectin (Dong et al., 2000). These selectins then weakly attach to Lewis 
X-antigens on the surface of leukocytes, allowing loose interaction along the 
surface of the endothelial barrier. On the other hand endothelial expression of 
integrins such as vascular cellular adhesion molecule (VCAM-1) allows 
arresting adhesion of Mac-1 expressing monocytes, which can then extravagate 
into the tunica intimae underlying the endothelium (Piqueras et al., 2000). It has 
been proven in animal models of atherosclerosis that VCAM-1 is expressed in 
large quantities by endothelial as part of the initial vascular response to 
cholesterol accumulation (Cybulsky and Gimbrone, 1991).  
 
1.2.3 Endothelial dysfunction  
Endothelial dysfunction can be defined as ‘a profound imbalance in the relative 
quantities of other vasoactive compounds such as angiotensin II and oxidants 
or a significant loss of ability of the endothelium to release the vasorelaxing 
compound nitric oxide (Verma and Anderson, 2002). It causes inappropriate 
vasomotor constriction of the vasculature resulting in aggravated luminal 
occlusions particularly from established atherosclerotic lesions. In most models 
of atherosclerotic development the significant loss of nitric oxide production by 
the endothelium is an important aspect of the development of pathophysiology 
of inflammation and other molecular processes in the vasculature (Szmitko et 
al., 2003). The nitric oxide is also linked to the production of an anti-thrombotic 
atmosphere through restricting the aggregation of platelets on the endothelium. 
It also prevents leukocyte sticking together with the endothelium through 
suppressing expression of adhesion molecules as well as maintaining vascular 
smooth muscle in a non-proliferative state (Gauthier et al., 1995). According to 
Ross (1999), there is a sensitive environment which is balanced in a vascular 
system and any changes to this environment can trigger endothelial activation. 
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1.2.4 Growth and Development of an Atherosclerotic Lesion 
The growth of an atherosclerotic lesion has been attributed to the chain reaction 
effect of processes stimulated in the initiation stage described earlier. 
Components of the inflammatory response like the interleukin 18 (IL-18) are 
known to play a pivotal role. They have the ability of IL- 18 to interact with IL-12 
and stimulate interferon-gamma (IFN-). The combination of these processes 
can motivate macrophage activation and present an opportunity for rapid cell 
death. This results in the creation of the necrotic core in advanced lesions 
(Ross, 1999). The growth of the plaque continues as long as the environment 
allows it and arterial dilation in some cases will be stretched until it reaches 
maximum capacity. The plaque then starts to intrude into the lumen, making it 
continuously narrower and this can causes an obstruction in the blood flow 
which in turn may reduce the production of nitric oxide in the endothelium 
(Ross, 1999). This consequence will create a positive feedback action as nitric 
oxide possesses anti-inflammatory properties through its ability to decrease 
cytokine-induced endothelial activation (Decaterina et al., 1995). The growth of 
the lesion and the low levels of nitric oxide build up stress on the arterial walls 
resulting in smooth muscle cells to produce proteoglycans. These 
proteoglycans are responsible for attracting and retaining more LDL molecules 
thus refueling the cycle and making the lesion grow bigger and bigger as 
illustrated in Figure 1.4 (Decaterina et al., 1995). 
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Figure 1.4: Different stages of atherosclerosis (Ellertsen, 2011).  
 
1.2.5 Plaque Rupture 
It is important to understanding the underlying mechanisms of plaque rupture 
because it is the major clinical implication of atherosclerosis and is the most 
common precursor to cardiovascular accidents and acute myocardial infarctions 
(Thim et al., 2008). Plaques which are prone to rupture have been identified to 
be generally consisting of thin fibrous caps and large necrotic lipid rich centres. 
The rupture can only occur when the thinned fibrous cap can no longer 
withstand the intensity of the force placed on it by the athermanous material 
behind. This causes the thrombogenic material to be released into the arterial 
lumen causing atherothrombosis because of the fact that the plaques usually 
accumulate in regions of non-laminar flow, some hemodynamic factors will put 
mechanical stress on the plaque thus providing a mechanism for erosion of the 
endothelial layer and increase the probability to rupture. The lack of fibrous 
material in the necrotic core also means that stress is focused only across the 
fibrous cap increasing its liability to rupture (Fernandez-Ortiz et al., 1995). 
It is important to point out that atherothrombosis does not always lead to an 
acute myocardial infarction. Sometimes the thrombus is too small and acts to 
plug and repair the rupture in process called superimposed thrombosis (Lee et 
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al., 2001). However, the implications of superimposed thrombosis are very 
serious as the new thrombus on the plaque has a tendency to encourage 
platelet adhesion and the thrombus can grow into the lumen causing stenosis. 
To add to this the plaque is also very vulnerable to subsequent ruptures as the 
cap has a very heterogeneous composition and is significantly weakened by 
previous ruptures (Thim et al., 2008). Some other processes can be responsible 
for plaque rupture for example hemorrhages in high pressured vessels may 
result in plaque contained hematoma capable of exerting pressure on the cap 
and causing a large plaque rupture (Cotran et al., 1999). Another way which 
can lead to rupture is when arteries calcify making them brittle and developing 
small fissures which grow resulting in plaque rupture or aneurysm (Gray, 
2002b). The events of plaque rupture and subsequent thrombosis have been 
found to be the main cause of up to 50% of ACS and myocardial infarction 
cases (Schroeder and Falk, 1996).  
 
1.3 Biomarkers for Cardiovascular Diseases 
1.3.1 General Introduction 
Developments in the identification of biomarkers that can identify individuals 
most at risk of cardiovascular diseases have been reported, they are mainly 
associated with inflammation or damage to cardiac tissues (Jaffe et al., 2006; 
Apple, 2007; McDonnell et al., 2009). These include established markers that 
are used to aid in the diagnostics of cardiovascular diseases like Creatine-
kinase MB (CK-MB), Myoglobin, Troponin I, and T and other novel markers 
which are still being investigated like, C reactive protein (CRP), B-type 
natriuretic peptide (BNP), and many others which will be discussed in detail 
later in this Chapter,(Babuin L, 2005; Jaffe et al., 2006; Apple, 2007; da Silva 
and Moresco, 2011). Although these biomarkers provide important clinical 
information about a patient’s condition and can aid in the prognosis, there are 
still some limitations in their use (Szmitko et al., 2003; Anderson, 2005). They 
do not always give adequate information and they lack on providing insight on 
   Introduction and Literature Review 
 
16 
W.M.Fakanya-Cranfield University-PhD Thesis 
location of the atherosclerotic plaque, its composition, and its liability to rupture 
and develop other major heart complications (Melanson and Tanasijevic, 2005; 
Jaffe et al., 2006). They also work better as a panel of several biomarkers so 
that they can complement each other in aiding diagnosis (Apple, 2007). These 
limitations, however, are far outweighed by the benefits as biomarkers make it 
possible for faster and more accurate diagnosis to be carried out at Point of 
care without the need for highly skilled personnel unlike the conventional ECG 
and other laboratory-based tests (McDonnell et al., 2009; da Silva and Moresco, 
2011). 
 
1.3.2 Properties of an Effective Cardiac Biomarker 
A cardiac marker is a biological analyte that is detectable in elevated levels in 
the blood upon the onset or progression of CVD including myocardial damage 
(Azzazy, 2002). It is important that an ideal cardiac marker exhibit several 
crucial characteristics due to the high risks of misdiagnosis that may result in 
fatalities. These desirable characteristics include: high clinical sensitivity and 
specificity, quick release for early diagnosis, suitable diagnostic window, ability 
to be assayed quantitatively, reasonable costs, and time-efficiency (Panteghini, 
2004). It is necessary to have these factors to aid in diagnosis, prognosis, 
monitoring, and risk stratification as well as guiding therapeutic decision of 
suspected cardiovascular diseases patients (Azzazy, 2002). There is currently 
no single cardiac marker on the market which has managed to deliver all the 
characteristics mentioned above (Braunwald, 2008), thus there are strong 
recommendations for a multi marker approach when diagnosing cardiovascular 
disease using biomarkers. Table 1.1 shows some of the biomarkers used in 
combination with each other to diagnose cardiovascular disease. This section 
will introduce some of these typical cardiac markers that are currently used and 
their clinical applications in diagnosing CVD. 
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Table 1-1 Classifications of biomarkers for the detection of cardiovascular 
diseases (Braunwald, 2008). 
Cardiovascular biomarker 
classification group Selected example 
Inflammation CRP, TNF-α 
Oxidative stress Oxidised LDL, Myeloperoxidase 
Extracellular matrix remodellers MMP, TIMP 
Neurohormones Renin, Angiotensin, Arginin 
vasopressin 
Myocyte Injury cTnT, cTnI, CK-MB, Myogloin 
Myocite stress Natriuretic peptides ANP, CNP and BNP 
Potential new markers Copeptin, Grwoth differentiation factor-15 
KEY (CRP): C-reactive protein,(TNF-α):tumor necrosis factor alpha, (LDL): low 
density lipoproteins,.(ANP): atrial natriuretic peptide, (BNP): brain natriuretic 
peptide ,(CNP): C-type natriuretic peptide, (MMP): metalloprotinaise,(TIMP): 
tissue inhibitors of matrix metalloproteinases 
 
As highlighted in Table 1.1 there are wide arrays of biomarkers that can be 
used in the diagnosis and monitoring of specific antecedents to cardiovascular 
diseases. Although these markers can be incorporated onto in vitro diagnostic 
tests in most central laboratories, there is a selected few that are dominant in 
the point of care setting POC that this project is aligned to. Novel markers 
constantly under investigation may end up playing an integral part in the future 
diagnosis of CVDs. However the current position requires in vitro diagnosis be 
carried out using the analysis of established markers that are discussed below. 
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1.3.3 Biomarkers for Inflammation 
The first class consists of biomarkers for general inflammation. Even though 
they lack specificity. This class has biomarkers that can act as independent 
predictors of adverse outcomes and identify asymptomatic patients with CVDs 
(Braunwald, 2008). C-reactive protein (CRP) which is one of the most 
established markers for CVD and general inflammation is part of this group. 
Figure 1.5  shows the structure of CRP with the chemical composition. 
 
 
Figure 1.5: Structure of CRP fragment and the chemical structue (Science 
Photo Library, 2012) 
 
It was first discovered by Tillett and Francis (1930) and was the first acute-
phase protein to be described. It is an exquisitely sensitive systemic marker of 
inflammation and tissue damage (Zhang et al., 1999; Pepys and Hirschfield, 
2003). Although it is considered a non-specific biomarker, its level rises steeply 
sometimes 1000 times over the  base line, as a result of tissue damage caused 
by infections and other acute inflammatory events including autoimmune 
diseases and malignancy, hence monitoring is considered very useful for 
screening and also disease management (McBride, 2008). 
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CRP has evolved from being a postulated marker that can possibly predict 
cardiovascular events and mortality to a proven direct partaker in the 
pathogenesis of atherosclerotic cardiovascular disease (Bisoendial et al., 2010; 
Nagai et al., 2011). Figure 1.6 shows how CRP is involved in several 
atherosclerotic stages. 
 
 
Figure 1.6: CRP as a risk factor for cardiovascular disease through several 
stages of atherogensis (Bisoendial et al., 2010). 
 
Research developments in this arena have proved that CRP is instrumental in 
the initiation of several pathogenic pathways which can cause atherosclerosis a 
precursor to cardiovascular disease (Sattler et al., 2005; Sun et al., 2005; 
Scirica, 2009), although some are still not convinced of its pathogenic role 
(Anand and Yusuf, 2010). Figure 1.7 shows the pathophysiology which results 
in the production of several proteins that can be used as potential biomarkers 
for cardiovascular diseases. 
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Figure 1.7: Summary of pathophysiology of cardiovascular diseases and 
potential cardiac markers including CRP (Apple et al, 2005). 
 
Several researchers have used CRP as a general marker for inflammation and 
later for predicting cardiovascular diseases (Anand et al., 2005; Schulz and 
Heusch, 2011). CRP is also significantly associated with the risk of stroke after 
cardiac surgery and may be involved in the inflammatory processes in post-
cardiac surgery stroke (Grocott et al., 2005). In vitro experiments with human 
aortic endothelial cells have shown that increased levels of CRP levels have an 
implication for atherothrombosis due to the generation of pro inflammatory 
cytokines and consequently the decrease of the TPA activity (Pepys and 
Hirschfield, 2003; Miller et al., 2005). Table 1-2, shows the characteristics of 
CRP protein and how it can be used as a marker for predicting the risk of a 
cardiovascular event. The cut off parameters for defining the level of potential 
risk are also highlighted. The overall concentration of CRP measured in the 
plasma varies from person to person, with the age and with lifestyle, for 
instance diet, alcohol consumption, smoking and physical activity. The levels of 
CRP are also influenced by several diseases, such as diabetes. 
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Table 1-2: The significant parameters of CRP as a Cardiac marker (Lemos, 
2004). 
Parameter CRP Specifications 
Clinical reference range 
‹ 1 mg L-1 low 
1-3 mg L-1 intermediate 
› 3 mg L-1 high relative risk 
Diurnal variation No 
Correlation of levels over time R=0.6 
Fasting sample required No 
Commercially available assay Yes 
Assay standardized Partially 
Half life 19 hours 
 
In healthy young adult volunteer blood donors, the median concentration of 
CRP is 0.8 mg L-1, the 90th percentile is 3 mg L-1, and the 99th percentile is 10 
mg L-1, but, following an acute-phase stimulus, values may increase from less 
than 50 µg L-1 to more than 500 mg L-1, that is, 10000 fold. De novo hepatic 
synthesis starts very rapidly after a single stimulus, serum concentrations rising 
above 5 mg L-1 by about 6 hours and peaking around 48 hours (Rifai, 2001; 
Pepys and Hirschfield, 2003). Because of the fact that CRP is an acute phase 
reactant, it is highly associated with cytokines that are involved in the 
development of the immune response (Rifai, 2001). Among these cytokines are 
interleukin-6 and tumour necrosis factor-α which subsequently belong in the 
same class. These will not be mentioned in detail, as their role in cardiovascular 
events is less significant than that of CRP. 
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1.3.4  Early Biomarkers for Mycosite Injury 
This category is the host of the most widely used biomarkers for the diagnosis 
of cardiovascular diseases. This is because of the sensitivity that the 
biomarkers in this group possess in flagging myocardial damage. Some of the 
pioneering biomarkers for CVD are part of in this group namely myoglobin and 
creatine kinase MB fraction (Braunwald, 2008; Hochholzer, 2010b). Myoglobin 
was the first non-enzymatic protein used for diagnosis of acute myocardial 
infarction and it was first used in the 1970s (Storrow and Gibler, 1999). A small 
molecule is quickly released into circulation as early as 2 h after the onset of 
symptoms of myocardial infarction. It has been found to have high sensitivity 
and high negative predictive value that makes it a valuable early screening test 
for myocardial infarction (Brogan et al., 1994). It peaks at 6-8 hours before 
returning to normal in 20-36 hrs after myocardial infarction. The major limitation 
which myoglobin carries is its low clinical specificity. This is because of its 
abundant presence in not only in myocardial but also in skeletal muscle cells. 
Injury in skeletal muscle as well as renal failure may also trigger an elevation in 
the plasma concentration of myoglobin thus lowering its clinical specificity 
(Storrow and Gibler, 1999). 
 
The Creatine Kinase enzyme has three known isoforms and these are found in 
different locations including heart muscle (CK-MB), skeletal muscle (CK-MM), 
and brain (CK-BB). Creatine kinase is increased in over 90% of myocardial 
infarctions (Christenson, 1998). Among the three isoenzyme forms of creatine 
kinase, CK-MB is highly sensitive in diagnosis of acute myocardial infarction 
and had been previously regarded as the “gold standard” in the 1980s until 
about 1995 (Christenson, 1998). The diagnostic specificity of CK-MB is limited 
because CK-MB is also present in skeletal muscle just like myoglobin. This 
means that it may increase during muscle trauma, physical exertion, 
postoperatively, convulsions, delirium tremens, and other conditions. Another 
limitation is that once the CK-MB is released into the blood stream it doubles its 
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concentration within 5–6h after the onset of chest pain and peaks in 12–24h 
(Males et al., 2001). This gives a narrow time window that makes it difficult for 
CK-MB to be used as an early marker. However it is possible to use CK-MB 
assays for the diagnosis of persistent or re-infarctions (Panteghini et al., 1998). 
It is because of this reason that CK-MB is so clinically useful in multi-marker 
panels. 
 
1.3.5 Cardiac Troponins 
These are relatively recently discovered biomarkers of myocyte injury 
(Braunwald, 2008). Cardiac Troponin T and I are cardiac isoforms of contractile 
proteins of the myofibril. They are very specific for cardiac injury and are not 
present in serum from healthy people. Due to their great sensitivity and 
specificity for myocardial cell damage, cardiac troponins (cTnI and cTnT) have 
been considered as the “gold standard” for AMI diagnosis (Alpert et al., 2000; 
Babuin, 2005). Figure 1.8 shows the different sub units that make the troponin 
complex and how they interact with actin and myosin. They are released in 2–4 
hours and remains in circulation for up to 8-10 days after the onset of the event. 
Current guidelines from the American College of Cardiology Committee state 
that cardiac troponins are the preferred markers for detecting myocardial cell 
injury. There is a striking resemblance in the kinetics of the cardiac Troponin 
and the CK-MB. They are both released early following AMI and like CK-MB it 
take several hours for both of troponins to be released into circulation before 
being detectable, hence both cardiac Troponins cannot be used as early 
markers. 
 
According to Jeremias (2005), the specificity of troponins for ACS is 
questionable because of other clinical situations like sepsis, hypervolemia and 
renal failure which may also cause an increase in Troponin levels. Despite 
these limitations Troponins are currently the most cardiac-specific markers with 
an added advantage of offering the widest temporal diagnostic window as they 
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remain abnormal for 4–10 days after the onset of AMI (Martins et al., 1996). 
Another advantage is that the peak concentration of the Troponin closely 
correlated with the infarct size that makes it a more quantitative diagnostic tool 
(Licka et al., 2002). Troponin is released during MI from the cytosolic pool of the 
myocytes. The degradation of actin and myosin filaments is responsible for 
prolonging the subsequent release. There are several conditions that are 
diagnosed with troponins and these include acute infarction, severe pulmonary 
embolism causing acute right heart overload, heart failure, and myocarditis 
(Christenson, 1998). 
 
 
Figure 1.8: The schematic diagram showing the interaction of cardiac 
Troponins with actin and myosin (Brighthub, 2009). 
 
The general cut off values for troponins was debatable until the National 
Academy of Clinical Biochemistry guidelines and measurement platforms 
stepped in with some recommended standards cardiac Troponin T values below 
0.05 ng mL-1 are indicative of negative TnT, and those values between 0.05 to < 
0.1 ng mL-1 indicates low TnT. However those values that lie between 0.1 and 
2.0 ng mL-1 indicate myocardial damage and values > 2.0 ng mL-1 indicate 
massive myocardial damage (Christenson, 1998). 
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1.3.6 Other Biomarkers  
Another source of cardiac biomarkers is the process of myocyte stress that is 
responsible for production of biomarkers like the natriuretic peptides. These can 
be narrowed down to three major peptides which are, Atrial natriuretic peptide 
(ANP), brain natriuretic peptide (BNP) ,and C-type natriuretic peptide CNP 
(Braunwald, 2008). ANP is prevalent in the atria whereas BNP is produced in 
the ventricles as a counteraction to stress. However, C-type natriuretic peptide 
CNP is derived primarily from endothelial cells and is rarely associated with 
CVD diagnosis (Iwanaga, 2010). The natriuretic peptides provide a linear 
relationship between diagnosis and mortality that can be adopted in the field of 
theranostics. The limitation is that the stability of these markers is poor stability 
in serum. This problem is, however, being overcome through the use of 
enzymatically digested regions originating from their precursor proteins that are 
more stable (Emdin, 2011). The process of oxidative stress is another minefield 
for potential biomarkers that can be used for the detection of cardiovascular 
diseases. Biomarkers like oxidised LDL and myeloperoxidase belong to this 
group. Myeloperoxidase has a stimulating effect on the formation of foam cells 
and atherosclerotic plaque formation as is an enzyme that helps in the oxidation 
of lipids (Hochholzer, 2010b). These markers however lack specificity and there 
are no direct measurement assay that can quantify them accurately (Braunwald, 
2008). 
 
1.3.7 New Biomarkers 
There is a need to discover and develop new biomarkers for diagnosis and 
management of acute myocardial infarction for three principal reasons which 
are to achieve early diagnosis, better prognosis and risk stratification (Jaffe et 
al., 2006). According to Wu (2005) two approaches can be used for the search 
for novel biomarkers which are the pathophysiology and the use of proteomics. 
The study of the pathophysiology as mention earlier can play a pivotal role in 
the discovery and development of new biomarkers. The diagram in Figure 1.7 
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shows potential markers in each stage of the pathophysiology of acute 
myocardial infarction. A good example for the use of proteomics in biomarker 
discovery is the discovery of  choline as a promising marker for ACS through 
evaluation of the NMR spectroscopy of human blood plasma (Jaffe et al., 2006). 
The current biomarkers used in the diagnosis of acute myocardial infarction are 
mostly indicators of necrosis. 
 
It is important to discover and utilise information from other markers that reflect 
earlier components of the physiopathology chain (Panteghini, 2004; Jaffe et al., 
2006). Investigations managed by Jaffe et al (2006) and Braunwald (2008) give 
overviews of some future cardiac biomarkers that may have potential to identify 
the patients at risk. Braunwald (2008) identified key prospects in markers like 
myeloperoxidase, metalloproteinase-9, soluble CD40 ligand, pregnancy-
associated plasma protein A, choline, ischemia-modified albumin, unbound free 
fatty acids, glycogen phosphorylase isoenzyme BB, and placental growth factor. 
He acknowledged them as having demonstrated promise and need to be more 
thoroughly evaluated for commercial development for implementation into 
routine clinical and laboratory practice. Some of these markers have since been 
dismissed as too general to be used for cardiovascular disease diagnosis. 
Prospective biomarkers are constantly being investigated and the recent 
developments have brought about several prospective markers although these 
are still being debated on and their potential being truly evaluated.  
 
Growth differentiation factor 15 (GDF-15) is one of the rising stars in the 
potential cardiac biomarker hunt. GDF-15 is a growth factor β cytokine (Kempf, 
2007). It was originally used to predict miscarriage in pregnancy because of  its 
high concentrations in the placental tissue (Tong, 2004). However discovered 
that increased levels of GDF-15 can also be found in activated macrophages to 
counteract pathological or environmental stress (Brown, 2002; Kempf, 2007). 
Another study conducted by Kempf et al. (2009)  identified the best risk 
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stratification strategies, found that there was synergy when GDF-15 was 
combined with BNP as the result improved the identification of high-risk patients 
compared with the individual markers. 
 
Another potential marker that was recently identified is copeptin; a non-
functional protein which is located on the same precursor as arginine 
vasopressin (Hochholzer, 2010a) Increased levels of arginine vasopressin have 
been correlated with risk of CVD, and the same has been done for copeptin 
which shares the same precursor with it. Copeptin was shown to be able to 
predict adverse outcome especially when it was used in combination with the 
amino-terminal of the BNP precursor (Khan, 2007 ). Another fantastic attribute 
is that it has been proven to be able to distinguish patients with an acute 
myocardial infarction from those with other causes of chest pain (Reichlin, 
2009). Unlike arginine vasopressin which is stable in serum the copeptine is 
vulnerable with a short half-life and a great affinity for binding to other proteins, 
which makes it difficult to measure (Stoiser, 2006). 
 
1.4 Current Methods for diagnosis of CVDs 
1.4.1 Background  
 
There is no standard way in which CVD is diagnosed; this is in part due to the 
disease being clinically silent until serious complications occur (Grainger, 2006). 
The current diagnosis of CVD is dominated by either expensive imaging 
techniques or risky invasive techniques. Sophisticated imaging techniques like 
the magnetic resonance imaging (MRI) or ultrafast computerized tomography 
(CT) require expensive equipment and highly skilled staff. The same problem 
applies to invasive techniques such as coronary or cerebrovascular 
angiography (Apple, 2007). The invasive procedures are known to have 
associated risks making them not ideal for mass screening. Some affordable, 
user friendly and less invasive diagnostic approaches have been developed as 
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alternatives but these come with their own limitations. A more clinical diagnostic 
approach is presented by scoring methods like the Framingham study or the 
Prospective Cardiovascular Münster Study (PROCAM) which considers several 
simple risk factors and classical symptoms of myocardial ischemia. The 
combinations of several obtained risk factors is believed to create a synergy 
and thus give better predictive power but a huge number of patients at high risk 
go undetected (Grainger, 2006).  
 
Current protocol stipulates medical professionals to focus their resources on all 
people with chest pains reporting at emergency department as having a 
potential AMI (Apple, 2007). This strains on the precious resources, and can 
lead to situations where patients with a milder CVD like angina are 
unnecessarily admitted and tested for possible heart attack. For this reason 
much recent research has focused on identifying individuals most at risk of 
primary cardiovascular events at the point of care (McDonnell et al., 2009). This 
makes it quick to administer effective prophylaxis, such as aspirin, beta blockers 
and statins, as well as give appropriate advice on lifestyle choices on an 
outpatient basis, and has the advantages of freeing up hospital beds and 
admitting only patients with a high probability of having an imminent AMI (Apple, 
2007; da Silva and Moresco, 2011). This section will look at some of the 
currently used diagnostic techniques for Cardiovascular Diseases. It will 
highlight the advantages and challenges associated with the current methods 
and will then give examples and discuss the need for the shift to point of care 
methods. 
 
1.4.2  Electrocardiography  
It the most commonly used diagnostic apparatus for cardiovascular diseases, 
as it is affordable and widely available. It is based on the electrical changes that 
occur temporally as the heart completes its usual cycle. These changes can be 
monitored in healthy sate and vary when compared to those in certain disease 
states (Breathnach and Westphal, 2006). There are two major tests that are 
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done using the electrocarduim which are the resting and the exercise testing. 
Resting testing is commonly used to rule out rather than rule in CHD as it has 
relatively low sensitivity (Gray H, 2002). The exercise testing is also known as 
the stress testing is performed under conditions that aim to exasperate stenosis. 
Patients will usually perform the ECG under pharmacologically induced stress 
or a treadmill. This procedure is important in the diagnosis of Angina (Gray H, 
2002). Exercise tests are usually performed following an indicative resting ECG 
or to aid risk assessment and disease state following AMI to allow the clinician 
to tailor rehabilitation and management for the individual patients. The clinician 
will monitor the patient’s condition not only by examining the graphical data as 
shown in Figure 1.9 but by observation of the patient’s physical condition 
(Breathnach and Westphal, 2006). 
 
 
Figure 1.9: The electrocardiogram at different heart activity (Muskopf, 2012). 
   Introduction and Literature Review 
 
30 
W.M.Fakanya-Cranfield University-PhD Thesis 
1.4.3 Imaging Techniques 
Magnetic resonance imaging MRI is an imagining technique that has significant 
benefits in the diagnosis of CVD as it is capable of providing information on 
plaque composition. According to Adame et al (2006) there are many 
applications of MRI in CVD diagnosis, contrast-enhanced magnetic resonance 
angiography (CE-MRA) uses materials such as gadolinium which has desirable 
magnetic properties to give greater contrast to vasculature clearly denoting 
stenosis. Another MRI technique such as vessel wall MRI (VW-MRI) which can 
be used to detect vascular remodeling has proven to be an excellent diagnostic 
tool (Adame et al., 2006). MRI can also give insight into the pathological state of 
an atheromatous plaque as well as elements of composition and thickness of 
the fibrous cap thus it can be used to more definitively identify patients at high 
risk of AMI or CVA (Cai et al., 2005). The major drawback of MRI is the cost. It 
is not suitable for patients with metallic stents or pacemakers as it utilizes a 
strong magnet (Adame et al., 2006). 
 
Computed tomography also commonly known as a CT scan is routinely used in 
the diagnosis of cardiovascular diseases. It combines multiple X-ray images 
obtained from a ring of rotating x rays with the aid of a computer to produce 
cross-sectional views of the body. Cardiac CT is a heart-imaging test that uses 
CT technology to visualize the heart anatomy, coronary circulation, and great 
vessels (Heuser, 1999; Cai et al., 2005). Figure 1.10 shows a CT angiograph of 
the heart taken from the back of the muscle.  
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Figure 1.10: Angiogram showing a blocked coronary artery left and unblocked 
after surgery right (Heuser, 1999). 
 
The quality of the results obtained is similar to those of the MRI. A modified 
variation of Ct, which is becoming more popular with the diagnosis of 
cardiovascular diseases is the Ultra-Fast Computer Tomography (UFCT), also 
called the electron beam CT. It varies from conventional CT scans because it 
does not have a rotating x-ray assembly; it has a ring of fixed crystal detectors 
and another fixed ring of tungsten x-ray targets, which act together (Thim et al., 
2008). A major disadvantage of the CT scan to its rival the MRI is that it uses X 
rays which have long been associated with cancer a schematic diagram for the 
components of such a device are shown in Figure 1.11. 
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Figure 1.11: Schematic diagram of the CT scan showing its major components 
(Thim et al., 2008). 
 
1.4.4 Immuno Techniques 
The analysis of cardiovascular markers can be carried out using immunology 
based methods like immunoassays. These utilise the specificity of immuno 
reactive components mostly antibodies, in binding to a specific pathogen, to 
qualitatively and quantitatively confirm the presence or absence of the antigen. 
The most common immuno assay is the enzyme-linked immuno sorbent assays 
(ELISAs). The enzyme linked immunosorbent assay (ELISA) is a method for 
detecting and quantifying a specific protein in a complex mixture. It was 
originally described by Engvall and Perlman (1971). In this method, the 
visualisation of the target antigen is realised through a colour-generating 
enzyme, covalently linked to a specific antibody. The colour formation is 
proportional to the concentration and can be used for quantification by 
analysing the absorbance. The ELISA method was made possible because of 
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scientific advances in a number of related fields, including the production of 
antigen-specific monoclonal antibodies by Kohler and Milstein (1976), and the 
ability to chemically link antibodies to biological enzymes whose activities can 
be measured as a signal (Avrameas, 1969). Besides the ELISA, there are 
several other immuno assays formats that were developed earlier including 
radioimmunoassay which use antibodies labelled with radioisotopes. It was first 
used before alternatives were sought because of health risks associated with 
radiation. Several variations have been made to the original ELISA with most 
changes being made on the method of transduction. A general term ‘immuno 
assays’ is more universally accepted. 
 
Focus will be placed on ELISA as the immunosensors developed in this work 
are based on the modification of the transduction of a sandwich ELISA. It is 
important to understand the structure and function of antibodies as they play a 
major role in immuno assays. Antibodies are produced by B-cells as part of the 
immune response system that identify and neutralise foreign objects such as 
bacteria and viruses known collectively as pathogen. The antibody recognises a 
unique part of the pathogen. Antibodies have been used as recognition 
elements in immunoassay and subsequently immunosensor development 
because of their high affinity, high specificity, versatility and commercial 
availability (Ricci, 2007). Antibodies derived from separate cell lines that 
recognise various regions on the immunogen are termed as polyclonal 
antibodies, and those derived from single cell line are monoclonal antibodies. 
There are five major classes of antibodies, which are, IgG, IgD, IgE, IgA, and 
IgM. Of all these the IgG is the most abundant class in serum has been used in 
immunoassay development for half a century. Figure 1.12 show the IgG 
antibody structure that consist of four polypeptide chains - two gamma, γ heavy 
chains and two kappa, κ chains connected by disulphide bonds. 
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Figure 1.12: Schematic diagram of the immunoglobulin structure (Invitrogen, 
2012). 
 
There are four main types of Immuno assay protocols for the detection of 
proteins: direct, indirect, competitive, and “sandwich” Immuno assays. The 
basic principles for the assays are similar and they include, the capture of the 
protein of interest, blocking of non-reacted surface, and recognition of the 
protein (Kemeny and Chantler, 1989). Direct Immuno assay is the simplest form 
of protein detection. It involves immobilising the protein of interest to the surface 
this is followed by a washing step and drying and blocking before a specific 
labelled antibody for the protein is added for detection. Figure 1.13 shows an 
illustration of a direct immuno assay. 
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Figure 1.13: Diagram showing direct immunoassay set up (AMRITA, 2012). 
 
The other format called indirect immuno assay has the ability to improve the 
sensitivity of the detection in this method the protein of interest is bound to a 
specific antibody after immobilisation onto the surface. A labelled secondary 
antibody against this primary antibody is then incubated for detection purposes 
as shown in Figure 1.14. It is important that the secondary antibody be raised in 
another species than the primary antibody to avoid non-specific binding 
(Kemeny and Chantler, 1989). 
 
Figure 1.14: Diagram showing indirect immunoassay set up (AMRITA, 2012). 
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By far the most common type of immuno assay detection is achieved by 
applying two specific antibodies for the protein in a “sandwich” format immuno 
assay. Antibody-sandwich immuno assays may be the most useful of the 
immuno-sorbent assays for detecting antigen because they are frequently 
between 2 and 5 times more sensitive than those in which antigen is directly 
bound to the solid phase (Law, 1996). An illustration of the sandwich assay is 
shown in Figure 1.15. The antigen being investigated is actually “sandwiched” 
between two antibodies which are the coated antibody immobilised on a surface 
and the detection antibody which is usually conjugated to a marker that can 
cause a quantifiable response which is proportional to its concentration 
(Kemeny and Chantler, 1989). 
 
 
Figure 1.15: Diagram showing indirect  sandwich immunoassay set up 
(AMRITA, 2012). 
 
This assay format will be used in this work since the biomarkers to be detected 
have a molecular weight suitable for a sandwich assay format. Another type of 
immunoassays called competitive immunoassays, which is used for detecting 
very small molecules is not covered in this work since it is not relevant in 
detecting large molecule antigens. 
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1.5 Biosensors 
1.5.1 Introduction to biosensors 
A key area that can be improved in cardiovascular biomarker research is the 
use of new and novel sensors to detect the established biomarkers. There have 
been several developments in the field of biosensors and several formats are 
shown to be capable of detecting and quantifying cardiac markers (Jaffe et al., 
2006). One of the first descriptions of a device with bio sensing capabilities was 
described in 1962. The device utilized the enzyme glucose oxidase coupled to 
an oxygen sensor to determine the concentration of glucose in the samples 
from patients during and after surgery (Clark and Lyons, 1962). A biosensor can 
be defined as a device which converts chemical information into a quantifiable 
electrical signal (Turner et al., 1987). It is an analytical device that is made up of 
a biological material such as microorganisms, tissue, enzymes, antibodies or 
biologically derived material that acts as the recognition molecules. These have 
to be utilised in conjunction with or attached to a transducer that can give an 
electronic signal proportional to the concentration of a specific analyte or group 
of analytes (Tothill and Turner, 1998).  
The recognition of the specific analytes can be a binding process, for instance 
involving an antibody in case of affinity based biosensors or an enzymatic, bio 
catalytic reaction (Thevenot et al., 2001; D'Orazio, 2003). The signal can be an 
end-point measurements or continuous but this is easily configured depending 
on the regulatory and market requirements. The advances in technology and 
the high expectation from the market especially for miniaturised, cost effective 
and environmentally friendly has resulted in biosensors becoming relevant in a 
wide range of analysis. The analytical capabilities of biosensors have been 
improved as faster microprocessors are constantly being developed (Newman 
and Turner, 1994). Figure 1.16 shows a schematic diagram for a biosensor. 
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Figure 1.16: Schematic diagram showing components of a biosensor (Solanki, 
2011). 
 
The classification of biosensors is usually according to the type of transducer 
thus there are categorized into electric, radiant or optical, thermal, magnetic, 
and mechanical, frequency transducer (Spichiger-Keller, 1998). According to 
D’Orazio, (2003) biosensors offer an almost unlimited range of applications in 
many different kinds of disciplines due to the incorporation of a biological 
component with its selectivity and specificity.  
 
Today, the applications of biosensors span from applied research to 
commercially available sensors. There are a wide range of applications from 
agriculture (Velasco-Garcia and Mottram, 2003) to the measurement of blood 
metabolites routinely in the laboratory or as point-of-care devices (Tothill, 2009). 
Considering electrochemical transduced biosensors, potentiometric and 
amperometric biosensors are the most described in the literature. However, 
affinity biosensors have generally proved more amenable to optical detection 
methods (Tothill and Turner 2003).   
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Immunosensors are a specific subset of biosensors at large and they are 
distinguishable because they consist of immuno-reagents as the biological 
sensing elements or receptors. These are mainly antibody or antigen 
immobilised in close contact with physicochemical transducers for example 
electrodes and optical fibres. The Measurement of the analyte in the sample is 
achieved by the selective transduction of the bonding of the receptor-target for 
example antibody-antigen reaction, resulting in a quantifiable electrical or 
optical signal (Tothill and Turner 2003). Immunosensors have made it possible 
for continuous detection to be achieved for a wide variety of analytes. The 
electrochemical immunosensor is particularly suited for situations where real 
time monitoring capabilities are required. Where the antibody-antigen 
interaction conventional immunoassay methods may require duration of several 
minutes to several hours, such interactions in electrochemical immunosensors 
are completed within microseconds to minutes. Immunosensors have the 
advantages of sensitivity and selectivity inherent to the use of immunochemical 
interactions (Tothill, 2009). The limitation of the immunochemical sensors rise 
from the fact that the regeneration of the immuno surface is often difficult thus 
they are mostly require single use disposable components. There is also an 
issue of cross-reactivity or interference. This can be both a blessing and a curse 
depending on the application of the immunosensor as well as the type of the 
target analyses (Tothill and Turner 2003).  
 
1.5.2  Optical Immunosensors 
Optical methods are among the oldest and best-established techniques for 
sensing biochemical analytes. They generally consists of a light source,  
modulating agent, and a photo-detector for processing the optical signal 
(Mendelson, 2000). Surface plasmon resonance (SPR) is a good example of an 
optical immunosensor. It is based on a phenomenon that occurs when light is 
reflected off thin films of metal and can be verifies by the arrangement based on 
the Kretschmann configuration (Liedberg et al., 1995). It is one of the first 
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examples of the demonstration of the functionality of affinity sensors based on 
optical transducer and is still popular (Perkins and Squirrell, 2000). It involves 
immobilising antibodies to the surface of a thin metal film for example gold 
deposited on the reflecting surface of a glass prism. Interaction of antigens with 
immobilised antibodies to the surface will elicit a change in the refractive index 
as variations in light intensity, reflected from the back of the film proportionally 
to the mass of antigens bound to the surface. When light is shone onto the 
grating at a certain angle of incidence, the momentum of the photons is 
converted into a collective motion of the electrons in the metal called surface 
plasmons (Liedberg et al., 1995).  
 
This results in a decrease in the intensity of the reflected light. The angle of 
incidence at which resonance occurs depends on the optical thickness 
(essentially refractive index) of the layer that is within 300nm of the diffraction 
component surface (the evanescent field), and thus, the SPR-based sensors 
facilitate direct label-free detection (Iwasaki et al., 2001). SPR measurements in 
the laboratory are often made with the chip in a flow cell to allow for controlled 
delivery of reagents and sample. The use of SPR for cardiovascular biomarkers 
is in its self not novel as some studies have already been done. Some SPR 
sensors have been reported based on immuno-sensors for biomarkers of 
cardiovascular diseases including for C-reactive protein (Meyer et al., 2006) and 
for myoglobin and cardiac Troponin I (Masson et al., 2004). The SPR 
commercial scene is currently dominated by the BIAcore system, and since the 
introduction of BIAcore a number of more sensitive SPR instruments have been 
lauched (McDonnell, 2001). One such machine is the AutoLab Spirit® which, 
unlike the BIAcore, the reflection is measured as a function of the incident angle 
of the light beam (Dutra and Kubota, 2007). Figure 1.17 shows the working 
mechanism of an SPR biosensor. 
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Figure 1.17: The working mechanism of a surface plasmon resonance (SPR) 
biosensor (Sabban, 2011). 
 
The use of fibre optics in immuno biosensors for cardiovascular disease is 
another classical example of recent developments in optical immuno-biosensors 
(Kwon, 2003). Other novel optical immuno-sensing techniques are being 
developed for the early detection of myocardial infarction. One such technique 
is called fluorescence resonance energy transfer (FRET). It involves utilizing the 
distance-dependent chemical transduction method of fluorescence resonance 
energy transfer. The FRET process requires two fluorophores termed the donor 
and the acceptor. When in close proximity, the donor absorbs energy from the 
excitation source and non-radioactively transfers the energy to the acceptor, 
which in turn emits fluorescent energy. This distance-dependent property is 
utilised to detect conformational changes when antibodies combine with their 
respective antigens. This technology has already been used in detecting 
biomarkers for cardiovascular diseases (Grant et al., 2004). 
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1.5.3 Piezoelectric/acoustic Immunosensors 
The Quartz Crystal Microbalance (QCM) is an extremely sensitive mass sensor, 
capable of measuring mass changes in the nanogram range. QCMs are 
piezoelectric devices fabricated of a thin plate of quartz with electrodes affixed 
to each side of the plate. Piezoelectric ceramic materials can be produced by a 
less expensive process, however  the ceramics are limited by their lack of long 
term stability compared to single crystal materials which are less sensitive but 
when carefully handled have a significantly long-term stability (Bunde et al., 
1998). Single crystal materials are quartz, tourmaline and gallium phosphate. Of 
the two it is the quartz crystals which are common type of single crystal 
materials used in analytical application due to their electrical, mechanical, and 
chemical properties (Bunde et al., 1998). 
 
The resonant frequency of the quartz crystal depends on several parameters, 
for instance the size, the density, the shear modulus, but also the cut. Quartz 
Crystal Microbalance (QCM) is a special sensor that has acoustic impedance 
detector by mass loading. Piezoelectric also known as acoustic immunosensor 
such as the quartz crystal microbalance (QCM) and other surface acoustic 
devices are classified as direct immunosensor, when immuno-reagent is used 
as the receptor. Quartz crystal immunosensors are dependent on the 
immobilisation of antigen or antibody at the surface of a piezo-electric material 
(Uludag and Tothill, 2010). The natural vibration frequency of the support is 
changed when there is a significant immunochemical recognition reaction. The 
applications of QCM are diverse and many commercial piezoelectric detectors 
are now available. They have been proven to show the possibility of developing 
faster diagnosis assays compared to traditional detection methods for 
cardiovascular diseases (Wong-ek, 2009). 
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1.5.4  Electrochemical Immuno-sensors  
The electrochemical transduction appears to be the fastest growing trend in the 
development of biosensors. This growth is linked to the benefits it offers like 
miniaturisation, specificity and sensitivity as well as the success story of the 
blood glucose biosensors, which has emerged to be the leading commercial 
biosensor of all time (Apple, 2007). Electrochemical transduction based 
immunosensors have been used in the detection of a range of analytes (Salam 
and Tothill, 2009; Kadir and Tothill, 2010). The detection of cardiovascular 
biomarkers using immuno-electrochemical assays has been attempted for 
cardiac troponins (Mohammed and Desmulliez, 2011) and for myoglobin 
(Suprun et al., 2011). It is on this basis that immuno electrochemical biosensor 
platform was developed for this work.  
 
Electrochemical immunosensors are based on conventional antibody based 
enzyme immunoassays that are typical of most ELISA platforms. Immunoassay-
based sensors have been developed to exploit the high degree of specificity 
and affinity of antibodies for specific antigen. Their mechanism catalysis of 
substrates by an enzyme conjugated to an antibody produces products such as 
ions, pH change or In this particular application, a given chemical, metabolite, or 
modified protein can act as the antigen, and an EC response linked to antibody 
binding with the antigen (Darain et al., 2003). The Direct immuno-
electrochemical detection without the use of labelling can be performed by 
cyclic voltammetry, chronoamperometry, impedimetry, and by measuring the 
current during potential pulses, a process called pulsed amperometric detection. 
These methods are able to detect a change in capacitance or resistance of the 
electrode induced by binding of protein. Despite having a lot of variety in the 
label free immnoelectric sensor platforms, it is the labelled amperometric 
immunosensor, which is popular (Darain et al., 2003). 
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The principle of electrochemical immunosensor using amperometric transducer 
in detecting cardiac biomarkers is similar to that of other applications in the field. 
In principle the antibody or analyte of interest is immobilised on a membrane 
and the analyte is measured by signal derived from a conjugated tag that is 
attached to either the antibody or analyte (Piras and Reho, 2005). Two types of 
immunoassays are generally employed which are competitive or sandwich 
assay. Both are characterised by the coupling the electrode to the antibodies 
raised against the biomarker of choice to an electron transport chain via low 
molecular weight mediators. These are redox species that transfer electrons 
between the electrode and redox active bio-molecules via an alternate 
oxidation/reduction reaction(Kadir and Tothill, 2010).  
 
There are several of such species including peroxides, phosphotases, urases, 
and glucose oxides mediated electron transfer (Piras and Reho, 2005). 
Peroxidase is a good enzyme label in this application. When given a suitable 
substrate like 3, 3’, 5, 5’- tetramethylbenzidine hydrochloride (TMB) and 
hydrogen peroxide it is capable of producing an oxidised product that can be 
electrochemically reduced to produce electrons. These electrons are 
responsible for generating a catalytically enhanced current which is easily 
detected if a constant potential is applied (Darain et al., 2003). These 
approaches are essentially conventional binding assays which used enzyme 
label to detect the reaction and involve multistep procedures of incubating and 
washing that often found in traditional immunoassay formats based on microtitre 
plates (Darain et al., 2003). Improvements in as assay development for 
immuno-electrochemistry for example the use of gold nanoparticles have made 
this a common research area with potential commercial outcomes (Luo et al., 
2006; Saha et al., 2012). This study will include the development of immuno-
electrochemical biosensors for cardiovascular diseases. Since this technique 
will be used in these assays, a more comprehensive cover of the method will be 
discussed in the specific sections required in the work. 
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1.5.5 Detection of Cardiovascular Diseases using Biosensors 
Laboratory analysers are an invaluable resource but have several limitations, 
they are more suited for a hospital setting where there are trained personnel 
who can operate the machine and interpret the results accurately as well as 
phlebotomists who can take blood and supply the sample. Effective intervention 
of cardiovascular disease strongly relies on a rapid turnaround time (Apple, 
2007). This is the time taken between taking the blood sample from the patient 
until the results are obtained. The standard for chest pain diagnosis that is 
ideally it should be between 30 minutes to one hour, with 30 minutes or less 
being the optimum and this is not always possible if tests are performed in a 
centralised laboratory (O'Regan, 2003). Recent market demand devices that 
are more compact and can be used independently by the end user.  
 
There are no known over the counter devices for cardiovascular disease 
diagnosis but a step towards this has been achieved through the point-of-care 
devices. Bench top analysers are an example of such devices and are usually 
modified main laboratory analysers that have been miniaturised. They usually 
resemble larger systems and are capable of offering an array of tests that can 
assist in the diagnosis of a particular area of interest. A good example is the 
analysers that have a cardiac panel that enables them to test a single sample 
for a multitude of cardiac markers. This type of analysers also have the ability to 
use a variety of analytical methods including enzyme activity measurements, 
spectrophotometric substrates, haematological particle counting, immunoassay 
and biosensors (Luppa et al., 2011 ). A summary of such devices have been 
summarised in Table 1-3. Figure 1.18 shows the triage bench analyser. The 
triage is one of the pioneering compact analysers for cardiovascular disease. It 
was launched in 1998 and while all the other machines were laboratory based 
the triage had approval to be used as a point of care device. It is capable of 
detecting three cardiac markers, which are Troponin I, Myoglobin, and CK-MB. 
It is based on optical transducer which detects an output from a cartridge which 
employs the lateral flow technique (Christenson, 1998). 
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Table 1-3: Summary of current diagnostic devices for cardiovascular diseases 
Supplier Biosite Response 
Biomedical/ 
Roche 
Roche First Medical Dade Behring Biomerieux Abbot 
Product Triage Cartridge RAMP cardiac 
marker system 
Cardiac reader Alpha DX Stratus Vidas CK-MB I-start 
Analysis type Fluorescent 
microfluidics 
Fluorescence and 
microfluidics, read 
on table top reader 
Dried down strip 
with gold labelled 
antibodies and table 
top analyser 
Disk analysed in 
tablet op reader 
Flurometric 
analyser machine 
Flurometric 
analyser machine 
Hand held 
Immunosensor 
based analyser 
Readout time 15 min 10-12 min 12 min 18 min 13 min 30 min 10 min 
Limit of Detection Tns 1ng mL-1 0.3 ng mL-1 0.05 ng mL-1 0.5 ng mL-1 0.3 ng mL-1 0.11 ng mL-1 0.008 ng mL-1 
Dynamic Range Tns 1-80 ng mL-1 0.3 -50 ng mL-1 1-40 ng mL-1 0.5-100 ng mL-1 0.3-150 ng mL-1 0.01-30 ng mL-1 0.008- 50 ng mL-1  
Markers detected TroponinI 
Myoglobin 
CKMB 
Myoglobin 
CKMB 
TroponinT, 
Myoglobin 
CKMB 
Troponin I 
Myoglobin 
CKMB and CK 
TroponinT and I, 
Myoglobin,  
CKMB 
Myoglobin 
CKMB 
Cardiac troponin I 
CKMB 
BNP 
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Figure 1.18: The Triage® cardiac panel system is able to detect myoglobin, 
creatine kinase-MB fraction and cTnI from whole blood, Biosiste Inc (2009). 
 
The triage has several advantages, which has made it a success, The major 
ones being that the transduction and output device can work on any specified 
antigen. This means that it is not limited to detecting just cardiac markers but 
other blood proteins like haemoglobin 1C. The second advantage is that it uses 
whole blood that means it does not require sample pre-treatment at all. It uses 
capillary action that will draw blood from the sample port to a filtration 
membrane before exposing the Serum to the lateral flow device in the 
cartridges. The downside for the triage and most other analysers is the 
expensive costs. The costs associated with buying the machine around £3800 
when launched and cartridges at around £8 per test, are too high for home 
users and the amount of blood which is required need to be drawn out by a 
trained phlebotomist hence it cannot be used as an over the counter test. Great 
strides are being made towards eliminating these obstacles as demonstrated by 
launched iSTAT® which is a hand held device from Abbot shown in Figure 1.19 . 
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Figure 1.19: The iSTAT® system for POC detection of cTnI (Abbot, 2011). 
 
This devise utilises a dual-site coupled onto an electrochemical sensor. An 
alkaline phosphatase-conjugated secondary antibody is used to recognise and 
bind to the immobilised antigen before substrate is applied. The substrate is 
then catalysed by the alkaline phosphatase and electrons are produced that can 
be transduced to a proportional concentration of the analyte immediately. Test 
results can be remotely sent and be integrated into lab information systems 
(Abbott, 2011). 
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1.6 Aims and Objectives 
1.6.1 Aims  
The world is becoming more environmentally aware and as such miniaturisation 
is the general trend in medical diagnostics as with most consumer electronic 
goods (Newman and Turner, 1994). The demand for diagnostic products that 
can be accessed by the less developed countries without consistent power 
supplies and in some cases technical knowhow of operating some big 
laboratory based instruments. This has promoted research to focus on the 
development of portable low powered and easy to use diagnostic equipment 
capable of Point of care testing (McDonnell et al., 2009). Cardiovascular 
disorders remain one of the leading causes of death worldwide. The amount of 
individuals affected is increasing constantly. Especially in developing countries, 
a dramatic increase has occurred during the last decades (World Health 
Organisation 2011). 
Recent research focus on diagnosis of cardiovascular decease is centred on 
trend of identifying not only fast, accurate, reliable, and affordable diagnostic 
tools which are robust and compact but also capable of facilitating a predictive 
function for prognosis and risk stratification (da Silva and Moresco, 2011). 
Electrochemically transduced biosensors are capable of providing a solution to 
this problem, if they are designed to detect specific cardiac markers(Silva et al., 
2010). The use of immunosensors particularly those that use screen-printed 
electrodes is the cheapest and most effective way of doing this. Screen printed 
electrodes are capable of being commercially produced in bulk at very low cost 
and offer other desirable characteristics like miniaturisation, disposability and 
ease of use (Garcia-Gonzalez, 2008; Tothill, 2009). This project aims to achieve 
this by developing immuno-electrochemical assays and incorporate them on to 
screen-printed gold electrodes to make multi marker immuno-based biosensors 
for the detection of cardiovascular diseases. 
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1.6.2 Objectives 
Immunoassays in the form of ELISA assays were be developed for selected 
cardiac markers, which are cardiac Troponin T (cTnT) and C-reactive protein. 
This provided a learning platform for the assay setup and feasibility before it 
was transferred onto screen-printed electrodes. This is because ELISA plates 
are easier to work with in terms of high volume investigations as they can 
accommodate 96 wells. This makes it easier to develop and optimise assays. 
The next step was to transfer the optimized ELISA assay to the immuno-sensor 
platforms in the hope that the optimised parameters for the plate assay will have 
a similar performance on the electrode surface. 
 
A manufacturing perspective was investigated in this project to identify 
appropriate ink compositions and curing techniques for making competent 
electrodes that provide a platform immunosensor development. This was 
complemented with the investigations on the best surface chemistries for 
optimised binding and blocking of biosensor surfaces. 
 
An evaluation of current protein stabilization techniques was made with 
particular reference to the preservation of immobilised active proteins. Attempts 
to formulate new ways were made. The evaluation of the biosensor developed 
was done to test measurement of cTnT and CRP. Comparisons of the 
performance of the developed immuno-sensors against other commissioned 
methods and devices was made. A systematic summary of the objectives of this 
project is given by Figure 1.20. 
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Figure 1.20: Flow chart outlining the different phases of work carried out in this study. 
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2 Screen Printed Electrodes, Fabrication and 
Characterisation  
This section discusses screen-printed electrodes and their role in 
electrochemical transduced sensors with particular reference to immuno-
sensors. It will give an insight into material compositions and the methods of 
manufacturing. Some experiments conducted in an attempt to improve the 
performance of the electrodes before they can be used as immuno sensors will 
be shown and discussed. 
 
2.1 Introduction to Screen-Printed Gold Electrodes (SPGE) 
 
The general market trends in the diagnostics and analytical devices are 
undoubtedly oriented towards miniaturisation. Across fields of the analytical 
trade, it is evident that the interfacial nature of measurements favours the 
fabrication of miniaturised analytical devices. According to Garcia-Gonzalez 
(2008) it is because of this context that the thin and thick-film technology are of 
great utility to the diagnostic and analytical trade. Screen-printing is a well-
known thick film technique that is now widely used for the mass-production of 
disposable electrochemical sensors. Generally screen-printed electrodes are 
made from templates which allow for the simultaneous production of usually 
three tracks which will become the working, reference and auxiliary electrodes 
(Erlenkotter, 2000). This potentiostatic system allows them to be used as single 
use drop-on sensors in a static mode or in flow systems (Alvarez et al., 2002; 
Santos et al., 2004). The advantages of a single-use disposable sensor include 
the elimination of problems associated with carryover of contamination and 
sterilisation and also minimises the fear of expensive damage often associated 
with a re-usable sensor (Erlenkotter, 2000). Sensor micro-fabrication 
technologies such as thick film screen-printing, thin-film lithography, silicon 
technology, optical sensor technology can provide a pathway for the simple and 
inexpensive mass production of disposable electrodes. Screen-printed 
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electrodes (SPEs) rely on planar carbon or gold working electrodes and a silver 
reference electrode that are printed on an expensive plastic or ceramic support. 
Hence, each strip can be considered as a disposable electrochemical cell onto 
which the sample droplet is placed (Alvarez et al., 2002). 
 
Different electrode geometries can be fabricated using suitable patterned photo 
masks or stencils. Electrode structures with 0.5 µm dimensions can be 
produced with modern micro lithographic processes, while larger (75-100 µm) 
structures can be achieved using screen-printing (Wang, 1995). Screen-printing 
is a printing technique that uses a woven mesh to support an ink-blocking 
stencil. The attached stencil forms open areas of mesh that transfer ink or other 
printable materials. A roller or squeegee is moved across the screen stencil, 
forcing or pumping ink past the threads of the woven mesh in the open areas 
forming a sharp-edged image onto the substrate as shown in Figure 2.1. The 
paste-films have a typical thickness between 10 and 50 µm. The performance of 
sensors fabricated by thick-film technology depends critically on the applied 
materials and the manufacture. There is a wide range of inks and substrate 
materials that can be used to produce low cost sensor strips. Commercial 
carbon and good metal conductors like platinum and gold are used in Ink 
formulations for printing the working electrodes, whereas silver-based inks are 
used for obtaining the reference electrode (Wang, 1995). 
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Figure 2.1:Schematic representation of the screen-printing process (Hobby, 
1997). 
 
There are several significant advantages of thick film technology, which have 
attractive option for the fabrication of sensors and biosensors. These include 
flexibility of design and choice of materials, easy integration with electronic 
circuits, low cost in infrastructure and mass production, the possibility of 
automation of the fabrication process as shown in Figure 2.2, a low barrier for 
technological transfer from thick-film to other technologies (Alvarezicaza and 
Bilitewski, 1993). Miniaturisation is feasible, along with a high degree of 
electrochemical activity of the devices deriving from their high specific area and 
microporous structure. However, thick-film technology also has its own 
drawbacks.  
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This technology mostly has problems related to compatibility between the 
different materials, and between the materials and the manufacturing process 
(Erlenkotter, 2000). Other shortcomings are related to sensor-fabrication 
processes, such as the need of complicated curing cycles with high 
temperatures and long times, and low reproducibility of the constructed devices 
resulting, for example, from evaporation of solvents in the paste formulation 
(Galan-Vidal, 1998).  
 
Figure 2.2: The production of screen-printed electrodes on an industrial scale 
(Hobby, 1997). 
 
Several commercial companies are capable of making screen-printed 
electrodes for immuno-sensing applications and commercially sell them. Other 
companies are only capable of making the inks that can be used to make the 
electrodes. The table below shows the companies that are associated with the 
production of inks or the manufacturing of screen-printed electrodes. 
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The sensors used in this project were designed by Cranfield University and 
fabricated using screen printing facilities at Dupont, the inks used in the 
fabrication of these electrodes were supplied by Dupont. Figure 2.3 shows the 
set-up of the screen-printed electrodes from Dupont used in this project. 
 
 
Figure 2.3: Screen-printed electrodes used in this project. 
 
The quality of the sensor inks is a significant factor that contributes the overall 
quality of the electrodes. Carbon inks are however, still relevant for sensing 
applications because they are relatively inexpensive and lead to low 
background currents and a wide potential range. Such inks are composed of 
graphite particles, a polymeric binder  and other additives that play a role in the 
dispersion, printing and adhesion processes (Garcia-Gonzalez, 2008). The 
exact formulations are treated as proprietary information that helps them gain a 
competitive advantage over competition. Such differences in the ink 
composition like the size of particles, and in the printing and curing conditions, 
may strongly affect the overall analytical performance of the resulting sensors. 
Materials with more desirable characteristics like gold are now getting 
significant research interests. This is because of the good electrical conductivity 
and it ability to form strong Au-S bonds with self-assembled monolayer’s 
(SAMs) (Bain, 1989). The strong bond between gold and SAMs brings forth the 
enormous possibilities of immobilisation of bio-molecules on its surface, which 
resulted in wide application in bio-sensing technologies.  
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Table 2-1: The commercial organisations associated with screen-printing of 
electrodes.  
Company Name Location Description Products 
BST Bio Sensor 
Technology 
GmbH 
Germany The design, development and production of thick film based 
biosensors 
 
VT 
Technologies 
Czech 
Republic 
Research and development of 
new types of electrochemical 
sensors and biosensors.  
  
 
 
University of 
Florence 
Italy The group of Prof. Marco Mascini from the University of 
Florence produces screen 
printed electrodes (SPE) on a 
plastic base 
 
Dropsens Spain Innovative Technology-Based Firm specialised in the design 
and manufacture of instruments 
for Electrochemistry Research. 
 
Ercon USA Biomedical and Electrochemical 
sensor Materials 
Silver/Silver Chloride 
Carbon Graphite 
Platinum, Gold, Catalyst 
Insulayer™ 
FIP Microporous Media™ 
Kanichi UK  Knowledge based company 
that specialises in developing 
custom-made electrodes  for 
advanced sensor systems 
Contract research, 
Electrochemical sensors, 
nanoparticles , custom 
synthesis 
Gwent Group UK Consultancy and industrial 
fabrication of diagnostic 
biosensors 
Fabrication equipment, 
Consultancy, Research, 
Manufacturing 
Dupont USA, UK Suppliers of Inks and screen 
printing facilities for Biosensors 
applications 
Silver/Silver Chloride 
Carbon Graphite 
Platinum, Gold, Catalyst 
Insulation layers, Fabrication 
facilities 
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2.1.1 Characterisation of Screen-Printed Electrodes 
There are many publications reported about the electrochemical characteristics 
of screen-printed electrodes (Osborne et al., 1996; Cui et al., 2001a; Cui et al., 
2001b; Grennan et al., 2001; Morrin et al., 2003). Screen-printed gold 
electrodes SPGEs have been mentioned to be the basis of most sensors for 
heavy metals detection (Noh and Tothill, 2006). They have also become 
popular as immunosensors in recent years (Salam and Tothill, 2009; Kadir and 
Tothill, 2010; Heurich, 2011) which will be their main function in this project. 
Many important chemical processes occur at the surface of a solid. Some 
examples include catalysis, electrochemistry and adhesion. Understanding 
these processes requires an understanding of the composition and structure of 
the surfaces. The analytical techniques that can selectively characterize solid 
surfaces can be divided into two categories: techniques that are primarily used 
for elemental analysis at surfaces, and techniques primarily used for surface 
imaging (Garcia-Gonzalez, 2008).  
 
Several methods are used to try to characterise and understand the surface 
chemistries of immuno-sensor. These help to validate batch-to-batch 
consistency as well as to assess the viability of the electrodes. The most 
common optical method is the use of the electron microscopy. Electron 
microscopy is an imaging technique that used an electron beam to probe a 
material. Since the wavelength of an electron is much smaller than the 
wavelength of visible light, diffraction effects occur at much smaller physical 
dimensions (Kimseng and Meissel, 2001). The imaging resolution in electron 
microscopy is approximately 1 nm, which is much better than the µm resolution 
of light microscopy. When electrons penetrate a sample, they are diffracted to 
form a diffraction pattern. This diffraction pattern can be transformed with a lens 
to obtain the sample image. The use of electron beams requires that the sample 
be placed in a vacuum chamber for analysis. A variable of this kind of machine 
are the Scanning electron microscopy (SEM) and the environmental Scanning 
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electron microscopy (ESEM). The instruments are used for studying surface 
morphology. Nonconductive samples will need to be treated by evaporated gold 
or graphite coating over the sample to prevent charging effects. These charging 
effects are capable of distorting the electric fields in the electron microscope 
and thus affecting the quality of the image. A recent innovation in scanning 
electron microscopy is the environmental scanning electron microscopy (E-
SEM), it uses several stages of differential pumping between the electron gun 
and the sample, which is placed in a vacuum of a few torr. This allows imaging 
of samples that would quickly vaporise in a high-vacuum environment (Kimseng 
and Meissel, 2001). This method will be used to characterize the surface 
composition and morphology of the working electrodes used in this work. 
 
 
Cyclic voltammetry is the most widely used technique for acquiring qualitative 
information about electrochemical reactions. It consists of scanning a potential 
on a stationary working electrode in an unstirred solution so that the measured 
current is limited by analyte diffusion at the electrode surface. The electrode 
potential is swept between two values at a fixed rate, when the potential 
reaches the second value, the scan reverse back to the starting voltage. A basic 
shape of the current response for a cyclic voltammetry experiment is shown in 
Figure 2.4. For a fully reversible reaction, the forward sweep curve is similar to 
that of linear sweep voltammetry. On reversing the scan direction, electrons are 
withdrawn from electrode and the material reduced in the forward sweep are 
oxidized back (Bard, 2001). The cyclic voltammogram is characterized by 
several important parameters. Two peak currents and two peak potentials 
provide the basis for the diagnostics developed for analysing the cyclic 
voltammetric response as shown in Figure 2.4.  
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The anodic and cathodic peaks Epa and Epc respectively play a major role as 
well as the peak currents ratio ipa and ipc. In this, experiment the Ipa values 
that were used in the Randles-Sevcik equation.In cyclic voltammetry, the 
Randles-Sevcik equation describes the effect of scan rate on the peak current 
(Gosser, 1993). For simple redox events such as the ferrocene/ferricenium 
couple, the peak current depends on both the concentration and diffusional 
properties of the electro-active species and the scan rate. Using the 
relationships defined by this equation, the diffusion coefficient of the electro 
active species can be used determine the active surface area of the working 
electrode (Bard, 2001). 
 
 
Figure 2.4: Cyclic voltammogram recorded for a reversible redox in single 
potential cycle Epa = anodic peak potential; Epc = cathodic peak potential; Ipa 
= anodic peak current; Ipc = cathodic peak current. (Bard, 2001). 
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The analysis of the electrodes using cyclic voltammetry is based on the fact that 
a cyclic voltammogram of a fully reversible system will display a known set of 
characteristics governed by a series of equations (Gosser, 1993). One of the 
major equations is the Randles-Sevcik equation which at room temperature is. 
 
 = 2.69 ∙ 10 ∙  ∙  ∙  ∙  ∙  Equation 2-1 
 
Where n is the number of electrons, A the electrode area in cm2, C the 
concentration in mol/cm3, D the diffusion coefficient in cm2/s, and  the scan 
rate (in V/s). The equation can be used to estimate the percentage of the active 
surface of the working electrode (Bard, 2001).  
 
2.1.2 Aims and Objectives 
The aim of the work described in this chapter was to define the composition of 
the final electrodes that will be used in the development of biosensors for 
cardiovascular diseases. There were many combinations of inks that could have 
been used and this search was narrowed down to three compositions that had 
to be investigated to find the electrode with the best combinations. This was 
done through primarily cyclic voltammetry but an immuno assay was also 
carried out on the chosen different electrode combinations to validate the 
results of the cyclic voltammetry.  
 
A secondary aim was to investigate the effect of the method of curing on the 
performance of the electrodes. Investigations were conducted to evaluate the 
performance of electrodes cured using a conventional technique that utilised 
oven drying a more faster alternative that used infra-red IR drying. This was 
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done by monitoring the electrochemical behaviour using cyclic voltammetry. 
The experiment was complimented with the evaluation of the curing techniques 
to the surface chemistry and morphology. This was determined using 
environmental scanning electron microscope E-SEM. 
 
2.2 Materials 
Potassium chloride (KCl), potassium ferricyanide (K3Fe(CN)6+3H2O), TMB (3, 
3’, 5, 5’- tetramethylbenzidine hydrochloride), PBS (phosphate buffered saline) 
containing 0.137M sodium chloride, and phosphate buffer, 0.01M, pH 7.4 in 
tablet form, citrate phosphate buffer (0.05 M, pH 5.5) tablets, hydrogen 
peroxide, sodium hydroxide (NaOH) and sodium chloride (NaCl), bovine serum 
albumin (BSA) were purchased from Sigma-Aldrich (Poole, UK). Micropipettes 
were purchased from Eppendorf, UK.Pipette tips and 1.5mL tubes were 
purchased from Fisher Scientific (Loughborough, UK). Anti-Human C- Reactive 
protein capture antibody, Mouse monoclonal c6 to C reactive protein: ab 8272, 
Anti-Human C- Reactive protein, HRP Conjugated Detection Antibody were 
bought from (Abcam, Cambridge, UK). skimmed milk protein (KPL Ltd, UK), 
Reverse Osmosis (RO, Ultrapure) water (18 M MΩcm-1) was obtained from 
Milli-Q water system (Millipore Corp., Tokyo, Japan). Glassware and volumetric 
materials were of analytical grade.  
 
All measurements were conducted with Palmsens® portable electrochemical 
analyser (Palm instruments BV, Houten, Netherlands) or a four channels of an 
Autolab Electrochemical Analyser with general-purpose electrochemical 
software GPES 4.9 was purchased from Metrohm (Utrecht, Netherlands).The 
electrodes were connected to an edge connector and then connected to the 
electrochemical analyser using a modified connector (Maplin UK). An 
environmental scanning electron microscope was used to measure the surface 
morphology and composition on the working electrode. A XL30 SFEG scanning 
electron microscope (SEM) (FEI Company, Holland) was used to characterise 
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the surface of bare electrode. The analysis was done based on the 
XLFEG/SFEG scanning electron microscope operating instruction manual 
AnalySIS 3.0 software. The electrodes used in this project were designed by 
Cranfield University and fabricated using the facilities at DuPont. The gold 
working electrode was circular with a 22.6 mm2 planar area, a complementary 
carbon counter electrode and an Ag/AgCl reference electrode. The substrate 
material used is PET 125 µm Autotype HT5. Three types of electrodes JC, JA 
and JD were prepared with different Ink combinations. The Table 2-2 
summarises the compositions of the electrodes. 
 
Table 2-2: The distribution of components on three sensors used in this work. 
All the inks used are from DuPont. 
 
Type of Sensor  JA JC JD 
Type of Carbon Ink 7102 7102 BQ221 
Type of Gold Ink  BQ331 BQ331 BQ331 
Type of Ag/AgCl  5870 5880 5880 
Encapsulation 5036-blue 5036-blue 5036-blue 
 
The carbon electrode has an approximate dried thickness of 7 µm, while the 
gold and Ag/AgCl electrodes both have an approximate thickness of 18 µm. The 
encapsulation of 5036 blue had an approximate thickness dried of 4 µm. All inks 
are available from Dupont, UK. For the curing experiments, two sets of 
electrodes were fabricated, one set where the gold working electrode was cured 
using the conventional drying method and the other using infra-red technique. 
Different inks were also used from those that fabricate the JA, JC and JD. 
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2.3 Methods 
2.3.1 Cyclic Voltammetry for investigating different Inks 
Gold electrodes were first baked in an oven at 120 ºC and washed with reverse-
osmosis water before use. Stock solutions of 1 mM potassium ferricyanide 
K3[Fe(CN)6] were prepared in 0.1 M KCl. The electrodes were then tested using 
Cyclic Voltammetry (CV) to characterize the performance of the electrodes prior 
to any modifications thus to examine the initial performance of the electrodes. 
The electrochemical behaviour of potassium ferricyanide was measured using 
cyclic voltammetry at varying scan rates. Measurements were performed with 
electrodes being in a horizontal position and 100 µL of solution was pipetted on 
the gold working electrode. Scan rates of 30 mVs-1, 60 mVs-1, 90 mVs-1, and 
120 mVs-1 were used. Measurements were obtained by scanning 5 cycles from 
-0.5 to 0.8 V relative to Ag/AgCl reference electrode. 
 
The cyclic voltammetry (I-E) curves for the reduction of ferricyanide (1 mM) to 
ferrocyanide in a supporting electrolyte solution of 0.1M KCl at a pre-treated 
screen-printed gold electrode were obtained. Five electrodes were examined for 
each test using a Palmsens® portable electrochemical analyser (Palm 
instruments BV, Houten, Netherlands). The effect of different scan rates on the 
electrochemical behaviour of ferrocyanide toward the electrodes was observed. 
The relationship between the oxidation and reduction peaks, to the square root 
of the scan rate was calculated, and the percentage of the active surface area 
on the working electrode was estimated using the using Randles-Sevcik 
equation. The parameters used in the calculation are shown in Table 2-3. 
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Table 2-3: Parameters used in the Randel-Sevcik equation 
Equation Parameter Used Values Units 
Scan Rate (V) 0.05 [V/s] 
Area (A) 0.226 [cm2] 
Concentration (C) 0.001 [mol/cm3] 
Diffusion Coefficient (D) 7.60E-06 [cm2/s] 
Anodic Peak (Ipa) X [A] 
 
2.3.2 Cyclic Voltammetry for investigating different Curing 
Methods 
Two different curing methods for drying the ink on the substrate after screen-
printing were investigated. The first involved curing the electrodes in a static/box 
oven with a set temperature of 130°C for 20 min. The second technique 
involved drying the sensors for 4 min in a conveyor belt drier that utilise both 
Infra-Red (IR) and convection heat. Cyclic voltammetry was used to investigate 
the electrochemical behaviour of the two sets of electrodes. Measurements 
were performed with electrodes being in a horizontal position and 100 µL of 
solution was pipetted on the gold working electrode, Scan rates of (20mV/s, 
40mV/s, 60mV/s, 80mV/s and 100mV/s) were used and measurements were 
obtained by scanning 3 cycles from -0.5 to 0.8 V relative to Ag/AgCl reference 
electrode. The electrodes were connected to an edge connector plugged on a 
multi-channel AUTOLAB electrochemical instrument (Ecochemie, Utrecht, 
Netherlands) using electrochemical GPES 4.7 software. 
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2.3.3  Environmental Scanning Electron Microscope 
A XL30 SFEG scanning electron microscope (FEI Company, Holland), was 
used to characterize the surface of bare gold working electrode. The sensors 
were first baked at 120˚C for 30 min before being washed and dried with a 
gentle nitrogen stream. The analysis was done based on the XLFEG/SFEG 
scanning electron microscope operating instruction manual. The software, 
AnalySIS 3.0 was used for determining the composition the gold working 
electrode surface. 
 
2.3.4  Characterization of electrodes using Immuno Assay  
In Order to validate and complement the cyclic voltammetry results the sensors 
were also characterised using the immuno assay immobilised on the electrode 
surface. After choosing, the best electrodes from previous experiments an 
optimised immuno assay details of which are described in Chapter 3 were used. 
Three different concentrations of the antigen (C –Reactive protein from Human 
serum) were used on in triplicates for each of the sensors. The electrodes were 
then washed and connected to an edge connector, which is connected with a 
multi-channel Ecochemie electrochemical instrument from AUTOLAB, (Utrecht, 
Netherlands). All measurements were performed by adding 100	μl of 4mM TMB 
and 0.06% H2O2 in 0.05 M citrate phosphate buffer plus 0.1 M KCL with chrono-
amperometry methods at constant current and run for 200s using 
electrochemical GPES 4.7 software. A cross section was made at 80seconds 
and all the current measured at this time was averaged.  
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2.4  Results and Discussion 
This section describes the findings from the experiments that were conducted in 
an attempt to characterise the electrodes that were manufactured and used in 
this work, and the evaluation of electrode performance against two different 
curing techniques. Major emphasis of the characterisation was put on the three 
component inks for the electrodes that were, the gold colloid ink, the carbon 
counter and track ink, and the silver/silver chloride ink for the reference. Three 
different electrode configurations were produced using different ink 
compositions. Cyclic voltammetry of the electrodes was done to distinguish the 
best electrode combination to be used in this work. Potassium ferricyanide 
solution was used as it is capable producing a reversible reaction where one 
electron transfer [Fe (III) to Fe (II)] could be characterised by a peak separation 
between the anodic and cathodic peaks and a linear relationship between peak 
current versus scan rate is observed. This is because since one electron is 
used for each Fe3+ to reduce at the electrode, therefore the rate of reaction 
could be monitored by controlling the availability of electrons on the through the 
voltage (Cui et al., 2001a).  
 
The voltamograms produced were then compared to each other to find the ones 
that were providing superior performance in terms of producing the highest 
current peaks and reproducibility on a fixed voltage. It is expected that there will 
be characteristic sigmoidal shaped curves exhibiting oxidation and reduction 
peaks, the peaks are expected to vary proportional to the scan rates. The 
analysis of the peaks obtained can be done using two methods the first and 
simple one being based on a relationship between the oxidation and reduction 
peaks to the square root of the scan rate (Morrin et al., 2003). This relationship 
is important, as it is linearity shows the effectiveness of the diffusion of the 
electrolytes on the sensor surface. This is a good indicator for the quality of the 
electrode particularly when unstirred highly electrolytic solutions are used. 
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The second assessment was done using the Randal-Sevcik equation that is 
highlighted in the introduction. By inputting known values of the electrode area, 
concentration of a known reversible redox electrolyte, its diffusion coefficient, 
and the scan rate used, the percentage of the active surface on the working 
electrode can be estimated. This is directly proportional to the electro active 
behaviour of the electrode and thus has a significant impact on quality. A further 
validation of the obtained results was done using an immuno assay developed 
for the electrodes. This was done later on in the project when the JD sensor had 
already been chosen using the cyclic voltammetry results. The experiment was 
done to justify weather the right decision had been made earlier. The immuno 
assay used was for the CRP assay, which is discussed in detail in Chapter 3. 
 
For the evaluation of the drying techniques cyclic voltammetry was also used, 
also a complementary imaging experiment was done which used an 
environmental scanning electron microscope to analyse the surface 
composition of the working electrodes.  This analysis is based on energy 
dispersive X-ray microanalysis (EDAX) of gold (Au), carbon (C) and oxygen (O) 
component of the gold electrode surface as well as particle size. Besides 
providing the chemical composition of the surface, the environmental scanning 
electron microscope is also capable of enabling visualization of the surface on a 
micro scale. The roughness of the surface and granule form of gold particle on 
the working electrode surface was visually inspected. Correlations were made 
between the performance and surface roughness, which were consistent with 
literature. 
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2.4.1  Performance of Different Electrode Ink Compositions 
2.4.1.1  Cyclic Voltammetry 
The formulations of the inks used in the screen-printing of electrodes are a big 
business and the composition of such inks is proprietary knowledge that 
remains guarded as a close secret. Different inks are made by mixing different 
combinations of the ink composition material for example a carbon ink may 
contain carbon, alcohol, substrate in different proportions. The performance of 
the inks differs with each formulation and the intended application. In this 
experiment, three types of electrodes were assembled with different ink 
combinations they were then tested for their electrochemical performance using 
cyclic voltammetry and an immuno-assay. The results of the cyclic 
voltamograms are shown in Figure 2.5.  
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Figure 2.5: Voltamogram for the characterisation of the electrode screen-
printed electrodes. Cyclic voltammetry using 100 µL of 1mM K3[Fe(CN)6] in 
0.1M KCl pipetted on the gold working electrode, scan rates 30, 60, 90 ,120 mV 
s-1 were used scanning 3 cycles from -0.5 to 0.8 V relative to Ag/AgCl reference 
.(A) JA electrode, (B) JC electrode, and (C) the JD electrode. 
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The three diagrams show the voltamograms obtained after cyclic voltammetry 
of 1 mM pottasium ferricianide solution made in 0.1M KCL solution. The 
oxidation and reduction peaks are visible in all three electrodes, however the JD 
electrodes show more response as it has the highest peaks for any given scan 
rate as compared to the other two electrodes. A clear comparison can be made 
with the aid of the summary shown in Figure 2.6. The results obtained showed a 
similarity between the performance of the electrodes JC and JA. This shows 
that both variants of the Ag/AgCl , namely  5880 and 5870 yielded similar 
performance on the electrodes.  The experiments also showed that JD showed 
superior performance on the electrochemical testing. This may be because of 
the different carbon used BQ221, the results show that the BQ221 carbon 
performs better than the 7102 variant.  
 
 
Figure 2.6: Summary of the electrochemical performance of JA, JC, and JD 
electrodes. Cyclic voltammetry using 100 µL of 1mM K3[Fe(CN)6] in 0.1M KCl 
pipetted on the gold working electrode, scan rates 30, 60, 90 ,120 mV s-1 were 
used scanning 3 cycles from -0.5 to 0.8 V relative to Ag/AgCl reference, n=3, 
maximum CV=9.8%, Bars = standard deviation. 
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Using Randles-Sevcik equation the surface area of the working electrode was 
estimated. The highest scan rate of 0.12 V/s was used and the results obtained 
are shown in Table 2-4. The results showed that JD had the highest calculated 
active area on the working electrode; the values of the JC and JA were almost 
similar. 
 
Table 2-4: Table showing the results of the Randles-Sevcik equation. 
Sensor Type JA JC JD 
Calculated Active Area [cm2] 0.18 0.17 0.25 
Relative Calculated Active Area [%] 81.41 76.26 111.24 
 
2.4.1.2  Immuno Assay Test 
The current optimised CRP assay was done on each of the three electrodes, 
JA, JC and JD. Three different concentrations of the antigen (C –Reactive 
protein from Human serum) were used on in triplicates for each of the sensors. 
A hydrogen peroxide /TMB substrate was used to transduce immobilised HRP 
conjugated antibodies from the final step of the assay and produce electrons. 
The electrons were then measured as current using a Palmsens® portable 
electrochemical analyser (Palm instruments BV, Houten, Netherlands). The 
results obtained are shown in Figure 2.7 . 
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Figure 2.7: The Immuno assay results showing the advantage of using the JD 
electrode composition compared to the JC and JA varients. Electrochemical 
immunoassay for CRP was integrated on the different electrodes to make 
immunosensors and peak electrochemical signals at different CRP 
concentrations were used to assess electrode performance n=3.maximum 
CV=11.4%, Bars =standard deviation. 
 
The results confirmed those obtained by the cyclic votametry that there was a 
superior advantage on the performance of the JD sensor compared to the JA 
and JC. Higher signals were obtained on non-reference samples form the JD 
electrodes; this may be because it contained better carbon ink BQ221 while 
other contained the 7102 variant. 
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2.4.2  Effect of Different Electrode Ink Curing Techniques 
2.4.2.1  Cyclic Voltammetry 
Two main methods are used when curing screen-printed inks. These are the 
alternative drying which is drying the electrode in an oven with a temperature of 
around 120 ˚C for 2hrs. Another method involves using infra-red drying 
chambers which makes the inks to dry faster at higher temperatures without 
compromising the substrate. Infrared dryers were used to dry the screen-printed 
inks for 15 min at 200 ˚C. The effects of drying strategies have been known to 
affect the performance of the sensor. Figure 2.8 shows the results obtained in 
the analysis of the performance after different drying strategies of the immuno-
sensor inks. The results show that there is a major distinction in the 
performance of the different drying techniques. By using CV to characterise the 
electrodes the results showed that the electrodes which were alternatively dried 
gave higher oxidation and reduction peaks thus making them more sensitive 
than the infra –red (IR) dried sensors. There was better reproducibility on the 
alternatively dried sensors than the IR sensors. This is highlighted by the 
relatively high error bars (IR sensors CV=9.8% compared to AD CV 4.2%) in 
Figure 2.9. 
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Figure 2.8:.Voltammogram showing electrochemical performance of an 
alternatively dried sensor. Cyclic voltammetry using 100 µL of 1mM K3[Fe(CN)6] 
in 0.1M KCl pipetted on the gold working electrode, scan rates 20, 40, 60, 
80,100 mV s-1 were used scanning 3 cycles from -0.8 to 0.8 V relative to 
Ag/AgCl reference.(A) alternatively dried electrodes, (B) Infrared dried 
electrode. 
-40
-30
-20
-10
0
10
20
30
-0.8 -0.6 -0.4 -0.2 0 0.2 0.4 0.6 0.8 1
Cu
rr
en
t [
µA
]
Voltage [V]
A
 20 mV/s 40  mV/s 60  mV/s 80  mV/s 100  mV/s
100 mV s-1
20 mV s-1
-40
-30
-20
-10
0
10
20
30
-0.8 -0.6 -0.4 -0.2 0 0.2 0.4 0.6 0.8 1
Cu
rr
en
t [
µA
]
Voltage [V]
B
 20 mV/s 40  mV/s 60  mV/s 80  mV/s 100  mV/s
100 mV s-1
20 mV s-1
Screen Printed Electrodes, Fabrication and Characterisation 
 
77 
W.M.Fakanya-Cranfield University-PhD Thesis 
 
Figure 2.9: Summary of the Investigating effect of Alternative vs Infra-red drying 
techniques The R2 values were obtained using a plot of the square root of the 
scan rates used in Figure 2.8, n=3, maximum CV=9.8%, Bars = Standard 
deviation. 
 
Using Randles-Sevcik equation the surface area of the working electrode was 
estimated. The highest scan rate of 0.1 V/s was used and the results obtained 
are shown in Table 2-5. The results show that there was relatively higher active 
surface area on the working electrode of the alternatively dried electrodes, 
almost double of that of the infra-red dried electrodes. This showed that the 
alternatively dried electrodes were electrochemically more active than infrared 
dried electrodes. 
Table 2-5: Results of the Randles-Sevcik equation on different curing 
techniques. 
Sensor Type AD IR 
Calculated Active Area (cm2) 0.11 0.05 
Relative Calculated active area (%) 48.84 24.44 
R² = 0.9998
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2.4.2.2 Environmental Scanning Electron Microscopy (ESEM) 
The Environmental Scanning Electron Microscopy (ESEM) confirmed the 
electrochemical results obtained through cyclic voltammetry. Figure 2.10 shows 
the results of the ESEM. There was a clear difference in both the chemical 
composition and the morphology of the constituent particles on the gold surface. 
Considering that the same ink was used and it was fairly homogeneous when 
printing occurred it is expected that the composition of the elements on the 
working electrode will be uniform.  
 
Figure 2.10: The ESEM results showing the image and composition analysis of 
the gold surface of (a) alternatively dried sensors and (b) infrared dried sensors. 
The element weight information is an average of three spots on a single sensor 
for each drying technique.  
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Electrodes were baked for 120˚C for 30 min before being washed with reverse 
osmosis de ionised water and gently dried with a nitrogen spray. The working 
electrodes were then analysed using an ESEM. The results showed that the 
curing techniques affected the distribution of the ink composition of the working 
electrode. More pinholes were observed to be clearer on the alternatively dried 
sensors than the infrared dried sensors. This means that the surface was more 
smoother with the infrared dried sensors hence small surface area was exposed 
This was confirmed by the spectrums obtained that showed the amount of 
exposed gold higher in the convention-dried sensors (84.8%) than the Infrared 
dried sensors (65.34%). This had a knock on effect on performance and could 
justify the performance highlighted by cyclic voltammetry. 
 
2.4.2.3  Immuno Assay 
The immuno assay validated the results of the cyclic voltammetry and the 
environmental scanning electron microscopy. It is evident in the results shown 
by Figure 2.11 that there was a higher signal response from alternatively dried 
electrodes than Infra-red dried electrodes. 
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Figure 2.11: The Immuno assay results showing the advantage of alternatively 
dried electrodes over infrared. The differently cured electrodes were 
transformed to immunosensors by integrating a CRP immunoassay; the high 
peak currents obtained from detecting several CRP concentrations were used 
to identify the best curing method. n=3, CV=11.2%, Bars =standard deviation. 
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2.5 Conclusions 
Several results were obtained that brought understanding on the type of 
electrodes that was most suitable to be used in this project. From a selection of 
three electrodes with different ink compositions the JD electrode was used 
because it showed superior performance in both electrochemical and immuno 
assay evaluations. The major difference between the JD and the other 
electrodes was that it had a superior carbon ink. The carbon in in this design of 
electrode plays a major role as it constitute more than 80 per cent of the total 
ink coverage on an electrode (Morrin et al., 2003). This is because besides 
being used for the counter electrode it is also used for tracking the other 
electrodes to complete the circuit. As discussed earlier the actual compositions 
of the inks are regarded as proprietary information so there are major 
restrictions to what can be discussed regarding its composition. 
 
The results obtained showed a similarity between the performance of the 
electrodes JC and JA. This shows that both variants of the Ag/AgCl, namely 
5880 and 5870 yielded similar performance on the electrodes. This information 
is helpful in deciding the cost as different inks are made from different 
formulations that have different costs. In this instance, it would be advisable to 
choose the cheaper alternative between the two formulations as they do not 
make a significant difference in terms of performance in this case. However, it is 
important to consider other factors like shelf life especially where the reference 
electrode is concerned as well as the effect of assay conditions particularly the 
Ag may be removed from the electrode and interfere with the assay as in the 
case of acidic conditions. The JD electrode was chosen as the appropriate 
platform for the design of the immunosensor. The decision was vindicated by 
the immuno-assay results obtained after the development of the immuno sensor 
that showed that it was the right electrode to use to develop the sensor. 
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Three experiments were conducted to evaluate the effect of different curing 
conditions on the performance of the electrode. The curing (drying) conditions 
of an electrode play a major role in the rate and cost of production of electrodes 
(Hobby, 1997). Different techniques are constantly being investigated to 
improve the production process by finding fast and cheaper curing alternatives. 
The two curing methods that were investigated in these experiments differ 
mainly in that the Infra-red drying is a faster and cheaper method that the 
conventional oven drying. The results from all three experiments showed that 
the conventional drying resulted in better performing electrodes. The 
electrochemical results from the cyclic voltammetry confirmed this. The results 
from the scanning electron microscope showed that although the same ink was 
used for the working electrodes there were differences in the surface 
composition of the electrodes after curing them differently. This may have been 
caused by temperature variations and humidity conditions (Grennan et al., 
2001).  
 
There was a clear difference in both the chemical composition and the 
morphology of the constituent particles on the gold surface. Considering that, 
the same ink was used and it was homogeneous when printing occurred it is 
expected that the composition of the elements on the working electrode will be 
uniform. The E-SEM showed that the amount of the exposed gold on the infra-
red dried sensors was less than that from the conventionally dried electrodes, 
conventionally-dried sensors (84.8%) than the infrared dried sensors (65.34%). 
This may explain the superior electrochemical behaviour of the conventionally 
dried electrode as shown by the cyclic voltammetry and the immuno assay 
results. Although the IR drying may have commercial advantages on speeding 
the production line, it is evident that this has an impact on the quality. The 
results show that the conventional oven drying of the working electrode with 
relatively lower temperatures results in better performing gold electrodes and 
thus the electrodes used in this project were cured using the conventional 
drying method 
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3 Development of an Electrochemical Immunosensor 
for C-Reactive Protein 
3.1 Introduction 
This chapter will focus on the development of an immunosensor for C reactive 
protein using screen-printed gold electrodes. An assay was initially developed 
on a micro plate ELISA platform before it was adopted and optimised to make 
screen-printed electrode based immunosensors. The performance of the 
immunosensors was then compared to a commercially available ELISA assay. 
 
3.1.1 Electrochemical Immunosensors 
Electrochemical immunosensors are fast becoming a major contender in the 
race for robust immuno based biosensors because of their simplicity, high 
sensitivity and good reproducibility (Tothill and Turner 2003; Salam and Tothill, 
2009). They are analytical tools based on the interaction of antibody and 
antigen complex on an electrode transducer (Kadir and Tothill, 2010). The 
production of electrodes has become a booming business and several 
companies mentioned in the previous chapter are moving forward with the 
research and development of electrodes suitable for immuno sensing 
applications. Immuno sensors offer a long term economic viability as they are 
capable of being easily fabricated, inexpensive and reproducible manufacturing 
is possible for large quantities thus this can result in in development of low cost 
electrochemical immunosensors (Turner, 1998). 
 
The success of some commercial biosensors like the Exactech® glucose pen 
has raised the hopes of screen-printed fabrication technology on biosensor 
applications. Screen-printed electrodes have been used for the development of 
chemical sensor and immuno sensor applications for more than a decade 
(Parker et al., 2009). The basis of most electrochemical immunosensor systems 
is the ability of some enzymes to catalyse a substrate in a manner that can 
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generate an electrical signal on the electrode surface. Many of the commercially 
available electrochemical biosensors use enzymes that work on a substrate 
through a redox reaction. This results in either the generation or utilisation of 
electrons. Some examples of the enzymes include horseradish peroxidase, 
glucose oxidase, glutamate oxidase and lactate oxidase, these are mostly used 
in amperometric detection which is the most popular electrochemical technique 
(Shan et al., 2008; Salam and Tothill, 2009). Amperometric detection involves a 
measure of current from the oxidation-reduction of an electro active molecule 
when a constant potential is applied to an electrode measured against a 
reference electrode. The density of the measured current will be proportional to 
the concentration of the redox species in the solution (Dzyadevych et al., 2008; 
Kadir and Tothill, 2010). The redox reactions of the electro active molecules 
take place on the working electrode, which in this case is gold. The reference 
electrode will then define the potential against which other potentials could be 
measured because it has a known and constant potential at a given 
temperature. The counter electrode is responsible for draining all the excess 
current on the working electrode to prevent it from passing through the 
reference electrode. The potential of a working electrode vs. a reference 
electrode is usually made either more positive or negative by applying an 
appropriate potential (Salam and Tothill, 2009). 
 
Some drawbacks of the electrochemical method are that it is unable to detect 
direct interaction between an antibody and antigen. This may cause slight 
inconsistencies as small changes in enthalpy and physical conformation on 
antigen antibody binding occur (Dzyadevych et al., 2008). These may then 
result in unexpressed signal for some antigen. This is however, a generic 
problem that affects all immuno based diagnostic systems and the changes are 
often negligible. Other electrochemical methods that try to base the transduction 
on the direct interaction of the antibody and antigen complex have been used in 
the form of potentiometric and impedimetric platforms (Hu et al., 2003; Sun et 
al., 2011; Mao et al., 2012). The indirect method that utilises an enzyme has an 
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advantage that it is exempted from the high ionic and electrical interference that 
affect other methods. This has an impact on the quality of the results, thus an 
indirect detection technique based on a sandwich immuno assay that uses 
horseradish peroxidase labelled enzymes was used in this project. Another 
limitation of amperometric transducers is interference from electroactive 
compounds, particularly those that may originate from reagents (Garcia-
Cardena et al., 2001). C reactive protein has been detected using immuno 
electrochemical transduction in various assays that used a wide variety of 
electrochemical methods. Table 3-1 show some of the work that has been 
reported and achievements using these methods 
 
Table 3-1: Summary of published work on Immuno electrochemical detection of 
CRP 
Detection Technique Assay Range Reference 
Amperometry 0.3 to 100 µg mL-1 (Shaolin et al., 2011) 
Electrochemical Impedance 0.12 to 1.5 µg mL-1 (Hennessey et al., 2009) 
Electrochemical Impedance 0.1 to 20 µg mL-1 (Chen et al., 2008) 
Electrochemical Impedance 5 to 25 µg mL-1 (Zhu et al., 2003) 
Electrochemical Impedance 0.04 to 5.84 µg mL-1 (Rajesh et al., 2010) 
Square wave A/ Stripping 0.5 to 200 µg mL-1 (Zhou et al., 2010) 
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3.1.2 Role of Antibodies in Immunosensors 
Antibodies have been used as the bioreceptor molecules for immuno sensors 
as they are a natural product of the immune system. They poses high affinity, 
specificity, versatility and commercial availability , which makes them suitable 
for this role (Ricci, 2007). Antigen- antibody interactions involve non-covalent 
binding of an epitope to the variable region of the immunoglobulin chains. The 
interactions include hydrogen bonding, ionic bonds, hydrophobic interactions, 
and Van der Waals forces in a fashion known as induced fit hypothesis. The 
strength of these interactions is weak compared to that of a covalent bond and it 
depends on the very close fit between the antigen and the antibody, which 
attributes the characteristic responsible for the high degree of specificity (Ricci 
et al., 2007). The affinity and avidity are two common measures of the strength 
of Ab-Ag interaction, avidity is a measure of the stability of the complex that is 
formed from the binding of an antigen and antibody and affinity is the strength of 
the attraction. Low affinity antibodies bind weakly to the antigen and can easily 
dissociate, however high affinity antibodies will bind a close fit that is tight and 
thus stronger and more durable. The equation below summarises the 
association between antibody and antigen during binding. 
 
Ag + Ab
			

 !AbAg 
In this formular , k1 is the forward association rate constant and k-1 is reverse 
dissociation rate constant. The ratio of the two constants (k1/k-1) is the 
association constant, which is used to define the affinity. Several external 
factors can affect the overall association constant and these include 
temperature, pH and motion. 
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3.1.3 Immuno Assay Development 
The development of the assay component of the immunosensor development 
was based on the working principles of the ELISAs. Although many variants of 
ELISA have been developed and used in different applications, they all depend 
on the same basic principles that are coating, blocking, detection, and signal 
measurement. These elements have to be optimised to improve on the 
capabilities of the assay. With the hope of later transferring the optimised ELISA 
assays on to the electrodes to make the immuno sensors, this was done in this 
project. Sandwich ELISA assays for C-reactive protein was developed and 
optimised, the sandwich was chosen as earlier work by Salam and Tothill 
(2009) identified the sandwich method as the most suitable for the type of the 
electrode design that  were worked on. Another factor was that sandwich 
assays are relatively straightforward and there are several examples of 
miniaturised diagnostic devices that utilise them. The sandwich ELISA has more 
sensitivity in its detection and it offers a more direct quantification. In 
electrochemical immunosensors, the stability of the immobilised immuno 
reagents on the sensor surface is crucial.  
 
There is a wide range of enzymes that can be used in the indirect 
electrochemical transduction of immunosensors. A qualifying criterion is that 
they have to poses some redox properties that make them capable of catalysing 
the reduction or oxidation of a substrate to generate or consume electrons. 
Some good examples of such enzymes are the oxidases, peroxidases and 
reductases. These enzymes have been used in the past the development of 
redox based signal transduction. Horseradish peroxidases have been used in 
both optical and electrochemical capacities on redox based intermediation 
because it has the ability to catalyse reactions that change colour and generate 
electrons at the same time. This enzyme has a high substrate turnover rate and 
is tolerant of its substrate. Its active site is also close to the external surface of 
the protein, thus creating direct and mediated optical and electrochemical 
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transduction processes that are more efficient. In this project, it was used on 
both capacities as the ELISA platform used in the preliminary studies was 
optically detected and the immunosensors developed were electrochemically 
detected.  
 
The immobilised antibody on a sensor surface act as both a capturing antibody 
and also as the detector surface (Oh, 2005). Several methods can be used to 
immobilise antibodies on sensor surfaces. These include passive adsorption, 
the avidin–biotin system and self-assembled monolayers (SAMs). The antibody 
immobilisation step is critical in the development of immunosensors as it 
supports the backbone or foundation of immunosensor (Newman and Turner, 
1994). It also defines and gives the sensor its identity. If immobilised material is 
not well integrated to the sensor surface, it will affect the consistency and 
dependability of the sensor, even more so when intended to be reusable 
(Tothill, 2009). The diagram below Figure 3.1 shows the different mechanisms 
proteins like antibodies can be incorporated on to a sensor surface. 
 
Figure 3.1: Overview of the protein adsorption mechanisms on the sensor 
surface (Davies, 2007 ). 
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The strength of the interaction between the immobilised antibody and the 
surface should be stable enough to perform one or more assays. The ability to 
withstand the force exerted by the fluids in the washing step in the assay is 
requires as this procedure increase the risk of remobilising the antibodies and 
consequently dismantling the assay. The functionality of the antibodies is also 
compromised if the coating procedure is not done properly. The orientation of 
the antibodies is very important for its binding ability. This means that an 
irregular orientation of antibodies is less favourable than a meticulously directed 
immobilisation strategy that ensures the exposure of the binding region to the 
right orientation above the surface (Turner et al., 1987).  To improve on the 
immobilisation of the antibodies techniques like the use of self-assembled 
monolayers may be used. Self-assembled monolayer’s (SAMs) are a good 
example of covalent immobilisation and can be formed by means of sulphur 
containing groups on oxidised and hydroxylated surfaces and by means of 
thiols on metal surfaces (Srisombat et al., 2011; Altintas et al., 2012). The thiol 
molecules ,usually alkanethiols consist of three parts as shown in Figure 3.2 
and these include: a head group (S-H group),a  spacer or hydrocarbon chain), 
and a the tail group which is active and specific.  
 
 
Figure 3.2 An Illustration showing the three components of an ordinary thiol 
based self-assembled monolayer (Srisombat et al., 2011)  
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Alkanethiols with amine and carboxyl end groups have been reported for use in 
to immobilise proteins on sensor surfaces (Arya et al., 2010; Altintas et al., 
2012). The high affinity of the sulphur atom to noble metal surfaces is 
responsible for spontaneous formation of semi-covalently bounds. As a result of 
this there is a tendency for van der Waals forces to form between the 
hydrocarbon chains which then stabilize the structures and create an ordered 
monolayer. The terminal group of the molecule is responsible for the surface 
characteristics of the monolayer. For example to obtain hydrophobic –CH3 and 
–CF3 terminal groups are used and consequently –COOH, –NH2 or –OH groups 
yield hydrophilic surfaces. SAMs can be formed on surfaces either by simply 
immersing the metal substrate in a dilute solution of thiol /silane or alternatively 
they can be formed by vapour deposition (Schreiber, 2000). If a metal substrate 
is immersed in dilute thiol solution, a disorganised monolayer spontaneously 
forms and then slowly the molecules are evenly organised due to van der Waals 
forces. The quality of the assembled monolayer depends on the cleanliness of 
the metal substrate, the purity of the alkanethiol solutions used and the length 
and composition of the alkanethiol. The head group of the alkanethiol is critical 
to obtain a monolayer with the required functionality. Many alkanethiols with 
different head groups are commercially available for the immobilisation of 
biological recognition elements on biosensor surfaces such as  –COOH,  -NH2,  
-OH,  -biotin, and (NHS),-N-hydroxysuccinimide (Altintas et al., 2012). The use 
of SAMs in immunosensors for CRP have been reported before (Rajesh et al., 
2010) but mostly for electrochemical impedance measurements. 
 
After the successful immobilisation, other areas that need to be investigated are 
finding a suitable blocking agent. These are designed to fill in any gaps on the 
immobilised protein surface that can later result in non-specific binding of the 
antigen. Several solutions can be used for blocking; these include known 
concentrations of proteins like bovine serum albumin (BSA), and skimmed milk 
solutions. Polyvenyl acetate (PVA) has also been reported for use as a blocking 
agent (Kadir and Tothill, 2010), as well as some commercial products with 
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protected recipes like Stabilicoat® (Surmodicks, Minnesota). A suitable blocking 
agent will need to be investigated and it needs to possess some characteristic 
that enable it to perform well without interfering with the electrochemical 
processes. The blocking step is crucial to the development of viable immuno 
assays, according to Péterfi (2000), the importance of blocking in affinity assays 
is paramount and as such it cannot be overlooked. This is because the surfaces 
designed for the immobilisation of proteins are inherently sticky because of their 
modified surface chemistry. This makes them prone to permit nonspecific 
adsorption and thus excessive protein-surface interaction which results in the 
loss of activity (Sentandreu et al., 2007). 
 
The aim of this chapter is to describe how an immunosensor was developed for 
the C-reactive protein (CRP) biomarker. The clinical reference ranges for 
predicting cardiovascular events using CRP assay are ≥1 µg mL-1 low risk ,1-3 
µg mL-1 is medium risk and ≤ 3 µg mL-1 is high risk (Rifai, 2001). The work that 
was done in the development of an electrochemical immunosensor for CRP 
was based on optimised parameters first developed on the ELISA platform. The 
parameters were then transferred on to screen-printed gold electrodes (JD 
variant). These electrodes were chosen after an evaluation study was 
conducted on different types of electrodes described in chapter two. The 
adopted parameters from the ELISA were then further optimised to enhance the 
performance of the electrochemical immuno sensors, including investigating the 
effect of using covalent immobilisation techniques. The performance of the 
optimised immunosensors was then compared to that of the in house ELISA 
and a commercially acquired ELISA kit using spiked serum samples. The assay 
sensitivity was also explored using several plasma proteins. A direct sandwich 
ELISA format was developed and optimised for human C-reactive protein. Two 
types of mouse anti- human CRP monoclonal antibodies were used. One was 
conjugated to horseradish peroxidase (HRP) and was used as the detection 
antibody, and the other was immobilised as the capture antibody. Horseradish 
peroxidase was chosen because it is an enzyme with high substrate turnover 
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rate, its active site is in close proximity to the surface and thus it is capable of 
efficient electrochemical transduction process that aid sensitive detection 
(Schumacher, 2001). 
 
A commercially acquired chromogenic substrate based on 3,3’, 5,5’-
tetramethylbenzidine dihydrochloride (TMB) and H2O2 solution was used on the 
ELISA and self-made alternative was used on the immunosensor. The ELISA 
format used is shown in Figure 3.3. The electrochemical detection was done 
using chronoamperometry at -200 mV on the JD screen-printed immunosensors 
that have on board gold working electrode and an integrated Ag/AgCl pseudo-
reference electrode. The applied potential was selected through 
recommendations from work done on similar reagents and electrodes (Salam 
and Tothill, 2009). 
 
 
 
 
Figure 3.3: Schematic diagrams for (A) Sandwich immuno assay setup for the 
C-reactive protein on a screen-printed gold electrode. The antibodies are 
immobilised passively and the detection antibodies are conjugated with HRP. In 
diagram (B) the combination of TMB and H2O2 with HRP enzymes results in a 
reaction with indirect electron transfer on the gold working electrode surface. 
Development of an Electrochemical Immunosensor for C-Reactive Protein 
 
94 
W.M.Fakanya-Cranfield University-PhD Thesis 
Standard curves were generated using immuno sensors on standards with 
known concentrations of CRP in both buffer and spiked serum. The results were 
then fitted using a four-parameter curve fit which was used to extrapolate 
unknown concentrations (Warwick, 1996). The results of the unknown 
concentrations were then compared with those obtained on the same samples 
using a commercial ELISA. 
 
3.2 Materials  
Potassium chloride (KCl), potassium ferricyanide (K3Fe(CN)6+3H2O), TMB (3, 
3’, 5, 5’- tetramethylbenzidine hydrochloride), PBS (phosphate buffered saline) 
containing 0.137 M sodium chloride, and phosphate buffer, 0.01 M, pH 7.4 in 
tablet form, citrate phosphate buffer tablets, hydrogen peroxide, sodium 
hydroxide and sodium chloride, bovine serum albumin (BSA), 11-
mercaptoundecanoic acid (11-MUA), and 3,3-dithiodipropionic acid (DTDPA), 
were purchased from Sigma-Aldrich (Dorset, UK). Micropipettes were 
purchased from Eppendorf, UK. Pipette tips and 1.5 mL tubes, were purchased 
from Fisher Scientific (Loughborough, UK). Anti-Human C- Reactive protein 
capture antibody and mouse monoclonal c6 to C reactive protein: AB 8272, 
Anti-Human C- Reactive protein, HRP conjugated detection antibody were 
bought from (Abcam, Cambridge, UK). Skimmed milk protein, (KPL Ltd, 
Gaithersburg, USA). Reverse Osmosis (RO, Ultrapure) water (18 M MΩcm-1) 
was obtained from Milli-Q water system (Millipore Corp., Tokyo, Japan). 
Glassware and volumetric materials were of analytical grade. 
 
ELISA tests were first developed using a micro well polystyrene plates, 
MaxiSorp® plates purchased from Fisher Scientific, Loughborough, UK. An 
incubator/shaker from Labsystem iEMS® was used for temperature control 
incubation. A Florostar® plate reader was used which was set at appropriate 
wavelengths, BMG, UK. The electrodes used in this project were the JD type 
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designed by Cranfield University and fabricated using the facilities at DuPont 
(Bristol, UK). The gold working electrode was circular with a 1.3 cm2 planar 
area, a complementary carbon counter electrode and an Ag/AgCl reference 
electrode. The substrate material used is PET 125 µm Autotype HT5. The 
carbon electrode has an approximate dried thickness of 7 µm, while the gold 
and Ag/AgCl electrodes both have an approximate thickness of 18 µm. The 
encapsulation of 5036 blue had an approximate thickness dried of 4 µm. Inks 
used in the construction of the sensors are BQ221 carbon ink, BQ331 gold ink 
and the 5880 Ag/AgCl and are available from DuPont (Bristol, UK). Autolab 
Electrochemical Analyser with general-purpose electrochemical software GPES 
4.9 was purchased from  Metrohm (Ultrech , Netherlands).The electrodes were 
connected to an edge connector and then connected to the electrochemical 
analyser using a modified connector (Maplin UK). 
 
3.3 Methods 
3.3.1 Optimisation of the ELISA micro-plate based assay 
Detailed description of how the micro plate based ELISA assay was developed 
for C-reactive protein. The optimum coating and detection antibodies were 
investigated, several other parameters including experiments for discovering the 
best blocking solutions and incubation times were conducted and are discussed 
in this section. 
 
3.3.2 Optimisation of the Coating Antibody 
Antibody immobilisation on the micro plate was achieved through passive 
absorption. The optimisation of the coating antibody was carried out first to 
select the optimal concentration of the capture antibody to use for coating. A 
checkerboard concentrations method was used to optimise and select both the 
coating and the detection antibodies. A generic protocol for this method was 
adapted from Salam and Tothill (2010) was initially used but parameters were 
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optimised for the CRP antigen. A new ELISA plate was air brushed with 
nitrogen to clean it and then coated with various concentrations of the capture 
antibody (100 µL) mouse monoclonal anti human CRP antibody ab 8272 
(Abcam, Cambridge, UK ) dissolved in 0.05 M carbonate-bicarbonate buffer pH 
9.6. Different concentrations of the coating antibody (2, 4, 6, 8, 10 µg ml-1) were 
then deposited in triplicates and allowed to incubate overnight at 4 °C.  
 
The plate was then gently washed with Phosphate buffer saline plus 0.05 % 
Tween 20 (PBS-T) three times and dried by inverting and blotting the plate on 
paper towel. The plates were then blocked for 60 minutes at 37 °C with 300	μl 
of 1:10 dilution of milk protein (KPL Ltd., UK) in PBS. The plates were then 
washed in a similar manner as described above and standard concentration of 
the antigen 100 µL of (0, 0.5, 1, 10, 50 ng mL-1) was added to the well and it 
was incubated for 1 h at 37 °C. The plate was then washed again and a 
conjugated rabbit monoclonal anti human CRP antibody with HRP Ab 8296 
(Abcam, Cambridge, UK). A concentration of 0.375 µg mL-1 in PBS with milk 
was added to the plate and incubated for 1 hour at 37 °C. The plate was finally 
washed 4 times and a 100 µL solution of TMB based chromogenic substrate 
was added and incubated for 30 min before the reaction is stopped by 100 µL of 
1 N sulphuric acid solution.  
 
3.3.2.1 Investigating Appropriate ELISA Blocking Solution. 
The investigation of the most suitable blocking solution was done between three 
recommended choices from previous work at Cranfield Health. Three blocking 
solutions were investigated for the C-reactive protein assay. These included 
blocking agents previously reported in literature including a 1 in 10 dilution of 
skimmed milk protein in PBS (Salam and Tothill, 2010), 1% PVA (Kadir and 
Tothill, 2010) and BSA which is a traditional blocking agent. This was done by 
running the assay using the method described in Section 3.3.2.4. Using plates 
coated with 6 µg mL-1 of coating antibody and running three concentrations (0, 
25, 50 ng mL-1) of antigen in triplicate for each of the blocking solution. 
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3.3.2.2 Optimisation of the ELISA Detection Antibody  
A new Elisa plate was air bushed with nitrogen to clean it and it was labelled 
and coated in triplicated with 100 µL the optimised capture antibody 
concentration of 6µg/ml of mouse monoclonal anti human CRP antibody ab 
8272 (Abcam, Cambridge, UK ) and allowed to incubate overnight at 4 °C. The 
plate was then gently washed with Phosphate Buffer Saline plus 0.05% Tween 
20 (PBS-T) for three times and dried by inverting and blotting on paper towel. 
The plates were then blocked for 60 minutes at 37 °C with 300 µLof 1:10 
dilution of skimmed milk in PBS. The plates were then washed in similar 
manner described above and standard concentrations of the antigen 100 µL of 
(0, 0.5, 1, 5, 10, 20, 40, 60, 80, 100 ng mL-1) were added to the microwells and 
it was incubated for 1 h at 37 °C. The plate was then washed again before 100 
µL of different concentrations of conjugated rabbit monoclonal anti human CRP 
antibody were added. The antibodies were diluted with PBS to give final 
concentrations of 0.1, 0.25, 0.375, 0.5 µg mL-1 and incubated for 1 hour at 37 
°C. The plate was finally washed six times and a 100 µL solution of TMB based 
chromogenic substrate was added and incubated for 30 min before the reaction 
was stopped by 100 µL 1 N sulphuric acid solution.  
 
3.3.2.3 Optimisation of the ELISA Incubation Times  
After successfully selecting optimum coating and detection antibody 
concentrations, Investigations were done to find the best incubation time for the 
assay. The first experiments were done for the optimum incubation time for the 
coating antibody. The assay was completed as described in Section 3.3.2.4 but 
several incubation times were tried for the coating (15 min, 30 min, 1 h, 2 h, 5 h) 
at 37 °C and for overnight coating (16 h 4°C). The other assay parameters were 
kept constant. For the antigen and the detection antibody limited times were 
investigated because of the known strength of the antibody antigen thus only 
incubation times of 15 min, 30 min, 1h, 2 h were investigated. 
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3.3.2.4 Detection of CRP using the Optimised Micro Plate ELISA 
Taking into account the best conditions in the investigations for the optimisation 
of the ELISA assay a protocol was devised that was used for determining the 
final standard curve and interpreting unknown concentrations in the samples. In 
this final protocol, 100 µL of the optimised capture antibody concentration of 6 
µg mL-1 of mouse monoclonal anti human CRP antibody was used for coating 
and this was allowed to incubate for 2 h at 37°C. The plate was then gently 
washed three times with phosphate buffer saline plus 0.05% Tween 20 (PBS-T) 
and dried by inverting and blotting on paper towel. The plates were then 
blocked for 60 minutes at 37 °C with 300 µL of 1:10 dilution of skimmed milk in 
PBS. The plate was then washed and dried again and standard concentrations 
of the antigen 100 µL (0, 0.5, 1, 5, 10, 20, 40, 60, 80, 100 ng mL-1) were added 
to the microwells and it was incubated for 1 h at 37 °C. The plate was washed 
again and 100 µL of 0.1 µg mL-1 HRP conjugated rabbit monoclonal anti human 
CRP antibody was added to the plate and incubated for 1 hour at 37 °C. The 
plate was finally washed six times and a 100 µL solution of TMB based 
chromogenic substrate was added and incubated for 30 min before the reaction 
is stopped by 100 µL of 1 N sulphuric acid solution. The curves were fitted using 
a four-parameter curve fitting described in Section 3.3.8. 
 
3.3.3 Method of Optimising the CRP Assay on Screen Printed Gold 
Electrodes  
The immuno assay for CRP was optimised to function on the electrode surface. 
The method used for the optimisation of the gold electrode was adapted from a 
procedure described by previous work on development of a biosensor for 
Salmonella detection by Salam and Tothill (2009). Antibody immobilisation on 
the gold working electrode was carried out using passive absorption and it was 
this processes which was optimised first to get the best concentration of the 
capture antibody to use for coating. As usual, the electrode strips were first 
baked at a temperature of 120 °C for 30 minutes, washed and rinsed with 
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distilled water to remove any particle contaminants. The working electrode was 
then coated with a drop of 10 µL of mouse monoclonal antibody dissolved in 
0.05 M carbonate-bicarbonate buffer pH 9.6. Different concentrations of the 
coating antibody (5, 10, 20, 50, 100 µg ml-1) were deposited in triplicates and 
allowed to incubate overnight at 4 °C. The electrode surface was then gently 
washed with PBS-Tween, two times, rinsed with distilled water and air-dried 
with nitrogen.  
 
The working electrodes surface was then blocked for 30 minutes at 37 °C. The 
blocking solution was a 1:10 skimmed milk dilution in PBS. The electrodes were 
then washed in similar manner described above, standard concentration of the 
antigen (20 µL of 1 µg mL-1) was added to the working electrode and it was 
incubated for 2 h at 37 °C in a moist Petri dish. The electrode was washed 
again and a conjugated rabbit monoclonal antibody with HRP (20 µg mL-1) in 
PBS with milk was added to the electrode and incubated for 1 hour at 37°C. The 
electrodes were then connected to an edge connector, which is connected with 
a multi-channel AUTOLAB electrochemical instrument from Metrohm (Utrecht, 
Netherlands). All measurements were performed by adding 100 µL of 4 mM 
TMB and 0.06% H
 2O 2 in 0.05 M citrate phosphate buffer plus 0.1 M KCL 
combined in a 1:1 ratio, with chronoamperometry methods at -200 mV constant 
current and run for 200 to 300 s using electrochemical GPES 4.7 software. 
Similarly, the same was done for the optimisation of the conjugate and a 
reverse approach was done where the capture antibody was chosen to remain 
constant at 60 µg mL-1 and the antigen remained at 1 µg mL-1 but HRP 
conjugated antibody was varied between (10, 20, 30, 50, 100 µg mL-1). 
Incubation conditions for the coating antibody were also investigated by varying 
time and temperature. 
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3.3.4 Surface Modification of the Gold Electrode with Thiol group 
Self Assembled Monolayers (SAMs) 
Self-assembled monolayers were made using two chemicals, 11-
mercaptoundecanoic acid (11-MUA) and 3,3-dithiodipropionic acid (DTDPA) 
that have long and short carbon spacers respectively. This was done by baking 
the JD electrodes in an oven at 120 °C for 30 min before plasma cleaning them 
in oxygen free nitrogen at 50w for 2.5 minutes (Emitech K 1050X, EM 
Technologies, Kent, UK), at a power of 50 W with a bleed vacuum trip of 3 x 10-
1
 mbar and an ashing time of 1 minute. The working electrodes were then 
washed with ethanol using a pipette. For the 11-MUA monolayer , of 2mM of 
11- mercaptoundecanol solution was made and the electrode  were deposited 
in it ensuring that the working electrodes faced up and they were not on top of 
each other. The working electrodes were incubated in the dark at room 
temperature overnight. The electrodes were then washed with deionised water 
and dried using nitrogen gun with a gentle flow. 
 
 
 
11-mercaptoundecanoic acid 3,3-dithiodipropionic acid (DTDPA) 
Figure 3.4: The chemical structures of the two compounds used to modify the 
surface of the gold working electrodes through creating self-assembled 
monolayers SAMs. 
 
For the DTDPA monolayer, 3% w/v of 3,3-dithiodipropionic acid in ethanol was 
made and the added to the working electrodes, ensuring that the working 
electrodes faced up and they were not on top of each other. The working 
electrodes were incubated in the dark at room temperature overnight before 
being washed and dried. These methods were based on direct translation of the 
optimised surface modification of QCM-1 chips using similar chemicals that was 
done by our colleagues (Uludag and Tothill, 2010). 
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3.3.5 Characterisation of the chemically modified working 
electrode  
The thiol modified gold electrodes were characterised using contact angle 
measurements and cyclic voltammetry. The measurement of contact angle is an 
invaluable basic technique used to assess the interaction of a surface with a 
standard liquid solution. The Young Dupree equation is used to calculate and 
quantify this relationship and it is based on adhesion and surface tension 
(Kumar and Prabhu, 2007). The contact angle measurements were done first as 
they did not alter the modified surface and thus the electrodes could be used 
again for the cyclic voltammetry analysis. For the contact angle measurement, 
three modified electrodes from each of the two chemical modification used as 
well as the bare electrodes were investigated, the electrodes  were gently dried 
with a nitrogen gun and mounted on the stage of a CAM 100 Optical Contact 
Angle Meter from KSV instruments (Helsinki, Finland). A drop of Millipore water 
was added on the surface of the working electrode and the contact angle was 
analysed using the CAM 100 software and the average contact angle was 
automatically calculated. Figure 3.5 below shows the setup of a contact angle 
measurement using a CAM 100 Optical contact angle meter. 
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Figure 3.5: A Screen-printed gold electrode mounted on the stage of a CAM 
100 Optical Contact Angle Meter. The image on the screen is for a drop of de 
ionised water being injected to the gold surface before measurements are 
taken. 
 
The surface modified electrodes were then characterised using cyclic 
voltammetry. This was conducted by placing 100 µL of solution (1 mM 
potassium ferricyanide K3[Fe(CN)6] prepared in 0.1 M KCl) on the electrode 
surface. The electrochemical behaviour of potassium ferricyanide was 
measured using cyclic voltammetry at 50 mVs-1, measurements were obtained 
by scanning 5 cycles from -0.5 to 0.8 V relative to Ag/AgCl reference electrode 
using a multi-channel AUTOLAB electrochemical instrument. 
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3.3.6 Surface modification evaluation using immunoassay 
A 20 μL of an equal volume of EDC–NHS (0.4M EDC and 0.1M NHS prepared 
in distilled water was applied to activate the electrode surface for 15 min at 
room temperature. The two chemicals are capable of activating the carboxylic 
groups on the exposed side of the SAMs to enable reaction with the ligand. The 
chemistry behind this is explained in literature (Vaughan et al., 1999) and is 
summarised in Figure 3.6. 
 
Figure 3.6: The chemistry of the covalent immobilisation of the CRP antibody 
1c11 on self-assembled monolayers of 3,3-dithiodipropionic acid (DTDPA) 
using EDC-NHS coupling method. Figure adapted from Park et al, (2004). 
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The electrodes were then subsequently washed again and gently dried using N2 
flow. A 10 µL of the antibody solution (50 µg mL−1) of mouse monoclonal 
antibody against Human CRP dissolved in 0.05 M carbonate bicarbonate buffer 
pH 9.6 was deposited over the surface for immobilisation. Exposed ester groups 
were then blocked with 20 µL of 1Methanolamine–HCl. The electrodes were 
then washed in similar manner described above and 20 µL of standard 
concentrations of the antigen (0, 25, 50, and 100 ng mL-1) were added to the 
working electrodes and it was incubated for 1 hrs at 37 °C in a moist Petri dish. 
The electrodes were washed and a HRP conjugated mouse monoclonal 
antibody against human CRP (20 µg mL-1) in 1:40 dilution milk protein was 
added to the electrode and incubated for 30min at 37 °C. The electrodes were 
then washed and connected to an edge connector, which is connected with a 
multi-channel AUTOLAB electrochemical instrument from Metrohm (Ultrech , 
Netherlands). 
 
3.3.7 Optimisation of the assay for antigen addition 
Two methods for introducing the antigen were investigated which are the 
standard procedure and the premixed procedure. Both methods start with the 
passive immobilisation of the antibodies on the working electrode followed by 
blocking. This was done by first baking the electrodes in the oven at 120 °C for 
30 min and washing and drying and drying them before being coated with 20 µl 
of 60 µg mL-1 coating antibody solution in carbonate bicarbonate buffer pH 9.6. 
The electrodes were then incubated for 2 h at 37 °C. The electrode surface was 
then gently washed with phosphate buffer saline with 0.05% Tween 20 two 
times and rinsed with distilled water before air-drying with nitrogen. The working 
electrodes surface was blocked (30 min at 37 °C with 50 µL milk protein diluted 
with PBS) in a controlled humid condition, the electrodes were then washed and 
air-dried. The following steps then differed depending on the antigen addition 
method used. 
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The first method was the systematic (step-by-step) assay in which the antigen 
and the detection antibody are introduced separately with a washing step in 
between. In this procedure after blocking, standard concentrations of the 
antigen 20 µL of (0, 12.5, 50 and 100 µg mL-1), were added to the working 
electrodes of different sensors in triplicates. They were then incubated for 1 h at 
37 °C in a moist petri dish before being washed and a conjugated mouse 
monoclonal antibody with HRP 20 µL of 30 µg mL-1 in 1:40 dilution milk protein 
was added to the electrode and incubated for 1 h at 37°C. The electrodes were 
then washed and connected to an edge connector, which is connected with a 
multi-channel AUTOLAB electrochemical instrument. The substrate was added 
and measurements were done. 
 
For the premixed procedure, the antigen was mixed in solution with the 
conjugated mouse monoclonal antibody for 1 h. The solutions were made to 
ensure that the concentration of both the antigen (0, 12.5, 50 and 100 µg mL-1) 
and the detection antibody (30 µg mL-1) were not compromised by the 
premixing. Compensatory calculations for the concentrations were done that the 
final premix well has the suitable concentrations. The mixture was then 
incubated for 1h on a Stuart SB3 rotator (Appleton Woods, Birmingham, UK), 
with the rotator at a 10° inclination angle. A 20 µL of the solution of the premix 
was then deposited on the blocked working electrodes and incubated for 
another 1 h. For both methods the electrodes were then washed and connected 
to an edge connector, which is connected with a multi-channel AUTOLAB 
electrochemical instrument. All measurements were performed by adding 100 
µL of 4 mM TMB and 0.06 % H2O2 in 0.05 M citrate phosphate buffer plus 0.1 M 
KCL with chronoamperometry methods at -200 mV potential and run for 200 s 
to 300 s using electrochemical GPES 4.7 software. 
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3.3.8 SPGE Calibration Plot and Interpretation of Result 
After discovering that the premixed antigen addition gave favourable results, It 
was adopted for used in the optimised immunosensor protocol. The exact pre 
mixed procedure described in Section 3.3.7 was to create a standard curve that 
would be later used to quantify spiked serum samples with unknown CRP 
concentrations. Serial diluted concentrations of the standards (0.1 , 0.156, 3.12, 
6.25, 12.5, 25, 50, 100 ng mL-1) were tested using  Both the immunosensor and 
ELISA methods and calibration curves were fitted by non-linear regression 
using the following four parameter logistic function (Warwick, 1996 ). 
In this equation y is response or current obtained, a and d , are the maximum 
and minimum values of calibration curve, respectively, 	# is the concentration at 
c = inflection point and b is the slope. The limit of detection (LoD) is defined as 
the minimum concentration of an analyte that can be detected with statistical 
confidence. There are many ways of estimating LoD and they depend on the 
level of confidence required. In this work the LoD of CRP was defined as that 
equivalent to three times the value of standard deviation (σ) of the blank signal. 
This was calculated based on the following equation 3-2 were σ becomes the 
standard deviation of the zero value (Warwick, 1996). 
In this equation a= minimum asymptote of the estimated response at zero 
concentration, d= maximum asymptote of the estimated response at infinity 
concentration, x represents the concentration of the analyte and b is the slope 
of the curve at c. Another important parameter to consider is the limit of 
quantification. While this depends on the level of confidence required to be 
presented on the assay, the U S Food and drug administration F.D.A defines it 
as the mean of the blank plus 10 times standard deviation (F.D.A, 2001). 
$ = % − '
(1 + )#*+
,-
+ ' Equation 3-1 
./	 = 	#	 0 %	– '%	– 	' − 	334
56,	 Equation 3-2 
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3.3.9 Comparing the Performance of the SPGE and the Optimised 
ELISA with a Commercial ELISA 
The developed CRP assay on the screen-printed gold electrodes and the 
optimised ELISA assay were compared to a commercially acquired human CRP 
immuno assay that was purchased from immunology consultants laboratory 
(Newburg, USA). The three techniques were used to detect the amount of CRP 
antigen spiked in commercial serum. The assays were performed according to 
their optimised protocols described in sections 3.3.2.4 and 3.3.8. For the 
commercial ELISA a protocol incorporated in the kit was followed closely. This 
consisted of re-suspending lyophilised controls and standards with sample 
diluent buffer as directed. All samples were to be diluted 200 times with the 
sample diluent buffer.  A 100 µL of the standards, samples and controls were 
pipetted to the provided pre-coated micro plate and incubated for 1 hr. The next 
step was washing with appropriately diluted washing buffer that was provided, 
before putting 100 µL of the 10 times diluted detection antibody and incubating 
for 30 min. The plate was then washed again and 200 µL of chromogenic 
substrate was added in each used well and the plate was incubated at room 
tempreture in the dark for 15 min. A stopping solution was then added to each 
well (100 µL) and the plate was read on the fluorostar® plate reader at 450 nm 
wavelength.   
Six samples with unknown concentrations of CRP were made by spiking a 
random amount of antigen into commercially acquired serum. The serum 
samples were the inter diluted ensuring that the concentrations of the antigen in 
them will be different. The spiked serum samples were then analysed in 
triplicates using the optimised and commercial ELISAs as well as the optimised 
immuno sensor. Standard curves were plotted and the unknown concentrations 
of CRP in the samples were interpolated and results compared, the limit of 
detection of all the methods was established. 
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3.3.10 Cross Reactivity Studies 
Cross reactivity is a measure of the specificity of the antibodies to the antigen of 
interest. Although this was confirmed by the antibody manufacturers there is 
always a need to verify the claims if the resources are available. In this 
experiment, other proteins were used to investigate the specificity of the 
developed immuno assays on the optimised ELISA and the immunosensor 
platform. Commercial serum was spiked with antigens to make three solutions 
with 25 ng mL-1 of CRP, cardiac troponin t and prostate specific antigen (PSA). 
These solutions were then assayed in triplicate using the three methods 
analysed using the methods described in Sections 3.3.2.4 , 3.3.9 and 3.3.8. For 
the commercial ELISA a protocol incorporated in the kit was followed closely. 
Standard curves were plotted and the signal from the various proteins was 
interpolated and normalised against the highest output based on the positive 
control of the commercial ELISA. 
 
3.4 Results and Discussion 
3.4.1 Development of an micro plate based ELISA assay 
The chequerboard method was used to optimise the ELISA assay. The 
optimized coating antibody was investigated first and a Nunc Microtittre flat-
bottomed plate was used as it has enhanced binding abilities due to its surface 
chemistries with more exposed carboxyl groups. The detection antibody was 
then investigated followed by other assay parameters like incubation times and 
blocking reagents. The optimised micro plate based ELISA was then compared 
to a commercial alternative and the developed immunosensor. 
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3.4.2 Investigating the ELISA Coating Antibody Concentration 
Various coating antibody concentrations were investigated (2, 4, 6, 8, and 10 
µgmL-1) and the results are shown in Figure 3.7. The results showed that there 
was an increase in the signal output with an increase in the concentration of the 
coating antibody for the CRP assay. This trend was however consistent until 6 
µg mL-1 concentration after which there was no major difference observed with 
subsequent increases in the coating antibody. This indicate that the optimum 
coating concentration is around 6 µg mL-1 as any further increase did not give 
any advantage to the signal output. The results also showed that there was 
saturation at around 15 ng mL-1, this may have been caused by the fact that the 
detection antibody concentration was not yet optimised and the provisionally 
used concentration of 0.375 µg mL-1 was probably too concentrated. 
 
Figure 3.7: The standard curves showing the effect of increasing concentration 
of coating antibody on the signal obtained. Varying concentrations of the 
coating antibody (2, 4, 6 ,8 10 µg mL-1) were investigated by matching the rest 
of the parameters on a plate immunoassay . n=3, maximum CV=6.2%. 
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3.4.3 Optimising the Detection Antibody for CRP 
After obtaining the optimum coating antibody of 6 µg mL-1, the next step was to 
investigate the best concentration of the detection antibody. It was discovered in 
preliminary experiments that the HRP conjugated anti human CRP used in this 
experiment was very active and saturation was being achieved prematurely 
thus resulting in a low dynamic range. The experiment was designed to focus 
on concentrations below 0.5 µg mL-1 as these were more feasible and dilute 
enough not to saturate the assay. The results are shown in Figure 3.8, they 
show that there is a relationship between increasing the signal and the 
concentrations of the anti CRP HRP conjugate. However, the relationship 
ceases to exist at 0.375 µg mL-1, where any increase in the concentration of the 
detection antibody did not give any further advantage. The best dynamic range 
was given by the least concentrated detection antibody concentration (0.1 µg 
mL-1) which was the only one capable of detecting up to 100 ng mL-1 CRP 
concentrations. 
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Figure 3.8: The effect of increasing concentration of the detection antibody on 
the signal obtained. Varying concentrations of detection HRP conjugated 
antibody (0.1, 0.25, 0.375, 0.5 µg mL -1) were investigated. n=3, maximum 
CV=6.8%. 
 
3.4.3.1 Optimising the Blocking Buffer 
Three blocking solutions were investigated for the C-reactive protein assay. 
These included blocking agents previously reported in literature including a 1 in 
10 dilution of skimmed milk protein in PBS (Salam and Tothill, 2010), 1% PVA 
(Kadir and Tothill, 2010) and BSA which is a traditional blocking agent. This was 
done by running the assay using the method described in Section 3.3.2.4. Using 
plates coated with 6 µg mL-1 of coating antibody and running three antigen 
concentrations (0, 25, 50 ng mL-1) of antigen in triplicate for each of the blocking 
solution.  
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The results of this experiment showed that the 10 % skimmed milk protein gave 
the best blocking with good consistency and limited nonspecific binding. Figure 
3.11 shows that the columns representing no antigen reading (blank) gave the 
lowest reading when compared with bovine serum albumin (BSA) and PVA 
polyvinyl acetate (PVA). The standard deviation of the wells with 10 % milk was 
also much smaller and more consistent than that for the other blocking agents 
that were investigated. It was decided to continue to use the 10 % milk protein 
for future immuno-assays. 
 
3.4.3.2 Optimising the Incubation Time for the ELISA Coating Antibody 
The coating of the plate is arguably a very important step as it can directly affect 
the results of the assay. A performance study was done to identify the optimum 
incubation time, which ensures that the maximum capture antibody was bound 
onto the solid state. Figure 3.9 indicates that there is an increase in the signal 
with increasing the incubation times. This increase however reaches a plateau 
between 1 and 2 h of incubation time. The results also show that there is no 
major benefit of incubating overnight to that of 2 h. The incubation of 2 h was 
thus adopted for the coating antibody for all future assays. 
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Figure 3.9: The effect of different incubation times on assay response. A micro 
plate was coated with 6 µg mL-1 of anti-human CRP antibody and incubated for 
varying times (0.25, 0.5, 1, 2, 5 hr) at 37°C as well as 16h at 4°C, the rest of the 
assay parameters were synchronised, n=3, maximum CV=5.9%,bars represent 
standard deviation. 
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3.4.3.3 Standard Curve for the optimised ELISA 
Taking into account the best coating antibody concentration (6 µg mL-1) and the 
best detection antibody concentration (0.1 µg mL-1) a standard curve was 
constructed to show the full capabilities of the CRP Elisa Assay. The results in 
Figure 3.10, shows the optimised standard curve of the CRP assay.  
 
Figure 3.10: The standards curve for optimised ELISA assay for C- reactive 
protein with a linear plot insert. Standard concentrations of CRP (0.1 ,0.156, 
3.12, 6.25, 12.5, 25, 50, 100 ng mL-1) were assayed using optimised 
parameters.n=3 ,bars = standard deviation, maximum CV=7.4., LoD=1.9 ng mL-
1
. 
Figure 3.10 shows that the standards curve for the optimised ELISA assay for 
CRP. The calculated limit of detection for the assay was 1.9 ng mL-1 and this 
was calculated by extrapolating the calculated signal of adding the background 
absorbance to a value three times the standard deviation from its replicates. 
This is was a good result as it is capable of distinguishing low risk from high-risk 
patients, thus making this assay suitable for inclusion in a biomarker diagnostics 
test for risk of cardiovascular disease. The targeted dynamic range was 0.5 to 
50 ng mL-1 and this result is comparable to other kits on the market. 
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3.4.4 Development of the Screen-printed immuno-sensor for CRP  
The optimisation of the assay carried out on the ELISA was then transferred to 
the biosensor platform. The differences in the surface chemistry, sample 
volumes and other factors like limited surface area for binding meant that the 
assay required optimisations on to the screen-printed electrodes in order to 
achieve optimal results. Far more concentrated antibody solutions would be 
required to give detectable signals especially if high sensitivity is to be 
achieved.  
 
3.4.4.1 Optimising the coating and detection antibodies 
Both the coating and the detection antibody concentrations had to be 
investigated on the screen-printed electrode platform. Different concentrations 
(5, 10, 20, 30, 50, 100 µg mL-1) of coating antibody (10 µL of mouse 
monoclonal antibody dissolved in 0.05 M carbonate-bicarbonate buffer pH 9.6) 
were investigated. The coating antibody were deposited in triplicates and 
allowed to incubate overnight at 4 °C, before an electrochemical assay was 
done as described in Section 3.3.8 using at 1 µg mL-1 CRP antigen standard 
and 20 µg mL-1 detection antibody concentration.  Similarly, the same was done 
for investigating the optimised detection antibody. The coating antibody was 
standardised at the optimum concentration 60 µg mL-1) and the antigen was 
also fixed at 1 µg mL-1 but the detection antibody concentrations were used (10, 
20, 30, 50,100 µg mL-1) to find the optimum. The electrodes were then washed 
and connected to an edge connector to a multi-channel AUTOLAB 
electrochemical instrument from Metrohm (Utrecht, Netherlands). 
The results obtained for these experiments are shown in Figure 3.12. The 
general trend showed that the peak for the coating antibody concentration is 
around the 60 µg mL-1. The drop in the signal after the peak can be due to 
packing impedance or steric hindrance. There was an increase in signal with 
increasing concentration of the detection antibody. This appears to reach a 
plateau at 30 µg mL-1 concentration, where the highest signal was achieved. 
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This plateau is caused by several factors including the fact that there is 
saturation of the antigen with the HRP conjugated detection antibody. There 
may also be a possibility that the applied voltage can only yield a maximum of 
the peak current given the type of the electrode and the quality of the immune-
assay. 
 
 
Figure 3.11: The effect of the different blocking agents were investigated on the 
sandwich assay. A plate was coated with 6 µg mL-1 of coating antibody and  
incubated for 2 h at 37°C before being washed, three different blocking agents 
(300 µL of 10 % milk protein, 1% PVA, 5% BSA ) were investigated. n=3, 
maximum CV=5.8 %,bars represent standard deviation. 
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Figure 3.12: The optimisation of the coating and detection antibody for C-
reactive protein assay on screen-printed gold electrodes (SPGEs), varying 
concentrations of the detection (10, 20, 30, 50, 100 µg mL-1) and for coating (5, 
10, 20, 30, 50, 100 µg mL-1) antibody concentrations were investigated. n=3, 
maximum CV=4.9%, bars made using standard deviation. 
 
3.4.4.2 Optimisation of the Method of Antigen addition 
Immuno assays are enhanced by several factors that include the orientation of 
the assay procedure particularly concerning the introduction of the antigen. 
From a product development point of view it is more beneficial to have an assay 
which performs better with an setup which involves the detection antibody 
interacting with the antigen before being introduced to the immobilised capture 
antibody. This will simulate the procedure that is employed by most lateral flow 
devices. While plate immuno-assays with the exception of competitive ones 
operate on an step by step application it is more desirable to have a premixed 
antigen antibody complex as this may save on assay time and may improve on 
the assay sensitivity.  
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In this experiment, the incubation of the HRP conjugated antibody with the 
antigen-capture complex is compared to an alternative setup where the two 
(antigen and detection antibody) are premixed in free solutions. It was also 
important to synchronize the contact time of the assay in order to make sure 
that the concentrations of the reagents were not compromised through dilution. 
 
In both methods, the electrodes were coated with 20 µl of 60 µg mL-1 coating 
antibody solution in carbonate bicarbonate and incubated for 2 h at 37 °C. The 
working electrodes surface was washed and  blocked (30 minutes at 37 °C with 
50 µL milk protein diluted with PBS) in a controlled humid condition, the 
electrodes were then washed and air-dried. For the standard procedure, CRP 
standard concentrations (20 µL of 0, 12.5, 50 and 100 µg mL-1) were added to 
the working electrodes in triplicates. They were then incubated for 1 h at 37 °C 
in a moist petri dish before being washed and a conjugated mouse monoclonal 
antibody with HRP 20 µL of 30 µg mL-1 in 1:40 dilution milk protein was added 
to the electrode and incubated for 1 hr at 37°C. In the case of the premixed 
procedure, the detection antibodies and the compensatory antigen 
concentration were premixed in solution with the conjugated mouse monoclonal 
antibody and incubated at room temperature for 1h, with a Stuart SB3 rotator 
(Appleton Woods, Birmingham, UK) with the rotator at a 10° inclination angle. A 
20 µL of the solution of the premix was then deposited on the blocked working 
electrodes and incubated for another 1 h. The electrodes were then washed 
and connected to an edge connector, which is connected with a multi-channel 
AUTOLAB electrochemical instrument. The substrate was added and 
measurements were done by adding 100 µL of 4 mM TMB and 0.06 % H2O2 in 
0.05 M citrate phosphate buffer plus 0.1 M KCL with chronoamperometry 
methods at -200 mV potential and run for 200 s to 300 s using electrochemical 
GPES 4.7 software. 
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Figure 3.13 shows the results obtained, the premixed assay showed there was 
increase in sensitivity than the standard systematic setting. This could be 
attributed to the fact that before the antigen was captured directly on the sensor 
surface it had more flexibility to interact and bind to the detection antibody in 
solution. Unlike the systematic set up where the antigen will already be 
immobilised by the time the detection antibody is introduced. Another 
disadvantage of the systematic method is that the excess antigen will have 
been washed away before getting a chance to bind to the detection antibody, 
This may explain the enhanced signals and the proportional response shown in 
Figure 3.13. 
 
 
Figure 3.13: The effect of premixing the detection antibody with the antigen on 
signal performance. Electrodes were coated and blocked, in the standard assay 
CRP antigen concentrations were added, while for the premixed procedure, 
detection antibodies and the antigen were premixed at room temperature first.. 
n=3, maximum CV=9.4% and bars represent standard deviation. 
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3.4.5 Optimised CRP Assay on Screen-Printed Gold Electrodes 
A standard curve was constructed using the optimised assay described in 
section 3.3.8. The standard curve obtained is shown in Figure 3.14.  The assay 
was done using the method described in section 3.3.8 and the calibration plot 
was used to extrapolate CRP from spiked serum samples. The comparative 
studies of samples and cross reactivity were conducted using this curve. The 
final developed SPGE immunosensor exhibited working ranges from 2.2 to 100 
ng mL-1. This is well in range for the detection limit required for the standard use 
of CRP, thus the immuno-sensor demonstrated the feasibility of electrochemical 
detection of CRP using screen-printed gold electrodes.  
 
Figure 3.14:The Graph showing standard curve for the C-reactive protein assay 
on screen-printed gold electrodes (SPGEs). Concentrations of CRP antigen in 
buffer were premixed with detection antibody before an assay was done on the 
immunosensor. n=3, CV=9.8%, bars= standard deviation LOD=2.6ng mL-1. 
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3.4.1 Exploring the use of self-assembled monolayers to enhance 
assay sensitivity 
Although the optimised immunosensor that was developed using passive 
adsorption was competent to meet the diagnostic assay parameters, there was 
need to investigate on other immobilisation methods that could potentially 
improve the antibody immobilisation on the sensor surface. The antibody 
immobilisation plays a crucial role in the fabrication of immunosensor, and the 
immobilization and orientation of the antibody on transducer surfaces like gold 
has become another focus of study in the biosensor field (Hao et al., 2009). 
Regardless of the kind immobilisation procedures chosen, it is important that 
more antibodies are immobilized on the transducer surface (Furuya et al., 
2006). Furthermore, functionality of antibodies should be preserved and that 
more active sites should be accessible. Immobilisation methods could be 
classified into covalent and non-covalent combinations. Several covalent 
coupling methods are available to immobilise the antibody depending on the 
specific reactive groups. The amine (-NH2), thiol (-SH2) and aldehyde (-COOH) 
coupling chemistries are well-established procedures. Covalent coupling is 
stable and, in general, does not need any modification of the antibody. The 
immobilization level is easily controlled and the ligand consumption is low. (Choi 
and Chae, 2010).  
Self-assembled monolayers (SAMs) are monolayers of well-defined structural 
and chemical properties. There are a variety of SAMs made by chemical 
adsorption, such as alkylchlorosilanes with long alkyl chains and organosulfur 
compounds like thiols, disulfide, and sulphides (O'Dwyer et al., 2004). 
Alkanethiol SAMs are widely used bioreceptor linker molecules because they 
offer two major advantages which are abundant functional groups to immobilize 
bioreceptors and a fully packed monolayer that results in limited nonspecific 
binding (Chaki and Vijayamohanan, 2002; Salam and Tothill, 2009). The 
stability of the SAM has been linked to the size of the carbon spacer and the 
longer the chain the more stable the SAM (Love et al., 2005). For this reason 
larger molecules like 11-mercaptoundecanoic acid (11-MUA) have been 
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favourites for the making of SAMs (Chaki and Vijayamohanan, 2002). However 
other authors have argued that short carbon spacers have advantages of 
lowering non-specific binding and thus increasing sensitivity (Bolduc and 
Masson, 2008).  
 
In this experiment self-assembled monolayers were made using two chemicals, 
11-mercaptoundecanoic acid (11-MUA) and 3,3-dithiodipropionic acid (DTDPA) 
that have long and short carbon spacers respectively. This was done by baking 
and plasma cleaning electrodes .The working electrodes were then washed with 
ethanol using a pipette, for the 11-MUA monolayer , electrodes were dipped in a 
2mM of 11- mercaptoundecanol solution overnight in the dark at room 
temperature. For the DTDPA monolayer, 3% w/v of 3,3-dithiodipropionic acid in 
ethanol was used in the same conditions. The electrodes were then washed 
with water and gently dried with a nitrogen gun. 
 
3.4.1.1 The Characterisation of the chemically modified working 
electrodes  
After the preparation of the self-assembled monolayer, cyclic voltammetry was 
used to determine the integrity of the method used to deposit the self-
assembled monolayers. After their deposition, it is physically impossible to see 
they had been formed and to what extent the coverage The results obtained are 
shown in Figure 3.15. The results showed that there was very limited 
conductivity on the modified surfaces as shown by near flat cyclic 
voltamograms. The voltamograms for the bare electrode showed the most 
conductivity and there was limited conductance on the11-MUA compared to the 
bare electrode. The DTDPA surface had the least conductance, which may 
translate to impedance being caused by the monolayer. The contact angle 
measurements were done to confirm this. The results showed decreased 
wettability on modified surfaces compared to the bare electrode. This could be 
attributed to the increased lyophobicity of the surface by the chemicals. 
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Figure 3.15: Cyclic voltammetry for validating the deposition and formation of 
Self assembled monolayers by thiol group chemicals that facilitate covalent 
coupling with the capture antibody. 5 scans of cyclic voltammetry were done 
using 1 mM potassium ferricyanide K3[Fe(CN)6] were prepared in 0.1 M KCl at 
50 mV S-1 scan rate.  
 
The average contact angle for bare screen-printed electrodes was 39.88° ± 
0.72, and the modified surfaces gave a higher angle measurement with 47.81° 
± 1.90 for 11-MUA and 45.98° ± 1.90 for DTDPA. The monolayers of 11-MUA 
and DTDPA are capable of depolarising the gold surface thus making it more 
water repellent. 
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3.4.2 Immunoassay for Evaluating Different Immobilisation 
Techniques 
Immuno assays were carried out to evaluate the effectiveness of the covalent 
coupling due to the two thiol group chemicals (11-MUA and DTDPA). The 
coupling is a result of the activation of the carboxyl groups by NHS and EDC via 
carbodiamide chemistry is one of the most popular methods (Park et al., 2004; 
Salam and Tothill, 2009). This method is based on the formation of NHS esters 
that will react with nucleophilic groups of the antibody under elimination of NHS 
and formation of a covalent bond. As mentioned earlier there have been 
reported improvements in the orientation and packing of the coating antibody 
due to the use of chemical compounds like 11-MUA and DTDPA (Uludag and 
Tothill, 2010). The two compounds were tried against a conventional passive 
immobilisation technique and the obtained results are shown in Figure 3.16.  
The results showed that the bare electrode gave a better consistent signal than 
the covalent immobilisation methods. Several factors may explain these 
unexpected results, the first being that there may have been damages to the 
electrodes when they got in contact with ethanol during washing or formation of 
the covalent surfaces. Ethanol was used as a solvent as 11-MUA is not water-
soluble. The electrodes used have an on board Ag/AgCl reference electrode 
that can be easily eroded away by volatile solvents like ethanol. 
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Figure 3.16: The impact of different covalent surface modifications to the assay 
performance of C-reactive protein on screen-printed gold electrodes 
(SPGEs).Two sets of electrodes were chemically treated  with self-assembled 
monolayers (DTDPA and 11-MUA) to facilitate covalent coupling. Optimised 
electrochemical immuno-assays were done to evaluate the effect of SAMs on 
the assay performance. n=3, CV=9.7%,bars = standard deviation 
 
The results showed non-specific binding on the 11-MUA coated chips. The 
control signal of 11-MUA coated chips was relatively higher than for other 
immuno sensors (Bare and DTDPA), this may have been caused by molecules 
trapped in the lattice of the 11-MUA monolayer. The 11-MUA monolayer has 
long carbon spacers due to its chemical structure, this means there is a 
considerable distance between its reactive groups and this in turn influences the 
distance between the sensor surface and the ligand. Unlike smaller molecules 
like DTDPA with short carbon spaces, Long chain SAM molecules that have 
been proven to trap proteins non-specifically in several ways (Love et al., 2005).  
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Figure 3.17: Diagram showing possible sources of non-specific binding on 
SAMs, (1) unutilised reactive groups (2) imperfect monolayers and (3) surface 
morphology (Choi and Chae, 2010). 
 
Bio sensing surfaces functionalized with alkanethiol SAMs suffer from non-
specific binding. The three main reasons are non-immobilized bio receptors like 
antibodies, imperfectly formed monolayers and polycrystalline gold grain 
structure (Love et al., 2005). Non-specific binding on the activated head group 
of the SAM where antibodies are not immobilized and reactive surfaces are 
exposed and unutilised they can attach non-specifically (Figure 3.17, 1). 
Several techniques have been tried to control this, especially through  de-
activating the head group with ethanolamine-HCl (O'Dwyer et al., 2004; Furuya 
et al., 2006). This was done in this experiment, although non-specific binding 
was still observed .Non-specific on the 11-MUA coated chips binding may also 
have been caused by imperfect monolayers form on polycrystalline gold 
surfaces as shown in (Figure 3.17 , 2 ), and unevenly distributed gold surface 
(Figure 3.17, 2 and 3 ). As the performance of passive absorption was meeting 
the diagnostic requirements for a CRP assay no further input on covalent 
immobilisation was pursued for the development of this immunosensor. 
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3.4.1 Comparison of developed immunosensor with the 
commercial and Optimised ELISAs 
Comparative studies were done to ascertain the quality of the developed 
electrochemical immunosensors and the in-house micro-plate based ELISA 
assay for CRP. This was done by triangulating the two developed methods with 
a commercially acquired ELISA assay.  
 
3.4.1.1 Assay Performance 
The performance of immunosensor was tested against that of the commercial 
ELISA from Immunology Consultants Limited as well as the in-house developed 
ELISA assay. The results showed that all the three methods were capable of 
detecting the unknown CRP concentrations in the spiked serum with slight 
variations in signals produced. 
 
Figure 3.18: The evaluation of three detection methods for C-reactive protein 
using spiked serum samples with unknown CRP concentrations. A commercial 
human serum stock was randomly spiked with CRP. The samples were then 
diluted 200 x with PBS tween before being analysed in triplicates using the 
different methods. n=3, CV=6.2%, bars = standard deviation. 
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The results obtained are summarised in Table 3-2 which showed consistency in 
the determination of the unknown CRP concentrations with acceptable 
correlations between the methods. Both intra and inter assay analysis showed 
acceptable reproducibility expected of most commercial for diagnostic assays 
which is between ≥15%.  The intra assay variation is the percentage error due 
to the differences in the interpolated quantities of an analyte in a sample run 
several times on a single assay. In this experiment, this was achieved after 
running 5 reps of a sample and interpolating the unknown against a single 
standard curve assayed concurrent with the samples. For results that are more 
accurate far more reps were needed but the resources permitted limited choices 
on this. For all the three methods used, the highest intra-assay variation on the 
unknown samples was 13.8% and this was from the in-house ELISA. The rest 
of the methods had fewer values than this, which was encouraging. The inter 
assay variation on the samples was below 7 % on all the methods used, which 
meant that there was close agreement between the different methods that were 
used. In this case inter assay variation is being defined as the level of erroe 
against the agreement of interpolated values between the three different 
assays. Error! Not a valid bookmark self-reference. showed the correlated 
performance between the commercial and the in-house ELSA, and Figure 3.20 
shows the one between the developed electrochemical immunosensor and the 
commercial ELISA. Both correlations were exceptional with R2 values around 
closely approaching1. 
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Table 3-2:Showing the intra and inter assay reproducibility of the detected CRP spiked in serum samples, n=5. 
Sample 
Commercial 
ELISA 
( ng mL-1) 
Optimised 
ELISA 
( ng mL-1) 
Immunosensor 
(SPGEs) 
( ng mL-1) 
Commercial 
ELISA CV  
(%) 
Optimised 
ELISA CV  
(%) 
Immunosensor 
(SPGEs) CV  
(%) 
Negative Control  1.05 1.23 0.98 8.57 13.82 11.22 
Sample 1  21.32 20.04 18.64 5.48 6.76 1.61 
Sample 2  17.43 16.38 15.13 5.21 6.43 3.19 
Sample 3  13.36 12.56 12.57 7.24 8.94 2.41 
Sample 4  2.07 1.94 2.09 9.48 11.83 9.59 
Sample 5  41.96 39.44 39.58 3.03 3.74 1.02 
Positive Control. 77.32 74.58 75.36 0.53 0.88 0.64 
y = 0.9756x - 0.8432
R² = 0.9987
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Figure 3.20:Correlation of performance between the 
immunosensor and the commercial ELISA kit. 
Figure 3.19:Correlation of performance between the 
commercial ELISA kit and the one developed In-house. 
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3.4.1.2 Cross Reactivity Studies 
Cross- reactivity generally refers to assay specificity, which is the possibility of 
an assay to react with other unintended antigens. It occurs in cases where 
several antigens carry the same antigenic determinant as that of the one used 
in raising the antibody used in the immuno assay. Specificity is dependant 
mostly on the quality of the antibodies and it is an important analytical 
parameter for measuring the reliability of an immunosensor (Kawaguchi et al., 
2007; Salam and Tothill, 2009). The significance of cross-reactivity in 
immunosensors is that with higher cross-reactivity equates to more false 
positive tests (Jongh-Leuvenink et al., 2005). 
 
 
Figure 3.21: No significant cross reactivity between other plasma proteins and 
the CRP assay. The proteins (25 ng mL-1) were assayed using the standard 
optimised procedures of the different methods and they did not give out a signal 
statistically different from the blank which showed there was no cross reaction 
on the tested proteins. 
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The results of the cross reactivity studies were normalised against the positive 
control reading of each of the three assays. The results visibly showed that the 
antibodies did not have non-specific affinity for other plasma proteins that were 
investigated. 
 
3.5 Conclusions 
An electrochemical immunosensor based on a gold working electrode made 
using screen-printing technology was developed for the detection and analysis 
of CRP in serum samples. The clinical reference ranges for CRP assay are ≥1 
µg mL-1 low risk, 1-3 µg mL-1 is medium risk and ≤ 3 µg mL-1 is high risk. The 
performance of the CRP immunosensor was competent to satisfy these 
parameters as the developed electrochemical immunosensor has a LOD of 2.6 
ng mL-1 and spans a dynamic up to 100 ng mL-1, however when the dilution 
factor was factored in, the final dynamic range of the immunosensor was 0.52 
µg mL-1 to 20 µg mL-1. The need to dilute all serum samples 200 times with 
PBS- tween played a significant role in the attainment of the diagnostic 
objectives of the assay mainly for two reasons which are removing the matrix 
effect and ensuring high levels of CRP can be detected easily. 
 
Compared to in-house optimised ELISA, the performance of the commercial 
ELISA was superior to both the electrochemical immunosensor and the in-
house optimised ELISA. This is because the commercial ELISA had the lowest 
calculated lower limit of detection of 1.1 ng mL−1, unlike 1.91 ng mL−1 for the in-
house ELISA and 2.2 ng mL−1 achieved by the immunosensor. A correlation 
curve was plotted using randomly spiked samples between a commercial ELISA 
kit a correlation with a R2 value of 0.998 was achieved. The in-house 
immunosensor had an R2 value of 0.999 against the commercial ELISA. The 
data for comparing the three methods is however interesting, as there is no 
statistical difference in performance when it comes to detecting the random 
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samples that were tested. This is because the inter assay variation between the 
two methods is within the accepted coefficient of variation of most diagnostic 
devices which is below 10%.  
 
Although a direct transfer of the immuno assay first developed on the ELISA 
platform was not possible, some valuable lessons and skills were transferable 
on the optimisation of the immuno sensor. The major difference between the 
two developed platforms was that the concentration of the antibodies needed. 
For the immunosensor, the higher concentrations of antibodies had to be used 
for both the coating and detecting than the ELISA platform. This was because 
there is need to counteract for the limited volumes used by the biosensor, as 
there are containment concerns. Unlike the microwells that can easily 
accommodate 300 µL, the screen-printed gold working electrode surface can 
take a maximum of 35 µL before the liquid overspills to other electrodes.  
 
The most effective concentration of the coating antibody was identified to be 60 
µg mL-1, which was exactly ten times the concentration of the ELISA. It is 
important to note that this does not mean the immunosensor used more 
antibodies than the ELISA, although it used more concentrated antibody 
solutions it required far less volumes than the ELISA did. The experiments 
showed that at 60 µg mL-1 antibody concentration there is the highest peak 
response to a standardized antigen concentration. It was observed that there 
was a characteristic tailing of the curve with concentrations of the coating 
antibody above 60 µg mL-1. This could be attributed to steric hindrance and 
other factors associated with the change in behaviour of highly concentrated 
antibodies. While the prospect of increasing signal with increasing the 
concentration of the antibodies were plausible, trade-offs were made to take 
into account the performance and costs relationship.. Experiments showed that 
although it was an interesting field to explore , there was no need to utilise 
covalent coupling in the CRP immunosensor as it managed to meet the clinical 
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reference range need for diagnosing cardiovascular diseases using CRP easily 
though passive adsorption. This option was however left for further exploration 
in future assays as the advantages of covalent coupling have been 
demonstrated to be phenomenal (Salam and Tothill, 2009). The method used in 
the surface modificationmay have been unfriendly to the electrodes, this was 
primarily because of the prolonged exposure of the electrode to ethanol which is 
a relatively strong solvent considering the materials on board the electrode. The 
electrode contains and on board Ag/AgCl reference electrode that is sensitive to 
ethanol, as such a new method with limited or no exposure of the ethanol to 
Ag/AgCl reference may improve the viability of utilising solvent-based surface 
modification techniques. This task however was left for further scrutiny in the 
next chapters. The detection antibody exhibited similar characteristics as shown 
on the optimisation of the capture where there was increasing signal with 
increasing concentration of the antibody. 
 
The data showed that the concentration of 30 µg mL-1was the optimum for the 
detection antibody. The investigation of finding out the best method for the 
detecting the antigen showed that there are better results if the antigen is 
premixed with the detection antibody before being exposed to immobilised 
capture antibody. This is because both the antigen and the detection antibody 
are free in solution they have a better chance of binding in line with Brownian 
motion laws. Generic assay parameters were investigated on the ELISA 
platform instead of the immunosensors to curb on cost and to enjoy increased 
flexibility the micro plate offers in assay development. Reagents such as the 
blocking solutions, and appropriate buffers were selected from literature, and 
there was enough literature to ascertain that the current blocking solution of 1 
to10 milk protein in PBS was competent enough for assays on screen printed 
gold electrodes (Salam and Tothill, 2009; Heurich, 2011). 
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4 The Development of a Gold Nanoparticle Enhanced 
Immunosensor for Cardiac Troponin T 
This chapter discuss the development of a gold nanoparticle enhanced 
electrochemical immunosensor for the detection of cardiac troponin T (cTnT). The 
development stages mimicked those described in the previous chapter for CRP. Two 
major distinctions in the development of this immunosensor are the use of gold 
nanoparticles (AuNPs) and the incorporation of self-assembled monolayers SAMs to 
aid in the immobilisation process. This was done in response to the challenges 
presented by the requirements of very low limit of detection for diagnostic cardiac 
troponin assays. A different protocol to that described in Chapter 3 was adopted for 
the development of SAMs, which increased their performance and applicability for 
use on the cardiac troponin Immunosensor.  
 
4.1 Introduction 
Gold nanoparticles have been recently gaining increasing attention in their use for 
enhancing immunoassays (Ambrosi et al., 2009; Salam and Tothill, 2009).This could 
be of a combination of factors including unique structure, as well as electronic, 
magnetic, optical, and catalytic properties. These attributes have made them a 
striking material for use in the development of biosensor systems and bioassays, 
including several other interesting applications in the field of electrochemical sensors 
(Pumera et al., 2005; Salam and Tothill, 2009). Due to their excellent 
biocompatibility, AuNPs have increasing application as signal enhancers (Stoeva et 
al., 2006; Saha et al., 2012). 
 
Direct adsorption of biological molecules on metal surfaces generally has a 
detrimental effect of denaturing them or facilitates extensive loss of function. This is 
mainly caused by the fact that most interactions between biomolecules and metal 
surfaces are very weak. This relationship however changes in the case of nano scale 
metals in which case the biocompatibility is improved, and as such allows for 
stronger adsorption of biomolecules without denaturation or loss of bioactivity (Hu et 
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al., 2003). The nanoparticles have large surface areas with high free energy. This 
allows biological molecules like enzymes and antibodies to be strongly adsorbed 
onto their surface easily (Ansari et al., 2010). Gold nanoparticles take advantage of 
two basic chemical interactions that have been developed for forming 
nanoparticle/protein conjugates these include  the reaction of protein sulfhydryl’s with 
functionalized phosphine-groups and electrostatic interaction of proteins with citrate-
passivated colloidal gold (Ackerson et al., 2006; Luo et al., 2006).They have 
considerable advantages when used in screen-printed electrodes. This is because 
they are capable of facilitating electron transfer reactions as well as increase the rate 
of reactions on the electrode. This enables lower working electrode potentials to be 
used and marked improvements in both the sensitivity and the stability of biological 
components on the working electrode (Jubete et al., 2009). Another advantage is 
where enzymes are used, they are unable to have direct electrical communications 
with electrodes surface as they will be mounted on nanoparticles and their centers 
are insulated with protein shells that block the electron transfer to the electrodes. 
They also benefit from their ability to be miniaturised with a diameter of 1–100 nm 
and are capable of being part of very small devices without compromising on 
function and microfluidic processes. AuNPs confer miniaturisation, signal 
improvement, and sensitivity amplification (Luo et al., 2006; Jubete et al., 2009; 
Tothill, 2009).  
 
In this chapter, methods of improving assay sensitivity will be explored with particular 
reference to two methods that are the use of gold nanoparticles, and the use of self-
assembled monolayers (SAMs) for antibody immobilisation. The use of self-
assembled monolayers in improving stability and orientation of immobilised 
antibodies for immuno sensors was partially discussed in Chapter 3. They are a 
good example of covalent immobilisation and can be formed by means of sulphur 
containing groups on oxidised and hydroxylated surfaces and by means of thiols on 
metal surfaces (Altintas et al., 2012). The thiol molecules, usually alkanethiols 
consist of three parts including: a head group (S-H group),a spacer or hydrocarbon 
chain), and a the tail group specific which is active and specific. Alkanethiols with 
amine and carboxyl end groups are have been reported for use in to immobilise 
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proteins on sensor surfaces (Arya et al., 2010; Altintas et al., 2012). The high affinity 
of the sulphur atom to noble metal surfaces is responsible for spontaneous formation 
of semi-covalently bounds. Because of this, there is a tendency for van der Waals 
forces to form between the hydrocarbon chains that then stabilize the structures and 
create an ordered monolayer.  
The terminal group of the molecule is responsible for the surface characteristics of 
the monolayer. For example to obtain hydrophobic surfaces –CH3 and –CF3 terminal 
groups are used and consequently –COOH, –NH2 or –OH groups yield hydrophilic 
surfaces. SAMs can be formed on surfaces either by simply immersing the metal 
substrate in a dilute solution of thiol /silane or alternatively they can be formed by 
vapour deposition(Schreiber, 2000). If a metal substrate is immersed in dilute thiol 
solution, a disorganised monolayer spontaneously forms and then slowly the 
molecules are evenly organised due to van der Waals forces. The quality of the 
assembled monolayer depends on the cleanliness of the metal substrate, the purity 
of the alkanethiol solutions used and the length and composition of the alkanethiol. 
The head group of the alkanethiol is critical to obtain a monolayer with the required 
functionality. Many alkanethiols with different head groups are commercially 
available for the immobilisation of biological recognition elements on biosensor 
surfaces such as –COOH, -NH2, -OH, -biotin, and -N-hydroxysuccinimide (Altintas et 
al., 2012). These methods were adopted for used in the development of an 
immunosensor for the detection of cardiac troponin T, a cardiovascular disease 
biomarker. There is great need for increased assay sensitivity as the diagnostic 
requirements for the detection of cardiac troponin t for diagnosis of cardiovascular 
disease are more challenging. The diagnostic range for cTnT needs performances of 
detection of up to 99th percentile cut point of the base line values. This equates to 
detecting very low concentrations of the biomarker, around 30 pg mL-1 of antigen 
with a significant signal variation from that of the control. Furthermore, cardiac 
troponin assays should work toward a goal of total CV of 10 % with a 1-h or less 
turnaround time (Azzazy, 2002). Surface immobilisation techniques described earlier 
in chapter 3 were investigated to see their effect on gold conjugated assays. Figure 
4.1 shows a schematic diagram of the set up for gold nanoparticles enhanced 
cardiac troponin assay. 
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Figure 4.1: Schematic diagram showing gold nanoparticles being used to increase 
assay sensitivity for the cardiac assay, Enzymes and antibody molecules are 
attached to the gold nanoparticle and cause enhanced signal output that positively 
influence sensitivity. 
 
An enhanced immunosensor for cardiac troponin T (cTnT), that utilises gold 
nanoparticles and covalently immobilised capture antibodies using self-assembled 
monolayer (11-MUA), will be presented in this chapter. Work conducted on a Quartz 
Crystal Microbalance (QCM) system for validating the conjugation of gold 
nanoparticles to antibodies will also be presented. Comparative studies of the 
performance of the electrochemical immunosensor against the QCM assays and 
hospital analyser were also conducted. Table 4.1below summarises some published 
work for immunosensors for cardiac troponin T 
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Table 4-1: Summary of published work on Immunosensors detection of cardiac 
troponin T 
Detection Technique Assay 
Range 
Reference 
Electrochemical SPE immunosensors with a  streptavidin 
and avidin system for signal amplification  
 0.1-10 ng mL-1 (Silva et al , 
2010) 
Electrochemical detection immunosensors using cabon 
nanotubes on the sensor surface for signal amplification.  
0.1-10 ng mL-1 (Gomes-Filho et 
al.) 
SPR immunosensor for human cardiac troponin T  based 
on self-assembled monolayers for signal amplification. 
0.05- 4.5ng mL-1 
 
(Dutra et al, 
2007) 
Dual quartz crystal microbalance for human cardiac 
troponin T in real time detection 
LoD 0.008ng 
mL-1 
(Dutra et al, 
2007) 
A nanostructured piezoelectric immunosensor (QCM) for 
detection of human cardiac troponin T. 
0.003 to 0.5 ng 
mL-1  
(Fonseca et al, 
2011) 
 
 
4.2 Materials  
Potassium Chloride (KCl), Potassium Ferricyanide (K3Fe(CN)6+3H2O), TMB (3, 3’, 5, 
5’- tetramethylbenzidine hydrochloride), PBS (phosphate buffered saline) containing 
0.137 M sodium chloride, and phosphate buffer, 0.01 M, pH 7.4 in tablet form, citrate 
phosphate buffer (0.05 M, pH 5.5) tablets. Hydrogen peroxide, sodium hydroxide 
(NaOH) and sodium chloride (NaCl), bovine serum albumin (BSA), 11-
mercaptoundecanoic acid (11-MUA) were purchased from Sigma-Aldrich (Dorset, 
UK).Potassium chloride (KCl) were purchased from Fisher Scientific (Loughborough, 
UK). Primary (batch 1c11), secondary antibody (batch 9g6 HRP conjugated) and 
(7E7 non conjugated), and human cTnT (Molecular Weight (MW) = 36 kDa were 
obtained from (Abcam, Cambridge, UK). Skimmed milk protein, (KPL Ltd, 
Gaithersburg, USA ). Reverse Osmosis (RO, Ultrapure) water (18 M MΩcm-1) was 
obtained from Milli-Q water system (Millipore Corp., Tokyo, Japan). Glassware and 
volumetric materials were of analytical grade. 
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ELISA tests were first developed using a micro well polystyrene plates, MaxiSorp® 
plates purchased from Fisher Scientific, Loughborough, UK. An incubator/shaker 
from Labsystem iEMS® was used for temperature control incubation. A Florostar® 
plate reader was used which was set at appropriate wavelengths, BMG, UK. 
Glassware and volumetric materials were of analytical grade. Pipettes and tips from 
Eppendorf®.The electrodes used in this project were the JD type designed by 
Cranfield University and fabricated using the facilities at DuPont (Bristol, UK). The 
gold working electrode was circular with a 0.226 cm2 planar area, a complementary 
carbon counter electrode and an Ag/AgCl reference electrode. The substrate 
material used is PET 125 µm Autotype HT5. The carbon electrode has an 
approximate dried thickness of 7 µm, while the gold and Ag/AgCl electrodes both 
have an approximate thickness of 18 µm. The encapsulation of 5036 blue had an 
approximate thickness dried of 4 µm. Inks used in the construction of the sensors are 
BQ221 carbon ink, BQ331 gold ink and the 5880 Ag/AgCl and are available from 
DuPont (Bristol, UK). Gold nanoparticles with a diameter ranges from 20-100 nm 
were purchased from BBInternational Ltd (Cardiff, UK). QCMA-1 system and QCMA-
1 chips with dual chambers for simultaneous sample and reference evaluation were 
obtained from (Sierra Sensors GmbH, Hamburg, Germany). Emitech K 1050X 
plasma cleaner (EM Technologies, Kent, UK). 
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4.3 Methods  
4.3.1 Preliminary characterisation of the antibodies performance using 
an ELISA assay 
Experiments were conducted to evaluate the performance of different antibodies that 
were commercially available for troponin T in order to select the best performing 
combinations for use on the immunosensor. 
 
4.3.1.1 Selection of the coating antibody and the optimal concentration on the 
ELISA platform 
Two antibodies, mouse anti human cardiac troponin t variables 9g6 and 1c11 were 
chosen as potential coating antibodies. These were investigated for their 
performance to identify the best working concentration to apply in the assay. In order 
to do that, a new ELISA plate was air bushed with nitrogen to clean it and then 
labelled and coated with various concentrations of the capture antibodies (2, 4, 6, 8, 
10, 12 µg mL-1) to be investigated. A 100 µL of the antibody solutions dissolved in 
0.05 M carbonate-bicarbonate buffer pH 9.6 were then deposited in triplicate (for 
each antibody type and concentration), and allowed to incubate overnight at 4 °C. 
The Plate was then gently washed with phosphate buffer saline plus 0.05 % Tween 
20 (PBS-T) three times and dried by inverting and blotting the plate on paper towel. 
The wells were then blocked for 60 minutes at 37 °C with 300 µL of 1:10 dilution of 
milk protein (KPL Ltd., UK) in PBS. The Plates were washed and standard 
concentrations of the antigen (100 µL of 0, 10, 50, 100 ng mL-1of cTnT) were added 
to the wells and it was incubated for 1 h at 37 °C. The Plate was then washed again 
and a HRP conjugated mouse monoclonal anti human cTnT (7E7) was added (100 
µL of 5 µg mL-1, in PBS with 1:40 skimmed milk) was added to the plate and 
incubated for 1 hour at 37 °C. The plate was finally washed six times and a 100 µL 
solution of TMB based chromogenic substrate was added and incubated for 30 min 
before the reaction is stopped by 100 µL 1 N sulphuric acid solution.  
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4.3.1.2 Selection of the detection antibody concentration on the ELISA 
platform 
Having realised that the 1C11 was a superior coating antibody, a working 
concentration of 10 µg mL-1 was used for coating in an attempt to investigating a 
suitable detection antibody concentration. A 100 µL solution of 10 µg mL-1 antibody 
(1c11) solution dissolved in 0.05 M carbonate-bicarbonate buffer pH 9.6 were 
deposited in microwells of a cleaned plate and allowed to incubate for 2h at 37°C. 
The plate was then gently washed with phosphate buffer saline plus 0.05% Tween 
20 (PBS-T) for three times and dried by inverting and blotting on paper towel. The 
plates were then blocked for 60 minutes at 37 °C with 300 µL of 1:10 dilution of 
skimmed milk in PBS. The Plates were then washed in similar manner as described 
above and standard concentrations of the antigen (100 µL of 0, 50, 100ng mL-1of 
human cardiac troponin t), were added to different wells and the plate was incubated 
for 1 h at 37 °C. The plate was then washed again and several solutions of different 
concentrations of HRP conjugated mouse monoclonal anti human cardiac troponin 
antibody (7E7) were added (100 µL of 5, 7, 10, 12 µg mL-1) to the plate and 
incubated for 1 hour at 37 °C. The plate was finally washed six times and a 100 µL 
solution of TMB based chromogenic substrate was added and incubated for 30 min 
before the reaction is stopped by 100 µL 1 N sulphuric acid solution.  
 
4.3.1.3 Standard curve for the cardiac troponin Assay on the ELISA platform 
Taking into account the best conditions in the investigations for the optimisation of 
the ELISA assay a protocol was devised that was used for determining the final 
standard curve. In this final protocol, 100 µL of the optimised capture antibody 
concentration of 10 µg mL-1 of mouse monoclonal anti human cardiac troponin t 
(1c11) antibody was used for coating and allowed to incubate for 2 h at 37°C. The 
plate was then gently washed three times with Phosphate Buffer Saline plus 0.05% 
Tween 20 (PBS-T) and dried by inverting and blotting on paper towel. The plates 
were then blocked for 60 minutes at 37 °C with 300 µL of 1:10 dilution of skimmed 
milk in PBS. The plates were then washed and dried again, standard concentrations 
of the antigen human cardiac troponin T (100 µL of 0, 1, 5, 10, 20, 30, 50, 100 ng 
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mL-1) were added to the microwells, and it was incubated for 1 h at 37 °C. The Plate 
was then washed again and 200 µL of 7 µg mL-1 HRP conjugated mouse monoclonal 
anti human cardiac troponin t (7E7) antibody was added to the plate and incubated 
for 1 hour at 37 °C. The plate was finally washed three times and a 100 µL solution 
of TMB based chromogenic substrate was added and incubated for 30 min before 
the reaction is stopped by 100 µL of 1 N sulphuric acid solution. The curves were 
fitted using a four-parameter curve fitting described in Chapter 3.3.8.  
 
4.3.2 Method of Optimising the Cardiac Troponin T Assay on the Gold 
Electrodes  
The immunoassay for cardiac troponin T was then optimised on the electrodes 
surface. This was done in order to select the optimal concentrations of the assay 
reagents for sensor development. Experiments conducted on ELISA platform were 
limited to validate functionality of the reagents. The method used for the optimisation 
of assay on the gold electrodes was adapted from previous work conducted to 
develop a biosensor for Salmonella detection (Salam and Tothill, 2009) which has 
been mentioned earlier in Chapter 3. Antibody immobilisation on gold working 
electrode with the passive absorption method was followed here and it was this 
procedure which was optimised first to achieve the best concentration of the capture 
antibody to use for coating the sensor surface. Experiments were conducted for the 
optimisation of both bare and 11-MUA modified working electrodes. Finally the 
conjugated gold nanoparticles were investigated. 
 
4.3.2.1 Optimisation of the coating and detection antibody 
 The JD electrode strips were first baked at a temperature of 120 °C for 30 minutes, 
washed and rinsed with distilled water to remove any particle contamination. The 
working electrode was then coated with a drop of 10 µL of mouse monoclonal anti 
cTnT (1C11) dissolved in 0.05 M carbonate-bicarbonate buffer pH 9.6. Different 
concentrations of the coating antibody (10, 30, 60, 90, 120 µg mL-1) were deposited 
in triplicates and allowed to incubate overnight at 4 °C. The electrodes surface were 
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then gently washed with Phosphate Buffer Saline with 0.05% Tween 20 (PBS-T), two 
times, rinsed with distilled water and air-dried with nitrogen. The working electrodes 
surface was then blocked for 30 minutes at 37 °C. The blocking solution was a 1:10 
skimmed milk dilution in PBS. The electrodes were then washed in similar manner 
as described above. A standard concentration of the antigen was premixed with the 
detection antibody to give a mixture comprising of a 50 ng mL-1antigen concentration 
and 50 µg mL-1of conjugated mouse monoclonal anti human cardiac troponin T 
antibody. The mixture was incubated to premix for 1h on a rotter away from sunlight. 
It was then added on top of the the blocked electrodes and incubated for 1hr at 
37°C. The electrodes were then connected to an edge connector, which is 
connected with a Palmsens® portable electrochemical analyser (Palm instruments 
BV, Houten, Netherlands. All measurements were performed by adding 100 µL of 4 
mM TMB and 0.06% H2O2 in 0.05 M citrate phosphate buffer plus 0.1 M KCL 
combined in a 1:1 ratio, with chronoamperometry at -200 mV constant current and 
run for 100 to 200 s. Similarly, the same was done for the optimisation of the 
conjugated detection antibody. A reverse approach was done where the capture 
antibody was chosen to remain constant at 90 µg mL-1 and the antigen remained at 
50 ng mL-1 in mixture with a variable detection antibody concentrations (30, 60, 90, 
120 µg mL-1).  
 
4.3.3 The use of self-assembled monolayers (SAMs) for capture 
antibody immobilisation  
Self-assembled monolayer was used to functionalise the gold working electrodes 
using 11-mercaptoundecanoic acid (11-MUA) .The procedure used in chapter 3 was 
modified in order to counteract on the performance limitations caused by the 
solvents on the Ag/AgCl and the rest of the sensor. The major change was the 
controlled administration of the solvent on to the sensor surface, and an increase in 
the concentration of the 11-MUA to compensate for the smaller volumes that were 
being used. A retrospective comparison of the two methods showed that the 
modified method described here performed much better than the previously 
described method in Chapter 3.  
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In the new procedure, the electrodes were baked in an oven for 120 °C for 30 min 
before being plasma cleaned with the gold facing up in oxygen free nitrogen for 2.5 
minutes (Emitech K 1050X, EM Technologies, Kent, UK ). After this, the working 
electrode was washed with deionized water and coated with 2 x 50µL of 4mM 11-
MUA placed three hours apart in an overnight incubation step at 4°C in darkness. 
This allowed the 11-MUA to form a self-assembled monolayer on the sensor surface. 
It is important to prevent rapid evaporation of the ethanol on the 11-MUA solution. 
 
After making, the 11-MUA modified working electrode using the procedure described 
above, it was validated using the methods described earlier in Chapter 3.3.8. The 
cyclic voltammetry of the surface modified electrodes was conducted by placing 100 
µL of solution (1 mM potassium ferricyanide K3[Fe(CN)6] in 0.1 M KCl) on the 
electrode surface. The electrochemical behaviour of potassium ferricyanide was 
measured using cyclic voltammetry at 50 mVs-1. Measurements were obtained by 
scanning 5 cycles from -0.5 to 0.8 V relative to Ag/AgCl reference electrode using a 
multi-channel AUTOLAB electrochemical instrument. The contact angle 
measurements were also taken by drying a bare and a modified electrode with a 
nitrogen gun and mounting them on the stage of a CAM 100 Optical Contact Angle 
Meter, before applying a drop of Millipore water to the surface of the working 
electrode. The contact angle was analysed using the CAM 100 software and the 
average contact angle was calculated. 
 
4.3.4 The use of gold nanoparticles in signal enhancement 
To improve the detection limit of the sandwich immunoassay, the use of gold 
nanoparticles was employed. Gold nanoparticles can act as a carrier of specific 
detection antibody and significantly higher amounts of peroxidase enzymes (Ansari 
et al., 2010). The higher enzyme label in the assay will accelerate the rate of reaction 
where small antigen concentration exist in the sample and thus increase the assay 
sensitivity (Saha et al., 2012). 
The Development of a Gold Nanoparticle Enhanced Immunosensor for Cardiac Troponin T 
 
146 
W.M.Fakanya-Cranfield University-PhD Thesis 
4.3.4.1 Conjugation of Gold Nanoparticles with Antibodies and HRP 
Gold nano- particles with average diameter of approximately 60 nm were purchased 
from (BBInternational, Cardiff, UK). The colloidal gold solution was stored at 4°C in 
the dark, as they were stored in distilled water they were used directly without any 
pre-treatment. The particle size of colloidal gold was 60 ± 4.2 nm and the number of 
particle is about 6.2 x 1011 particles mL-1. The antibody- colloid gold conjugate was 
prepared according to the procedure described by (Liu et al., 2010). In this 
experiment, gold nano-particles were conjugated with horse radish peroxidase 
(HRP) and anti cTnT 7E7 (unconjugated). Two eppendorfs were each filled with1mL 
of gold nanoparticles solution and 5 µL of 0.2 M NaOH was added in each vial before 
gently mixing well. A 10 µL solution of 1mg mL-1 HRP in water was then added to 
each eppendorf vial and incubated at 22°C for 60 minutes on a Stuart SB3 rotator 
(Appleton Woods, Birmingham, UK) with the rotator at a 10° inclination angle. After 
this a 5 µL solution of 2mg mL-1of detection antibody mouse monoclonal anti human 
cTnT 7E7 and incubate for 20 min on the rotor. The two eppendorfs were then 
centrifuged at 4°C for 25 minutes at 8000 rpm using the Heraeus Fresco 21 
centrifuge system, (Loughborough, UK). After extraction of the supernatant from the 
eppendorfs, the pellet was then re-suspended in a 3:1 with 0.05% PBS-Tween 20, 
concentrated milk blocking diluents solution to obtain a total volume of 100 µL. 
 
4.3.4.2 Quality control of conjugated Gold Nano particles 
To check if the conjugation was successful, 20 µl of 2.5M NaCl was added to 200 µL 
solution of 1 in 10 diluted modified gold colloid solution and checked for flocculation. 
If flocculation occurs, it indicates the modification is not successful and will need to 
be repeated (Saha et al., 2012). The concentration of the remaining gold 
nanoparticles after the conjugation procedure can be estimated by measuring the 
absorbance of the modified gold colloid solution and by comparing it with the 
standard concentration, which has known amounts of the nanoparticles. 
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4.3.5 The use of Quartz Crystal Microbalance to Investigate the 
Attachment of the Gold Nano particles to the Detection 
Antibodies 
In this work, the fully automated QCMA-1 system (Sierra Sensors GmbH, Hamburg, 
Germany) was used to validate antibody conjugation to gold nanoparticles through 
detecting cTnT using conjugated and and unconjugated antibodies. An optimised 
cardiac troponin t assay described by Vanheusden (2011) was used. A dilutions 
series of cTnT in PBS containing 10% concentrated milk blocking proteins was made 
to have a final concentration range between 1 and 100 ng mL-1. Dilution series were 
stored at 4°C and thawed immediately before use. A volume of 250 µl of the different 
cTnT concentrations were applied to both spots of the coated sensor chip. A 
sandwich immunoassay was performed by adding 200 µL of a 20 µg mL-1 detection 
antibody solution or a solution of the gold nanoparticles coated with detection 
antibody to the bound cTnT. The frequency shift was measured using the QCMA-1 
analyser software. The surface of the sensor chip was regenerated after each 
concentration with a short washing step with 0.1 M HCl. After the last concentration, 
the sensor chip regenerated again using a 20 mM NaOH solution. 
 
4.3.5.1 Preparation of QCMA-1 sensor chips 
The QCM gold sensor chips were cleaned prior to coating by nitrogen plasma 
etching (Emitech K 1050X, EM Technologies, Kent, UK) at a power of 50 W with a 
bleed vacuum trip of 3 x 10-1 mbar and an ashing time of 1 minute. After this, the 
sensor chip surface was coated with an insulating layer of 11-MUA. This was done 
by immersing the chips with the gold surface up in a 2mM 11-MUA solution in pure 
ethanol overnight at 22°C in darkness. Figure 4.2 shows the chemical structure of 
11-MUA. 
 
 
Figure 4.2: Chemical formula of 11-MUA (Sigma-Aldrich, 2012) 
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This allowed the 11-MUA to form a self-assembled monolayer on the sensor surface. 
Cyclic voltammetry (CV) was used to assess the extent of the coating. A chip was 
used as working electrode in a CV setup with an Ag/AgCl reference electrode and a 
carbon counter electrode. Analysis was performed by applying a 100 µl volume of a 
1 mM potassium ferricyanide on the working electrode and measuring the current 
produced by the redox reaction occurring after application of an external voltage 
sweep as described in Section 4.3.3. 
 
4.3.6 Immobilisation of the capture antibody on Modified surfaces of 
SPGE and QCM-1 chips. 
Covalent coupling of the cTnT (1C11) antibodies on to the gold surface of both the 
QCMA-1 chips and the screen printed gold electrodes was facilitated by the free 
carboxylic group 11-MUA using an EDC:NHS protocol as described by Uludag 
(2010). The exact chemistry of the EDC:NHS interaction is described in other 
publications (Van Delden et al., 1996). Figure 4.3 summarizes the chemistry used in 
the sensitization of the modified surfaces. 
 
Figure 4.3: Schematic overview of the EDC:NHS coupling procedure. (I) is the 
Carboxylic end group attached to the (chip) surface, (II) is EDC, (III) is 
Oacylisourea,(IV) is NHS, (V) is N-acylisourea, (IV) is diamino-PEO coupled to the 
surface, (VII) is the hydrolysis reaction of O-acylisourea, (VII) is the NHS activated 
carboxylic group and (IX) is the hydrolysis of this activated group (Van Delden et al., 
1996).  
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In these experiments two solutions a 400 mM EDC and 100 mM NHS solution in 
deionized water were mixed in a 1:1 rate and applied to the surfaces immediately 
after mixing them. For the SPGE, the solution was applied by adding 30 µL and 
incubating for 10 min, for the QCMA-1 system a total volume of 150µL was applied 
to pass through the sensor chip spots at a flow rate of 50µL per min. After this, a 
short washing step was performed with PBS buffer was performed for both methods. 
The next step was the attaching of the capture antibody. On the SPGE, this was 
done by adding 20 µL of 80 µg mL-1 1c11 anti human cardiac troponin t antibody on 
the working electrode and incubating for 2 hrs at 37 °C in a humid environment 
control chips were coated with anti-ochratoxin A antibody in the same conditions. 
 
For the QCM-1 chips since each chip contained two measurement spots, the cTnT 
specific antibody was attached to the active spot and an antibody non-specific for 
cTnT (anti-ochratoxin A) was attached to the control spot. The optimum 
concentrations of these antibodies were provided by the method developed (Van 
Heusden, 2011). In this method 30 µg mL-1 and 10 µg mL-1 of appropriate antibodies 
dissolved in sodium acetate buffer with 1% concentrated milk blocking diluents (KPL, 
Wembley Middlesex, UK) for the active and control, respectively. For both methods, 
the next step is washing off excess antibodies and blocking twice. First the free 
space on both spots was covered using 10% milk blocking proteins dissolved in 
PBS. Lastly, non-reacted EDC:NHS molecules were covered by a 1M ethanol amine 
solution. 
 
4.3.7 SPGE Optimised immunosensor protocol 
The optimised cardiac troponin t assay on screen-printed gold electrodes was based 
on the immuno assay that used gold nanoparticles. This assay consists of several 
steps that include the modification of the working electrode as described in Section 
4.3.3 and the sensitisation and coating of the working electrode as described in 
section 4.3.6. The optimum coating antibody concentration was found to be (60 µg 
mL of 1C11) and this was incubated for 2 h at 37 °C in a humid environment. During 
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blocking, appropriate mixtures of the antigen and the conjugated gold nanoparticle 
solutions are made to premix for 1 h in a gently spinning rotor. The conjugated gold 
nanoparticles (60mn) are diluted to a ratio of 1:10 in antigen solutions. It is essential 
that the working concentrations of both the antigen and the gold nanoparticles be 
uncompromised through dilution. After the excess blocking solution had been 
washed and the electrodes have been dried, 20 µL of the mixture of gold 
nanoparticles and the antigen standard were deposited on the electrodes and they 
are incubated for a further 1 h. The electrodes were then washed and connected to 
an edge connector, which is connected with a multi-channel AUTOLAB 
electrochemical instrument. 
 
4.3.8 Detection of cTnT in commercial serum  
A standard curve was plotted using standards with 75% commercial serum spiked 
with appropriate cardiac troponin t (cTnT). Thus was done to synchronise the 
standard curve with the same level of interference that would be in the spiked serum 
samples that were intended to be analysed and their cTnT concentrations 
interpolated using the curve. Although in an ideal world standard curve generated in 
whole serum would be desirable, In this case the sensitivity of the assay was 
severely compromised by interfering proteins and a compromise of 75% spiked 
serum was reached basing on the recommendations of work by department 
colleagues (Uludag and Tothill, 2010). 
 
In this experiment, commercialised human serum samples (Sigma-Aldrich) were 
diluted with 25%v/v PBS-T with additives to give a 75% v/v serum solution. The 
additives (0.5 M NaCl, 200 µg mL-1 BSA and 500 µg mL-1 dextran) had been proven 
to help with lowering non-specific binding (Uludag and Tothill, 2010). The 75% serum 
solution was used to make standards as well as samples spiked with unknown 
concentrations of cTnT. 
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4.4 Results and Discussion 
4.4.1 Preliminary microplate based studies 
ELISA tests were developed on the microplate in order to investigate the best 
antibody combinations as well as their performancefor troponin t detection. A 
standard curve was done to show the basic performance of the cTnT assay on a 
micro plate. 
 
4.4.1.1 Antibody combinations and coating antibody concentrations 
In order to investigate the optimal antibody combinations for the ELISA assay as well 
as the working concentration of the coating antibody. A generic ELISA protocol as 
described in Section 4.3.1.1 was conducted. The results obtained are shown in 
Figure 4.4, and these indicate that the antibody combinations of the 1C11 and 7E7 
gave better responses compared to those of 7E7 and 9g6. This different 
performance can be attributed to two factors that are antigenic affinity and the 
proximity of the epitopes on the antigen surface responsible for the generation of the 
antibodies (both detection and coating). There is a possibility that there may be 
superior antigenic affinity of the 1C11 coating antibody as compared to the 9g6, this 
will result in higher numbers of the antigen forming stronger bonds with the 1C11 
antibody that in turn is expressed as higher signal when the detection antibody is 
used. Another explanation could be that there could be close proximity between the 
epitopes responsible for the generation of the antibodies 9g6 (coating) and 7E7 
(detection). Monoclonal antibodies made from epitopes in close proximity can have 
an inhibitory effect when associating with the antigen(Law, 1996; Wild, 2000). This is 
because that the first antibody to associate with the antigen (in this case the coating 
antibody 9g6) may provide a physical barrier for other antibodies for example those 
used for detection (7E7) to access their binding site on the antigen (Dickason et al., 
1994; Law, 1996). The results of this experiment also showed that there was an 
increase in signal with increasing concentration of the coating antibody. A10 µg mL-1 
coating concentration for the micro plate based ELISA assay was chosen as the 
optimum. This is because it gave a high proportional yield competently achieved the 
requirements of the assay, without compromising on costs. The antibody 
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combination of 1c11 and 7E7 were chosen to be used for further experiments and a 
coating concentration of 10 µg mL-1. 
 
 
Figure 4.4: Micro plate based ELISA assay for selecting the best antibody and 
working concentration for cTnT sandwich assay, (a) plates coated with anti-cardiac 
troponin 9g6 and (b) plates coated with 1c11. In both assays 100 µL of various 
concentrations of coating antibody used and assayed against 100 µL of antigen 
concentrations (0, 10, 50, 100 ng mL-1) with a detection antibody (200 µL of 5 µg mL-
1) n=3, maximum CV= 4.3%. 
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4.4.1.2 Detection antibody concentrations 
After selecting the coating antibody to be 1c11 and choosing it’s concentration to be 
10 µg mL-1 the next challenge was to optimise the detection antibody. A microplate 
was coated with coating antibody (100 µL of 10 µg mL-1 1c11) and assayed with 
standard concentration of cTnT (0, 10, 50, 100 ng mL-1) and four concentrations of 
detection antibody 7E7 were investigated (5, 7, 10, 12, µg mL-1). The results 
obtained are shown in Figure 4.5 
 
 
Figure 4.5: The effect of increasing the concentration of detection antibody on the 
signal, varying concentrations of the detection antibody were assayed against 
standards after coating the plate with (200 µL of 10 µg mL-1) of HRP conjugated anti-
cTnT (1c11), n=3, maximum CV= 3.8%. 
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The results show that increasing signal was achieved with increasing detection 
antibody concentration. This relationship was shown to cease at 10 µg mL-1 where 
further increases in HRP conjugated 7E7 anti cTnT antibody, did not yield any 
significant enhancement of the signal. A concentration of 10 µg mL-1 was adopted to 
be suitable for the microplate assay. 
 
4.4.1.3 Standard curve of cTnT on micro plate assay 
After optimising the reagents concentrations of the ELISA assay, a standard curve 
for cTnT was plotted using the optimised conditions.  
 
Figure 4.6: Logarithmic scale of the optimised micro plate assay, (Inset) a liner plot 
of the same curve. Plates were coated with 100 µL of 10 µg mL-1 of 1c11 and 
assayed with cTnT serially diluted standard in buffer. The detection antibody was 
HRP conjugated anti cTnT antibody 7E7 (100 µL of 10 µg mL-1).n=3, maximum, 
barrs=standard deviation,CV=4.7%. 
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The assay had a lower limit of detection L.O.D of 2.2 ng mL-1, which higher than the 
baseline values of cTnT which are < 0.03 ng mL-1 (Licka et al., 2002; Babuin L, 
2005). Further optimisation of the assay parameters may result in better detection 
limit. However, since the aim is to develop an immunosensor, it was decided to move 
the assay to screen- printed electrodes as these were known to give higher 
sensitivity than ELISA tests (Tothill, 2009). 
 
4.4.2 Development of the screen printed immunosensor for cardiac 
Troponin T 
This section describes work that was done to develop an immunosensor for cardiac 
Troponin T based on screen-printed electrodes. The first optimisation was done on 
the bare electrodes and the next step utilised the surface modification of the working 
electrode using self-assembled monolayers SAMs. An enhanced alternative 
procedure for application of SAMs on working electrodes, which does not interfere 
with the electrodes in a manner described in Chapter 3 is offered. The final step of 
the optimisation involved the use of both SAMs and gold nanoparticles on the 
immunosensors. Gold nanoparticles were responsible for enhancing the signal 
output and thus increasing on the sensitivity of the immunosensor. 
 
4.4.2.1 Optimisation of the coating and detection antibodies on the bare 
electrodes 
The concentration of the antibodies both coating and detection play a major role in 
the functionality of the immunosensor. In an attempt to find the optimum 
concentrations for use on this version of the immunosensor , different concentrations 
of were used in the assays on the sensor surface. The results of the experiments are 
shown in Figure 4.7.The results show that there was rising signal with increasing 
concentration of the coating antibody. This rise in signal however curtailed and lost 
gradient after the 90 ng mL-1 and there was no significant changes with higher 
concentrations in the coating antibody. The best coating antibody on the bare 
electrode was thus shown to be 90 µg mL-1. The detection antibody showed a similar 
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trend that only that the optimum was at 60 µg mL-1. The results showed that although 
there was still an increase in signal with increased detection antibody after 60 µg mL-
1
, the increase in signal output was limited and not justify the use of higher amount of 
antibodies. 
 
 
Figure 4.7: The optimisation of the coating and detection antibody for cTnT assay on 
bare screen-printed gold electrodes. A 10 µL of different concentrations of anti cTnT 
1C11 coating antibody were immobilised on the gold working electrode. It was 
assayed with standard concentration of the cTnT antigen premixed with the detection 
antibody. A reverse approach was applied for investigating the detection antibody 
n=3, maximum CV=6.2%, error bars= standard deviation. 
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The optimised parameters of coating antibody (90 µg mL-1 of 1C11) and detection 
antibody (60 µg mL-1 of 7E7) were used next to prepare a standard curve for the 
optimised assay. The standard curve obtained is shown in Figure 4.8. 
 
 
Figure 4.8: Logarithmic scale of the immunosensor with no surface modifications, 
(Inset) a liner plot of the same curve. Bare working electrodes of SPGEs were 
coated and assayed with cTnT serially diluted standards in buffer. LoD 2.12 ng mL-
1
,n=3, maximum CV=10.9%, bars=standard deviation 
 
The standard curve for the cTnT using this immunosensor format had a lower limit of 
detection of 2.12 ng mL-1.This was higher  and much further from the detecting 
baseline values of below 0.03 ng mL-1 as required. The results showed that there 
was need to continue improving the immuno sensor and thus further optimisation 
such as the use of self-assembled monolayers was incorporated in the next 
immunosensor design. 
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4.4.3 Exploring the use of self-assembled monolayers to enhance 
assay sensitivity through covalent immobilisation 
As discussed earlier, self-assembled monolayers SAMs play a crucial role in the 
immobilization and orientation of the antibody on the transducer surface like gold and 
has become another focus of study in the biosensor field (Hao et al., 2009). There 
are a variety of SAMs available but in this study the monolayers were made using 
11-mercaptoundecanoic acid (11-MUA). This is because the stability of the SAM has 
been linked to the size of the carbon spacer and the longer the chain the more stable 
the SAM is (Love et al., 2005). For this reason larger molecules like 11-
mercaptoundecanoic acid (11-MUA) have been favourites for the making of SAMs 
functionalised surfaces for sensor application (Chaki and Vijayamohanan, 2002). 
 
The screen printed electrode surfaces were modified by first baking the electrodes in 
an oven for 120 °C for 30 min, followed by plasma cleaning them in oxygen free 
nitrogen at 50w for 2.5 minutes (Emitech K 1050X, EM Technologies, Kent, UK). The 
power settings were 50 W with a bleed vacuum trip of 3 x 10-1 mbar and an ashing 
time of 1 minute. After this, the working electrode was washed with deionized water 
before being coated with 2 x 50µL of 4mM 11-MUA in an overnight incubation step at 
4°C in darkness. After making, the 11-MUA modified working electrode using this 
procedure the surfaces were validated using cyclic voltammetry. This was done by 
placing 100 µL of solution (1 mM potassium ferricyanide K3 [Fe(CN)6] , 0.1 M KCl) on 
the electrode surface. The electrochemical behaviour of potassium ferricyanide was 
measured using cyclic voltammetry at 50 mVs-1., measurements were obtained by 
scanning 5 cycles from -0.5 to 0.8 V relative to Ag/AgCl reference electrode using a 
multi-channel AUTOLAB electrochemical instrument. The obtained results are shown 
in Figure 4.9.  
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Figure 4.9: Cyclic voltammetry for validating the deposition and formation of Self 
assembled monolayers by 11-MUA. 5 scans of cyclic voltammetry were done using 1 
mM potassium ferricyanide K3[Fe(CN)6] , 0.1 M KCl at 50 mV S-1 scan rate. The zero 
current on 11-MUA coated chips signifies insulation due to the successful formation 
of the monolayer. 
 
There were changes to the experimental procedure, from that described in Chapter 
3, for the method for making the 11-MUA SAM on the working electrode and the new 
method had improved conductivity. As discussed in Chapter 3, there was very limited 
conductivity on the modified surfaces. The cyclic voltamograms of the 11-MUA 
modified electrodes when compared to that of the bare electrodes clearly showed 
this shortfall in conductivity. In this experiment, the voltamograms for the bare 
electrode showed the most conductivity, however the 11-MUA surface coated 
electrodes performed electrochemically better than those made using the previous 
method. The change in the method of making the monolayer improved the 
conductivity of the electrode which ment that the monolayer formation would not 
impeade on the flow of electrons. This was shown by the relatively higher oxidation 
and reduction peaks on the SAM modified surface compared to those achieved in 
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Chapter 3. The contact angle measurements were done to confirm the formation of 
the monolayer and the results from their measurements are illustrated in Figure 4.10. 
 
 
Figure 4.10: Pictures showing the distribution of 100 µL drop of deionised water on 
(left) a 11-MUA coated Chip and (right) a bare electrode. 
The difference in the contact angle between the surface and the liquid shows 
polarisation properties of the surfaces. The results showed decreased wettability on 
modified surfaces (left) compared to the bare electrode (right). This could be 
attributed to the increased lyophobicity of the surface by the use of SAMs surface. 
As discussed in Chapter 3, the monolayers of 11-MUA are capable of depolarising 
the gold surface thus making it more water repellent.  
 
4.4.3.1 Optimisation of the coating and detection antibodies on the 11-
MUA modified electrodes 
A similar procedure to that described in Section 4.3.6 was employed  to investigate 
the detection and coating antibody for the immuno sensors that were coated with 11-
MUA. The procedure consisted of a surface sensitisation step that employs the use 
of the EDC/NHS coupling chemistries. In the procedure, 400 mM EDC and 100 mM 
NHS solution in deionized water were mixed in a 1:1 rate and 30 µL were applied to 
the surfaces immediately after mixing. Immobilisation of the coating antibody 1C11 
the follows followed by two blocking steps one of 1M ethanolamine for blocking un 
occupied active groups and anther with 1:10 milk protein. The remainder of the 
procedure is standard as described in Section 4.4.2.1. The obtained results are 
shown in Figure 4.11. 
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Figure 4.11: The optimisation of the coating and detection antibody for cTnT assay 
on 11-MUA modified screen-printed gold electrodes, electrodes were first sensitised 
with 30 µL of EDC/NHS solution before the assay. Different concentrations of anti 
cTnT coating and detection antibodies were investigated, n=3, CV=7.4%, error bars= 
standard deviation. 
 
The results showed the expected trend of increasing signal with increasing antibody 
concentrations. The peak antibody concentrations for the 11-MUA modified surfaces 
were less than for the bare electrodes. The optimum coating concentration was 60 
µg mL-1 and the detection antibody was 30 µg mL-1.These values were incorporated 
on to an assay and a standard curve was developed for the 11-MUA modified 
surface immunosensor for cTnT, this curve is shown in Figure 4.12. 
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Figure 4.12: Logarithmic scale of the immunosensor with 11-MUA surface 
modifications, (Inset), a liner plot of the same curve. Working electrodes of SPGEs 
were sensitised with 30 µL EDC/NHS  and were then coated with 10 µL of 60 µg mL-
1
 of 1c11 and assayed with cTnT serially diluted standard in buffer premixed with 
detection antibody HRP conjugated anti cTnT antibody 7E7 (60 µg mL-1), n=3, 
maximum CV= 9.8%. 
 
The calibration plot generated showed better sensitivity than both the bare electrode 
based assay and the micro plate based ELISA assay. The maximum current output 
was higher than that of the comparable bare electrode immunosensor and the 
gradient of the linear slop was steeper which showed that there was improved 
sensitivity. It had a LOD of 1.14 ng mL-1. Although this was still higher than the 
baseline values for cTnT in healthy individuals, it was better than the previous 
assays. This showed the 11-MUA SAMs had a significant effect in improving the 
assay performance on the immunosensor. However, there was need to improve the 
assay further and thus the use of gold nanoparticles was employed in the next assay 
setup. 
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4.4.4 Exploring the use of gold nano-particles to increase assay 
sensitivity through enhanced signal 
Gold nanoparticles (60 nm), were conjugated with horseradish peroxidase (HRP) 
and anti cTnT 7E7 antibody using a procedure described in Section 4.3.4.1. After 
making them, the success of the conjugation was confirmed by checking for 
flocculation after 20 µl of 2.5M NaCl was added to 200 µL solution of 1 in 10 diluted 
modified gold colloid solution. If flocculation occurs, it means the modification is not 
successful and will need to be repeated. However, this generic method does not give 
detail as to whether or not any antibody has been conjugated on to the gold 
nanoparticles. As it is impossible to visually see and quantify the success of the 
conjugation of the antibodies on the gold surfaces an automated biosensor based 
the Quartz Crystal Microbalances (QCMs) techniques for the detection of 
biomolecules. It is quicker than the conventional immuno assay and does not require 
a label. Gold nanoparticles were conjugated with detection antibody using a 
procedure described in Section 4.3.5 and QCM experiments were conducted to 
validate this conjugation. Figure 4.13 shows how the QCM was used to validate 
successful conjugation of the detection antibody on to the gold nanoparticles. This 
was done in the hope that comparing the performance of conjugated and 
unconjugated detection antibodies on immuno assays done of quartz crystals will 
ascertain any successful conjugations. The QCM-1 device used in this project is a 
biosensor capable of detecting low antigen concentrations. It could be used as an 
alternative technology for comparative studies to the electrochemical immunosensor 
that was being developed. Quartz Crystal Microbalance (QCM) is a special sensor 
that has acoustic impedance detector by mass loading, when an external voltage is 
applied to a quartz crystal the crystal starts oscillating at a specific frequency. This 
frequency changes when the crystal is loaded with extra mass (Freymuth and 
Sauebray, 1963; Uludag and Tothill, 2010). This relationship is shown by the 
Sauebray equation below.  
∆B =
1
∁DEF
∆G 
Equation 3-1 
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In this equation the frequency change (∆f) is proportional to the mass (∆m) of the 
adsorbed molecules per unit area. The CQCM is the mass sensitivity and equal to 
Vρ/2f2 (f is the resonance frequency, V and ρ are the shear modulus and density of 
quartz, respectively (Freymuth and Sauebray, 1963). This equation was used to 
show the proportionality between mass and the shift in frequency at the crystal 
surface and in assays for cardiac troponin T before (Wong-ek et al., 2010). 
 
 
Figure 4.13: Effect of successful conjugated gold nanoparticles on the frequency 
shift. The chips were reacted with either 1:10 antibody conjugated gold nanoparticles 
solution or 10 µg mL-1 of detection antibody solution. Method was adapted from work 
by (Van Heusden, 2011) n=3, maximum CV=6.9%. 
 
There was high frequency shift on QCM assay with the use of gold nanoparticles 
compared to the basic sandwich assay shows that the antibodies were successfully 
conjugated to gold nanoparticles. After the successful conjugation of the gold 
nanoparticles had been proven, the next step was to investigate the optimum 
concentration of the conjugated gold nanoparticle for use in the immunosensor. 
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4.4.4.1 Optimisation of the gold nano particles concentration  
The optimisation of gold nanoparticles is different from other methods described 
earlier for the passive adsorption and 11-MUA assay setups that utilised HRP 
conjugated antibody for detection. This is because the precise amounts of HRP and 
antibody bound on the gold surface were unknown. These amounts vary with the 
degree of conjugation effectiveness and the surfaces that are presented by the 
nanoparticles. Estimations of the amount of antibodies bound on the gold surface 
can be done but this requires some complex imaging techniques and thus this 
avenue was not explored. The concentration of the gold nanoparticles was based on 
the dilution from the stock formed after conjugation. Photometric analysis of the final 
product (100µL of conjugated gold nanoparticles) was done to compare the quantity 
of the gold nanoparticles before and after conjugation. This gave a number that can 
be used as concentration for the gold nanoparticles, however most of the times there 
was strong correlation between the before and after conjugation spectrophotometric 
readings and thus a simple fraction dilution series was opted in this experiment.  
The optimum coating antibody for the 11-MUA modified surface (10 µL of 60 µg mL-1 
7E7) was adopted and after sensitisation of the surface with EDC/NHS, different 
dilutions of the conjugated gold nanoparticle stock were assayed. Several 
concentrations of the conjugated gold nanoparticles (Neat, 1:2, 1:5, 1:15, and 1:20) 
were made and pre incubated with 50ng mL-1antigen for 1 h on a rotor. A 10 µL of 
this was then deposited on the surface of the,11-MUA modified, sensitised, coated 
and blocked electrodes and left to incubate for 1h before being washed and 
analysed using an electrochemical analyser (Metrohm, Ultech, Netherlands) The 
results obtained are shown in Figure 4.14. The results showed the expected trend of 
increasing signal with increasing concentration of the gold nanoparticles. However 
the peak of the trends was exhibited on the 1:10 dilution where the highest signal 
was achieved. Any further increases in the concentration beyond this point did not 
yield an expected proportional signal enhancement. 
The Development of a Gold Nanoparticle Enhanced Immunosensor for Cardiac Troponin T 
 
166 
W.M.Fakanya-Cranfield University-PhD Thesis 
 
Figure 4.14: The optimisation of conjugated gold nanoparticles for detection of cTnT 
assay on 11-MUA modified screen-printed gold electrodes. Electrodes were first 
sinsitised with 30 µL of EDC/NHS solution. A 10 µL of 60 µg mL-1) anti cTnT 1C11 
was immobilised on the gold working electrode. It was assayed with standard 
concentration of the cTnT antigen (50 µg mL-1) premixed with different 
concentrations of the conjugated gold nanoparticles. 
 
After the determination of the appropriate concentration of the conjugated gold Nano 
particles to use in the detection of the immuno assay, a standard curve was made 
using the optimum conditions. The optimised parameters of coating antibody (60 µg 
mL-1 of 1C11) on sensitised MUA modified working electrode surface, and detection 
utilising gold nanoparticles conjugated with HRP and 7E7 antibody (1:10 dilution with 
the antigen) were used and  a standard curve was plotted to show the capabilities of 
the immunosensor (Figure 4.15). The highest current output (-7.23 µA) was 
generated using gold nanoparticles. This assay set up had the most sensitivity 
basing on the high gradient of the slope. It was on this basis that the assay setup 
was adopted as the optimum and another standard curve was plotted using 75% 
serum for use in determining some unknown concentration of cTnT spiked in 
commercial serum. 
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Figure 4.15: Standard curve of the immunosensor with 11-MUA surface 
modifications and detected using conjugated gold nanoparticles. (Inset) a liner plot of 
the same curve LOD =0.51ng mL-1, n=3, maximum CV= 10.4%, error bars = 
standard deviation. 
 
4.4.5 Generation of a standard curve using 75% serum on the 
optimised gold nanoparticle immunosensor  
Biological samples consist of a complex mixture of compounds, including abundant 
proteins that tend to adsorb non-specifically to surfaces. When other abundant 
nonspecific proteins are present, however, it is extremely challenging to detect target 
biomarkers (Bolduc and Masson, 2008). This means that effective standard curves 
must be made using standards imbedded in the same material as the intended 
samples. This is even more important on assays that do not have a comprehensive 
dilution steps to take away the matrix effect of interfering proteins. In an attempt to 
accommodate interference expected from real serum samples in commercial 
diagnostic devices. Commercialised human serum samples purchased from (Sigma-
Aldrich) were used as standards.  
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Attempts to construct a standard curve using undiluted serum standards yielded 
undesirable results with high margins of error due to lack of reproducibility . The 
purchased serum was diluted with 25% v/v PBS-T with additives to give a 75%v/v 
serum solution that was used to make standards. The additives (0.5 M NaCl, 200 µg 
mL-1 BSA and 500 µg mL-1 dextran) had been proven to help with lowering non-
specific bindingin earlier work by colleagues (Uludag and Tothill, 2010). The 75% 
serum solution was then used to make standards as well as samples spiked with 
unknown concentrations of cTnT. 
 
 
Figure 4.16: Standard curve of the immunosensor with 11-MUA surface 
modifications and conjugated gold nano-particles for detection using antigen in 75% 
serum, (Inset) a liner plot of the same curve,LOD=0.58 ng mL-1, n=3, maximum CV= 
12.8%, error bars = standard deviation. 
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The curve resembled that of the same immunosensor format done for standards in 
buffer (Figure 4.15) but exhibited a lower maximum peak current. It was the curve 
that was used to interpolate the unknown concentrations of cTnT in spiked 
commercialised serum samples.  
 
4.4.1 Comparative summary of the different assay procedures used on 
SPGEs 
The four immunoassay set-ups used on screen-printed gold electrodes in this study 
were used to construct standard curves as described earlier. These standard curves 
were then compared against each other; Figure 4.17 and Table 4-2 shows the 
comparison of the standard curves of the three methods 
 
 
Figure 4.17: Comparison of the calibration curves that were generated using 
different assay optimisation techniques. The data from the calibration curves showed 
that the use of gold nanoparticles significantly enhanced the signal output and assay 
sensitivity And that the serum standards did not perform well unless diluted. 
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Table 4-2 The summary of the performance of various immuno assay set up on the cTnt immunosensor using screen printed 
electrodes. 
 
Passive Adsorption 11-MUA Modified Sensor 
11-MUA Modified Sensor + 60 
nm gold nanoparticles 
11-MUA Modified Sensor + 60 
nm gold nanoparticles 75% 
Serum standards 
Setup 
 
 
  
Calculated 
LOD 
2.12 ng mL-1 1.14 ng mL-1 0.51 ng mL-1 0.58 ng mL-1 
LOQ 6.8 ng mL-1 4.2 ng mL-1 1.4 ng mL-1 1.7 ng mL-1 
Equation 
y = -0.0475x - 
0.5203 
R² = 0.9899 
y = -0.113x - 0.4733 
R² = 0.9729 
y = -0.3434x - 1.1954 
R² = 0.9522 
y = -0.3279x - 1.1416 
R² = 0.9532 
Coefficient of 
Variance 
10.9% 9.8% 10.4% 12.8% 
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4.4.2 Detection of cTnT in commercial serum samples using the 
developed Immunosensor. 
Serum samples spiked with unknown concentrations of cardiac troponin t 
(cTnT) were made from human whole serum purchased from Sigma (Dorset, 
UK). The serum was diluted with 25% v/v PBS-T with 0.5 M NaCl, 200 µg mL-1 
BSA and 500 µg mL-1 dextran. These additives were intended to reduce non-
specific binding. The serum was then aliqoted into eight randomly labelled vials 
and spiked with unknown concentrations of cTnT that were controlled not to 
exceed 100 ng mL-1 as this was the known upper limit of detection on the 
calibration curve. The vials were further aliqoted into three sets’ the first set was 
analysed using the developed immunosensor using the calibration curve plotted 
in Figure 4.16. the remaining two sets were analysed using other devices that 
were intended to validate on the developed immunosensor. One was sent to the 
NHS Bedford Hospital where they were analysed using a clinical laboratory 
analyser, the other was analysed using the QCM-1 analyser using a method 
developed by a colleague (Van Heusden, 2011). Table 4-3 shows the results 
obtained. 
 
Table 4-3: The results from the analysis of eight unknown samples using the 
developed immunosensor, the QCM-1 and a Hospital Laboratory Analyser 
 Developed 
Immunosensor 
Hospital Analyser QCM-1 
Sample 1 6.5 ng mL
-1
 5.3 ng mL
-1
 3.8 ng mL
-1
 
Sample 2 22.8 ng mL
-1
 25.3 ng mL
-1
 17.9 ng mL
-1
 
Sample 3 3.2 ng mL
-1
 3.2 ng mL
-1
 Not detected 
Sample 4 15.4 ng mL
-1
 13.8 ng mL
-1
 9.2 ng mL
-1
 
Sample 5 55.4 ng mL
-1
 47.9 ng mL
-1
 33.7 ng mL
-1
 
Sample 6 9.4 ng mL
-1
 8.5 ng mL
-1
 5.9 ng mL
-1
 
Sample 7 66.9 ng mL
-1
  63.9 ng mL
-1
 56.7 ng mL
-1
 
Sample 8 1.2 ng mL
-1
 0.9 ng mL
-1
 Not detected 
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The results show that the developed immunosensor managed to interpolate all 
the samples and transcribe a proposed concentration of cTnT in the samples,It 
should be noted however that although the calibration function managed to 
estimate the concentartions of cardiac troponin in the unknown samples, the 
accuracy is questionable. This is because the limit of quantification, which was 
calculated as the mean of the blank plus 10 times the standard deviation, was 
far much higher than the calculated limit of detection. In general more and more 
high sensitivity assays find themselves on this conundrum (F.D.A, 2001) 
.Statistically significant replications would need to be done to validate the 
effectiveness of the immunosensor. The CV for the developed immunosensor 
was superior to that of the QCM but higher than that of the laboratory analyser 
at Bedford Hospital. There was a difference in the actual estimations of the 
cTnT in the samples between all the three methods. Figure 4.18 shows the 
correlation between the performances of the developed immunosensor for cTnT 
in comparison to (A) hospital analyser and (B) QCM-1 analyser. The three 
methods used makeshift specimens with 75% serum spiked with unknown 
concentrations of cTnT. The results show that although the developed 
immunosensor had more standard error (12% CV) than the hospital analyser 
(5% CV) there was a good correlation on the results obtained using the two 
methods (R2 0.991). this means that despite some calibrations differences 
between the two methods they had similar capabilities in distinguishing between 
different concentrations of cTnT. The QCM-1 method had a relatively high 
standard of error between the specimens (14% CV) and its lower limit of 
detection was higher in comparison to the electrochemical sensor. The QCM 
method was developed over a short period of time (2 months) and as such was 
not fully optimised thus it is difficult to ascertain its actual limitations. 
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Figure 4.18: Correlation plots showing the performance of the developed 
biosensor for cTnT against two other detection methods. Results from a hospital 
analyser (A) and QCM-1 analyser (B) were compared with those of the gold 
nanoparticle enhanced immunosensor. Bars indicate standard deviation. 
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4.5 Conclusions 
An electrochemical immunosensor based on gold- nanoparticles and self-
assembled monolayers SAMs for enhanced sensitivity was developed for the 
detection and analysis of cTnT in partly diluted serum samples. Screen printed 
gold electrodes with gold working electrodes were modified with 11-MUA to 
make surfaces suitable for covalent immobilisation of the capture antibody using 
the EDC/NHS chemistry. The covalent coupling enabled higher numbers of 
correctly orientated coating antibodies that helps in increasing the sensitivity of 
the assay. Incremental development was done in the development of the 
cardiac troponin immunosensor the first assay set up was based on the passive 
adsorption and conjugated detection antibodies and resembled that developed 
for CRP assay described in Chapter 3. This assay set up did not achieve much 
in terms of increasing sensitivity with a lower limit of detection LOD of 2.12 ng 
mL-1 and a maximum Coefficient of variance (CV) of 10.9%.  
 
Further development to the assay setup was done with the use of self-
assembled monolayers on the gold working electrode. An improvement on the 
method of generating self-assembled monolayers using 11-MUA was made. In 
the new method there was limited exposure of the electrodes to the solvents 
which had been identified to be causing problems in earlier work done on CRP 
immunosensor. Precautions to prevent rapid evaporation of the 11-MUA 
solution before the monolayer was created were done with the use of 
refrigeration and moisture tubs. Successful modification of the working 
electrodes was achieved and this was confirmed through cyclic voltammetry 
and contact angle measurements. The EDC/NHS chemistry was used to aid the 
covalent coupling of the coating antibodies in a manner described in previous 
literature (Van Delden et al., 1996). 
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The effects of covalent coupling were evidently fruitful as observed with an 
increase in maximum signal generated by the assay from (-2.98 µA for the 
passive adsorption) to (-4.78 µA on the covalent coupled assay).The LOD also 
improved significantly from 2.12 to1.14 ng mL-1. The next step in the 
development process was incorporating the use of conjugated gold 
nanoparticles on the assay set up to improve on sensitivity. A 60nm gold 
nanoparticles were coated with HRP followed by the detection antibody 7E7 
using passive adsorption method. The conjugation of the gold nanoparticles 
was quality checked using high salt concentration and examining for 
flocculation. The QCM-1 was also initially used for the checking of the 
conjugation of the antibodies on to the gold since it was an automated 
technique. Gold nanoparticles are capable of allowing more quantities of the 
detection reagents to be localised thus increasing the potential for enhanced 
signal output to occur in low antigen concentrations (Ansari et al., 2010; Saha et 
al., 2012). This has an advantage of lowering the limit of detection which is 
particularly important for the cTnT assay that has small antigen concentrations 
in baseline samples ≤ 0.03 ng mL-1. 
 
The clinical reference ranges for cTnT are defined by the ability of an assay to 
detect 99% of laboratory baseline values. This equates to lower limit of 
detection levels of around 0.03 ng mL-1. To achieve such high sensitivity a lot of 
development has to be done on the assay that incorporates techniques which 
helps to achieve this. The use of the gold nanoparticles significantly lowered the 
limit of detection further to 0.51 ng mL-1on buffer and 0.58 in 75% serum 
standards. This assay was comparable to other reported assays that used 
screen printed electrodes for detecting cTnT (Silva et al., 2010) but may have 
been outperformed by other reports of SPR based immunosensors (Dutra et al., 
2007). A standard curve was made with commercial serum to mimic the actual 
conditions of use. The interference posed by the serum samples was too much 
that it grossly affected the sensor performance. Other researchers have 
discovered that there is limited matrix effect on screen printed electrodes but 
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their research did not incorporate the use of SAMs which may have aided in this 
(Kadir and Tothill, 2010). Earlier work by colleagues had proven that a 75% 
serum dilution with PBS Tween and some additives was sufficient in reducing 
the nonspecific binding due to the protein matrix in serum (Uludag and Tothill, 
2010). This method was adopted in the hope that should a immunosensor be 
made it will be ready for proper serum samples provided there was a dilution 
step to counteract the matrix effect. The current strides made on the 
electrochemical immunosensor have achieved a limit of detection 0.58 ng mL-1 
with a dynamic range spanning to 100 ng mL-1. Although this is not enough to 
satisfy the diagnostic requirements of the cTnT for cardiovascular diseases, it 
could be used for screening high-end cardiac events.  
 
The performance of the developed immunosensor has been proven better than 
other biosensor methods like the QCM and the in-house ELISA methods. When 
analysing unknown concentrations of cTnT in samples the QCM-1 gave 
relatively high standard of error between the specimens (14% CV) and its lower 
limit of detection was high. The correlation results on 75% spiked commercial 
serum samples show that although the developed immunosensor had more 
standard error than the hospital analyser there was a good correlation on the 
results obtained using the two methods (R2 0.991). This means that despite 
some calibrations differences between the two methods they had similar 
capabilities in distinguishing between different concentrations of cTnT. The 
development of the immunosensor needs further optimisation to reach 
diagnostic ranges, however current performance is sufficient for screening high 
end cardiovascular events, as well as demonstrate proof of concept for a 
simultaneous immunosensor for the detection of cardiovascular diseases using 
screen printed electrodes. 
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5 Stability of the Immobilised Antibodies on the 
Immunosensor Surface 
5.1 Introduction 
 
The stabilisation of proteins is of great interest in a number of biosensor 
applications where shelf life during storage and operation are required. The 
main problems often encountered in the development of commercial biosensors 
is the stabilisation of enzymes and other proteins used in the bioactive layer 
(Gibson, 1999; McAteer et al., 1999; Jawaheer et al., 2002). Immunosensors 
often use high value proteins such as antibodies, analytical enzymes and as 
such, there is a need to employ effective stabilisation technology in an attempt 
to curb cost associated with denaturing and lack of activity of the often-
expensive biomolecules (Fernandez-Lafuente et al., 1999). Most proteins are 
easily affected by their microenvironment and this can either antagonise or 
enhance their activity, this is more so during use or storage. The sensor 
developed in this project can offer good examples of how several factors can 
affect both the shelf and operational stability of the immunosensor devices and 
these include; storage temperature, humidity, contact with other reagents or 
device surfaces, and operational conditions such as voltage. In such situations, 
the stability of the biosensor as a whole is desired and the focus of stabilisation 
is not limited to biomolecules (antibodies and enzymes used) but generally 
includes everything including the inks and the electrodes, therefore effective 
methods of stabilisation are needed to enhance the stability and retain the 
performance of the biosensor (Jawaheer et al., 2002). 
 
5.1.1 Types of biosensor stability 
 
For a biosensor to be successful it has to be stable during storage (shelf  life 
stability) and  also during use (operational stability). Shelf stability is defined as 
the improvement of activity retention of an enzyme, protein, diagnostic or device 
when stored under specified conditions after manufacture (Gibson, 1999). This 
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is an important parameter particularly for the commercialisation of adaptable 
materials that are capable of degrading over time, a good example of shelf 
stability is evident in the pharmaceutical industry where medications have a use 
by date indicated on the packaging. The same principle is often observed on 
simple diagnostics applications like the lateral flow devices for example the 
pregnancy tests, where the product is guaranteed for a specific duration from 
the date of manufacture. The shelf stability of a biosensor is often one of the 
crucial factors on deciding commercial viability of a developed biosensor 
(Fernandez-Lafuente et al., 1999). Operational stability on the other hand is the 
retention of activity of a protein or enzyme when it is actually in its intended use. 
This is often crucial when an analytical device incorporate a reusable sensor 
that needs to achieve a relatively long lifetime. However, although both shelf-
stability and operating stability are important parameters in biosensor 
development, shelf-stability is usually the more crucial parameter (Gibson, 
1999). This is because in some cases the operational stability is irrelevant for 
example in the manufacture of disposable single use biosensors like those 
developed in this project. 
 
5.1.2 Mechanisms of the Inactivation and Preservation of Proteins 
Several well-varied mechanisms are responsible for the inactivation of proteins 
and enzymes. The simple unfolding of the structure (denaturing) represents a 
small proportion of the methods by which enzymes and proteins inactivate 
(McAteer et al., 1999). Table 5-1 gives an overview of the different types of 
inactivation mechanisms (Gibson, 1999).  
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Table 5-1: Methods of Inactivation of Proteins.  
Inactivation Due to Chemistry of 
Protein Changing 
Inactivation Due to Other Changes 
Hydrolysis Unfolding 
Deglycosylation Loss of Cofactors 
Imide Formation Protein Aggregation 
Cyclisation Poisoning-Irreversible Inhibition 
Oxidation / Photooxidation Proteolysis 
Disulphide Bridges Formation Substrates of Microorganisms 
 
Most proteins including enzymes can deactivate in a number of different ways 
depending on the conditions and there are strong possibilities that several 
deactivation mechanisms may occur simultaneously. A wide variety of 
techniques can be employed to influence the stability of proteins for biosensor 
applications. Table 5-2 gives a summary of some of the methods that are 
currently used in industry (Gibson, 1999). 
 
Table 5-2: Summary of Methods of Protein Stabilisation 
Physico-Chemical Methods Additives/ Media Engineering 
Physical Entrapment Salts/ Including Buffers 
Chemical Modification Metal Ions 
Cross Linking Polymers 
Protein Engineering Solvents 
Immobilisation on Other Supports- 
Electrodes 
Water Modifiers-Sugars & polyhydric 
Alcohols 
 
The experiments described in this chapter focus on the methods highlighted in 
orange in Table 5-2 . The immobilisation of proteins offers many functional 
advantages for the construction of a biosensor. However, besides the generic 
functional need for proteins like antibodies or enzymes to be immobilised in 
biosensor development, there are often inadvertent stability advantages that 
come with the immobilisation of proteins on biosensor surfaces (Pessela et al., 
2004). 
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This chapter will discuss methods for stabilisation of biomaterials used in 
electrochemical immunosensor applications with particular reference to shelf life 
stability of immobilised antibodies. The immunosensors developed in earlier 
work described in Chapters 3 and 4, utilise proteins in the form of antibodies for 
both capture and detection functions as well as enzymes in the form of HRP. 
There is need to preserve these bio molecules and ensure that they are fully 
functional at the time of analysis. Two techniques investigated in this work will 
be discussed and these were aimed at improving the stability of the immobilised 
antibody. The use of self-assembled monolayers, and a commercial stabilising 
agent Stabiliguard® (Diarect, Germany) were employed. 
 
5.2 Materials 
Potassium Chloride (KCl), Potassium Ferricyanide (K3Fe(CN)6+3H2O), TMB (3, 
3’, 5, 5’- tetramethylbenzidine hydrochloride), PBS (phosphate buffered saline) 
containing 0.137 M sodium chloride, and phosphate buffer, 0.01 M, pH 7.4 in 
tablet form, citrate phosphate buffer (0.05 M, pH 5.5) tablets. Hydrogen 
peroxide, sodium hydroxide (NaOH) and sodium chloride (NaCl), bovine serum 
albumin (BSA), 11-mercaptoundecanoic acid (11-MUA) were purchased from 
Sigma-Aldrich (Dorset, UK). Samples of Stabilicoat® were supplied from 
Surmodics through their distributer Diarect , UK. Micropipettes were purchased 
from Eppendorf, UK. Pipette tips and 1.5 mL tubes, Potassium chloride (KCl) 
were purchased from Fisher Scientific (Loughborough, UK). Primary (batch 
1c11), secondary antibody (batch 9g6 HRP conjugated) and (7E7 non 
conjugated), and human cTnT (Molecular Weight (MW) = 36 kDa) were 
obtained from (Abcam, Cambridge, UK). Skimmed milk protein, (KPL Ltd, 
Gaithersburg, USA ). 
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Reverse Osmosis (RO, Ultrapure) water (18 M MΩcm-1) was obtained from 
Milli-Q water system (Millipore Corp., Tokyo, Japan). Glassware and volumetric 
materials were of analytical grade. Gold nanoparticles with a diameter ranges 
from 20-100 nm were purchased from BBInternational Ltd (Cardiff, UK). An 
incubator/shaker from Labsystem iEMS® was used for temperature control 
incubation. The electrodes used in this project were the JD type designed by 
Cranfield University and fabricated using the facilities at DuPont (Bristol, UK). 
The gold working electrode was circular with a 0.226 cm2 planar area, a 
complementary carbon counter electrode and an Ag/AgCl reference electrode. 
The substrate material used is PET 125 µm Autotype HT5. The carbon 
electrode has an approximate dried thickness of 7 µm, while the gold and 
Ag/AgCl electrodes both have an approximate thickness of 18 µm. The 
encapsulation of 5036 blue had an approximate thickness dried of 4 µm. Inks 
used in the construction of the sensors are BQ221 carbon ink, BQ331 gold ink 
and the 5880 Ag/AgCl and are available from DuPont (Bristol, UK). Autolab 
Electrochemical Analyser with general-purpose electrochemical software GPES 
4.9 was purchased from  Metrohm (Ultrech , Netherlands).The electrodes were 
connected to an edge connector and then connected to the electrochemical 
analyser using a modified connector (Maplin UK). 
 
5.3 Methods 
There were three stabilisation methods that were investigated for their potential 
to increase the performance span of the immunosensor over time. The use of 
self-assembled monolayers, a commercial stabilising agent Stabiliguard® 
(Diarect, Germany) and Trehalose (a natural alpha-linked disaccharide) were 
investigated for their ability to improve the stability of immobilised antibodies. 
Immunosensors were made in big batches were coated and blocked using the 
three techniques. A reference immunosensor batch was made using passively 
absorbed antibody that had no stabilisation mechanism employed. All the 
immunosensors used for this work were for the cardiac troponin t assay cTnT 
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as it had a wide breath of assay design. For enhanced reproducibility, the assay 
format used was the classic sandwich that did not employ the use of gold 
nanoparticles but detection with HRP conjugated mouse monoclonal anti cTnT 
(7E7) antibody. This was to eliminate any batch to batch variation associated 
with the conjugation of gold nano-particles especially when a new batch had to 
be made for every time measurement due to their lack of stability. 
 
5.3.1 Method for preparing immunosensors using passive 
adsorption 
Immunosensors for cTnT optimise of the coating and detection antibody for 
cTnT assay on bare screen-printed gold for passive adsorption were made 
using the method described in Section 4.4.2.1 .The electrodes were first baked 
at a temperature of 120 °C for 30 minutes, washed and rinsed with distilled 
water to remove any particle contamination. The working electrode was then 
coated with a drop of 10 µL of mouse monoclonal anti cTnT (90 µg mL-1 of 
1C11) dissolved in 0.05 M carbonate-bicarbonate buffer pH 9.6 and allowed to 
incubate for 2h at 37 °C in a moist environment. The electrode surface was then 
gently washed with phosphate buffer saline with 0.05% Tween 20 (PBS-T), two 
times, rinsed with distilled water and air-dried with nitrogen. The working 
electrodes surface was then blocked for 30 minutes at 37 °C. The blocking 
solution was a 1:10 skimmed milk dilution in PBS. The electrodes were then 
gently dried again with a nitrogen gun and split into three batches that were 
stored in different conditions. 
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5.3.2 Method for preserving immunosensors using covalent 
immobilisation 
This was done using the procedure described in Section 4.3.3.1. The electrodes 
were baked in an oven for 120 °C for 30 min before being plasma cleaned in 
oxygen free nitrogen at 50w for 2.5 minutes (Emitech K 1050X, EM 
Technologies, Kent, UK), at a power of 50 W with a bleed vacuum trip of 3 x 10-
1 mbar and an ashing time of 1 minute. After this, the working electrode was 
coated with 2 x 50µL of 4mM 11-MUA placed three hours apart in an overnight 
incubation step at 4°C in darkness. This allowed the 11-MUA to form a self-
assembled monolayer on the sensor surface. Two solutions a 400 mM EDC and 
100 mM NHS solution in deionized water were premixed 1:1 and applied to the 
working electrode surface immediately after mixing them (30 µL and incubating 
for 10 min). The electrodes were then washed in PBS-T and the capture 
antibody (10 µL of 90 µg mL-1 mouse monoclonal anti cTnT 1C11) dissolved in 
0.05 M carbonate-bicarbonate buffer pH 9.6 was added and allowed to incubate 
on the sensor surface for 2h at 37 °C in a moist environment. The electrodes 
were then washed and blocked, first for 10 min with 50 µL of 1M ethanol amine 
solution and then further blocking was done by covering with 50 µL 10% milk 
blocking proteins (KPL) dissolved in PBS for 30 min at 37 °C. The electrodes 
were then gently dried again with a nitrogen gun and split into three batches 
that were stored in different conditions. 
 
5.3.3 Method for preserving Immunosensors using Stabiliguard® 
Immunosensors were prepared using the procedures for both passive 
adsorption described in Section 5.3.1 and covalent immobilisation described in 
Section 5.3.2 with a couple of modifications. Stabiliguard ® (50 µL of neat 
solution was used for the blocking instead of using 10 % milk protein. The 
blocking time was cut from 30 min to 10 min but all the other parameters 
remained the same for both methods. These were the recommended 
parameters for the use of Stabiliguard for preserving the functionality and shelf 
life of immobilised antibodies. 
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5.3.4 Batching and Storage of Immunosensors 
The three types of immunosensors were made and stored so that each type 
had three batches of electrodes stored in different temperature and humidity 
environments. One batch was stored in petri dishes wrapped in foil at 4°C, 
another batch was stored in petri dishes wrapped in foil at room temperature 
and a third batch was stored in petri dishes wrapped in foil inside a vacuum 
desiccator with silica gel beads  
 
5.3.5 Analysis of the Functionality of the Immobilised Antibodies 
The immunosensors were analysed over time to check for the functionality of 
the immobilised antibodies using electrochemical measurements. The analysis 
was done for 1, 3, 7, 14, 28, 60, 90 days after the making of the immunosensor 
for each of the sensor type and storage condition. The analysis was done by 
Premixing the antigen (50 µL of cTnT) with the detection antibody HRP 
conjugated anti cTnT to give a final concentration of 50 ng mL-1antigen 
concentration and 60 µg mL-1of conjugated mouse monoclonal anti human 
cardiac troponin t antibody. The mixture was incubated to premix for 1hr min on 
a rotter away from sunlight. It was then added (20 µL) in triplicates to the 
blocked electrodes and incubated for 1hr min at 37°C. The electrodes were then 
washed and connected to an edge connector, which is connected with a multi-
channel AUTOLAB electrochemical instrument. All measurements were 
performed by adding 100 µL of 4 mM TMB and 0.06 % H2O2 in 0.05 M citrate 
phosphate buffer plus 0.1 M KCL with chronoamperometry methods at -200 mV 
constant current and run for 200 s to 300 s using electrochemical GPES 4.7 
software. 
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5.4 Results and Discussion 
5.4.1 Stabilisation of immobilised antibodies 
In this study, two methods were used for the antibody immobilisation on the 
sensor surface that is the passive and covalent immobilisation techniques.  
Unlike passive immobilisation that is relatively simple and relies on the 
adsorption of the antibodies on the sensor covalent techniques requires a series 
of steps that modify the surface to increase the efficiency of the immobilisation 
process. This has been reported to have an enhanced stabilising effect on the 
covalently immobilised antibodies (Wink et al., 1997; Altintas et al., 2012). A 
commercial reagent for stabilisation of immobilised proteins (stabiliguard) was 
also investigated. Although the constituents of the reagent are aclosely guarded 
commercial secret, research has shown the usefulness of water modifiers in the 
preservation of immobilised proteins. The use of polyalcohols, polyelectrollytes 
or a combination of both is consistent in most stabilisation products currently on 
the market. Polyalcohols include polyhydric molecules like sugars, sugar 
alcohols and other more exotic substituted sugar molecules. These modify the 
water environment surrounding a protein by competing for and replacing the 
free water (A.E.T Ltd, 2012). This has an effect of modifying the hydration shell 
of the protein in and confers protection to the protein while maintaining 3D 
structure and biological activity .The storage of biological materials in the 
presence of these polyalcohol molecules is suitable stabilisation of both solution 
based and dehydrated proteins with preserved biological activity. 
Polyelectrolytes on the other hand include numerous polymers of varying size 
charge and structure. The interactions between proteins and these polymers 
are electrostatic based on the charge groups. They are capable of forming large 
protein-polyelectrolyte complexes that retain full biological activity of the 
proteins. The important aspect on the use of these is the need for precision in 
calculating the stoichiometry of protein/polymer binding which is critical factor 
for maintaining enzyme activity in stabilised formulations (A.E.T Ltd, 2012). 
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There is a strong chance that the composition of Stabiliguard® is a combination 
of both polyalcohol’s and polyelectrolytes. The combination of the two has the 
advantage of having polyelectrolyte molecules binding to a large protein 
molecule and the smaller polyalcohol molecules fitting in within the matrix 
generated by the protein/polyelectrolyte complex as shown in Figure 5.1 .This 
has a net effect of improved protein protection that will make it retain the 
function for longer periods. 
 
 
Figure 5.1:The effect of combined polyelectrolytes and Polyhydroxyl 
compounds in stabilising immobilised proteins. Polyelectrolytes promotes the 
formation of soluble protein - polyelectrolyte complexes, polyhydroxyl 
compounds can then penetrate the structure more effectively leading to 
stabilisation (A.E.T Ltd, 2012). 
 
However, as mentioned before the actual constituents of the reagent are 
protected intellectual property. Self-assembled monolayers have been shown to 
increase the shelf life and functionality of immobilised proteins (Srisombat et al., 
2011). In this experiment self-assembled monolayers were made using 
alkanethiol group chemical 11-mercaptoundecanoic acid (11-MUA) purchased 
from Sigma-Aldrich UK. They were made by the treating the working electrode 
with 2 x 50 µL of 4 mM 11-MUA placed three hours apart in an overnight 
incubation step at 4°C in darkness. The EDC/NHS chemistry was then used to 
activate the functionalised surface and immobilisation of the antibodies 
followed. Figure 5.2 shows both the effect SAMs and Stabiliguard® on 
preserving the functionality of the immunosensor over time.  
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Figure 5.2: Effect of Stabiliguard® on preserving the functionality of 
immobilised antibodies on (A) passively adsorbed and (B) covalently 
immobilised using 11-MUA self-assembled monolayers. Each of the two setups 
had a Stabiliguard® stabilised and un stabilised variables and performance was 
compared over immunosensors stored in a variety of environments (4°C, room 
temperature and vaccum dessicator), n=9. 
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Although optimisation of the concentration of antibodies for covalent 
immobilisation on the actual cTnT assay recommended a lower concentration 
(60 µg mL-1) than that for covalent immobilisation (90 µg mL-1) the procedure 
for this experiment required uniform concentration of the immobilised antibody 
and thus the optimum for the passive adsorption was used (90 µg mL-1). The 
results show that there is significant retained functionality of the immobilised 
antibody for longer if Stabiliguard ® is used as a replacement for the blocking 
agent. This is evident in both passively immobilised  
Figure 5.2 (A) and SAM modified immunosensors Figure 5.2 (B). The results 
also showed that there is increased protein stability on immunosensors with 
self-assembled monolayers (covalent coupling). This is shown by the low 
gradient on the drop of activity compared to that of passive immobilised 
immunosensors; this was observed on both immunosensor types with or without 
Stabiliguard ®. Although the Immunosensors with SAMs had an advantage of 
higher signals, they did not rapidly loose signals in a manner exhibited by the 
immunosensors without SAMs 
5.4.1 The environmental conditions 
The environmental conditions during the storage and transportation of bio 
reactive products play an important role in their functionality and shelf life. 
Environmental factors like humidity, temperature, and air exposure all offer 
potential obstacles in the functionality of biomaterials. In this experiment, 
batches of different immunosensors for cardiac troponin t were made and 
stored in different conditions. They were then analysed over time to find out 
which environmental conditions were favourable for the storage of 
immunosensors as well as to evaluate the methods of protein stabilisation that 
had been used on them. Three environmental conditions were investigated 
which included storing the electrodes in a refrigerated environment at 4°C, at 
room temperature, and in a vacuum. Figure 5.3 show the effect of different 
storage conditions on the performance of immunosensors with passively 
adsorbed antibodies over time. 
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Figure 5.3 The effect of different storage conditions on the performance of 
immunosensors with (A) passively immobilised (B) covalently immobilised 
antibodies. Batches of immunosensors were stored in different conditions and 
analysed. n=3, CV=12.2%, Error bars represent standard deviation. 
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The results show a typical trend of deterioration in signal with immunosensor 
age. This was expected, as the immunosensors used did not have any 
mechanism for stabilisation of the immobilised antibodies. However, the 
immunosensors that were kept at room temperature deteriorated faster than the 
ones kept in the fridge and in the vacuum. The average showed that the 
vacuum preserved the immunosensors better than the fridge but due to the high 
margin of error exhibited by the experiment in general the advantage could not 
be validated. The same was done on different types of immunosensors and the 
obtained results are summarised in Figure 5.4. The results show different 
immunosensor performance after storage for up to a period of 90 days in 
different conditions (a) refrigerated at 4°C, (b) room temperature (c) room 
temperature in a vacuum. The results showed corresponding information to that 
given by Figure 5.3; the general trend shows that there is increased 
deterioration on immunosensors that were left on room temperature. 
Refrigeration and vacuum improve the life span of the immunosensor and 
Stabiliguard® significantly help in retaining functionality of the immobilised 
antibodies for longer.  
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Figure 5.4 The effect of time on the performance of various immunosensor 
compositions for cardiac troponin t stored at different conditions over 90 days. 
Immunosensors were stored at (A) 4°C (B) room temperature (C) room 
temperature in a vacuum. 
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5.5 Conclusion 
The stability of proteins on biosensor surfaces is crucial to the feasibility of any 
commercialisation prospects. This factor is crucial and can make or break the 
business viability of any biosensor product. In this Chapter, the use of water 
modifiers in the stabilisation of immobilised antibodies has been shown using a 
commercial product Stabiliguard®, (Surmodics, USA). Although the actual 
chemical composition of the product is proprietary, the evidence suggested that 
it was effective in preserving protein functionality for longer periods possibly 
using a combination of polyelectrolytes and Polyhydroxyl compounds (de Cordt 
et al., 1994). The use of Stabiliguard® made a difference on both passively 
immobilised and covalently immobilised antibodies using self-assembled 
monolayers. In both cases there was continued improved signal compared to 
immuno sensors without the stabilisation agent. Furthermore, the gradient of the 
drop of activity with time was less than that observed on immunosensors 
without the stabilisation agent, this was consistent with findings from other 
researchers (Wu and Grainger, 2006). The use of self-assembled monolayers 
has been demonstrated to have a positive impact on the stabilisation of the 
immobilised proteins (Wink et al., 1997; Altintas et al., 2012). Although SAMs 
were used in the assay for other benefits, including improved signals due to 
controlled antibody orientation, they were evaluated for their role in stabilising 
immobilised reagents to maintain prolonged functionality. Monolayers of 11-
mercaptoundecanoic acid (11-MUA) were made on the gold surface and 
immobilisation of antibodies was carried out using the procedure described in 
Section 0. When compared to immunosensors with antibodies immobilised via 
passive adsorption, the immunosensors with SAMs had more retained 
functionality over time. There was a significant resistance in the drop of 
performance over time for the immunosensors with SAMs compared to 
passively adsorbed antibody ones. The comparison of the two types of 
immunosensors was tricky in the regard that the immunosensors with SAMs 
had a higher starting signal compared to the passively adsorbed, due to the 
benefits of improved packing (Mrksich and Whitesides, 1996). However 
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considering this and using the performance-time gradient, it was demonstrated 
that SAMs are capable of improving the stability of immobilised antibodies and 
even perform better at this when used with other water modifying agents that 
enhance protein stability.  
 
The effect of environment on the immunosensor performance, with particular 
reference to storage conditions was also investigated in this work. 
Immunosensors for cTnT were made and batches were stored in three 
environmental conditions that included storing the electrodes in a refrigerated 
environment at 4°C, at room temperature, and in a vacuum. The performance of 
the electrodes from each of the batches was assayed with a uniform mixture of 
premixed antigen and antibody and then analysed using amperometry. The 
results showed a typical trend of decreasing in signal as the immunosensor 
aged in all of the three storage environments and for all the types of 
immunosensors. The data showed that the immunosensors that were kept at 
room temperature deteriorated faster than the ones kept in the fridge and in the 
vacuum. The immunosensors stored at room temperature showed the steepest 
decline in signal with time compared to the other two storage conditions. This 
could have been due to temperature and exposure to other factors like humidity. 
Data showed that the vacuum preserved the immunosensors better than the 
fridge (4°C) but due to the high margin of error exhibited by the experiment in 
general the advantage could not be validated The experiment had limitations 
imposed on the time that was investigated, and the frequency of the 
measurement. More information may have been collected if there were more 
closely spaced periods for performance analysis. This however was not 
economically feasible, as it would have entailed the making and usage of a lot 
of electrodes and reagents. More work need to be done in this area to improve 
the stability of immobilised bio regents like antibodies as it is crucial for 
commercialisation. 
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6 Final Discussion and Conclusions 
6.1.1 Overview 
This thesis covers the development of two immunosensors based on the 
enzymatic electrochemical transduction of modified screen-printed gold 
electrodes. The immunosensors were developed to detect two cardiovascular 
markers cardiac Troponin T (cTnT) and C-reactive protein (CRP). The 
immunosensor development started at investigating various components for the 
electrodes and some manufacturing parameters that were appropriate for 
producing high performance electrodes. The best electrodes were then adopted 
for use in the development of the immunosensors. The combined use of self -
assembled monolayers and gold nano-particles for enhancing signal in 
detecting cTnT is new technology that has was shown to increasing sensitivity 
of electrochemical assays. A new method for the development of self-
assembled monolayers on screen-printed electrodes without compromising the 
functionality of the electrodes was proposed. The development of 
immunosensors for the two cardiac markers cTnT and CRP gave a platform for 
proof of concept in the development of a multi marker electrochemical detection 
biosensors as the two electrodes could be combined on the same analyser and 
give signal from the same sample. 
 
6.1.2 Fabrication and Characterisation of Screen-printed 
Electrodes 
The fabrication of high quality electrodes is the foundation of the development 
of competent electrochemical biosensors. In this report aspects of the 
fabrication process were investigated with particular reference to investigating 
compatible ink combinations and optimum curing conditions. The actual 
compositions of the inks are proprietary information and this provides 
restrictions to what can be discussed regarding its composition. However, 
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superior electrode performance was noted on electrodes with better carbon 
notably the JD type of electrodes.  
This is because the carbon usually constitutes more than 80 per cent of the total 
ink coverage on an electrode (Cui et al., 2001b; Morrin et al., 2003). This is 
because besides being used for the counter electrode it is also used for tracking 
the other electrodes to complete the circuit. Electrochemical and immuno assay 
evaluations were done to characterise the different electrodes and identify 
optimum performers. Cyclic voltammetry is a key tool in the characterisation of 
electrodes (Garcia-Gonzalez, 2008). It was used to define the electrode’s 
activity as well as to calculate the percentage of the available area on the 
working electrode.  Experiments were conducted to evaluate the effect of 
different curing conditions on the performance of the electrode. The curing 
conditions of an electrode play a major role in the rate and cost of production of 
electrodes (Hobby, 1997). Different techniques are constantly being 
investigated to improve the production process by finding fast and cheaper 
curing alternatives. 
 
Although infra-red drying is a faster and cheaper method that the conventional 
oven drying (Morrin et al., 2003). The results showed that the conventional 
drying resulted in better performing electrodes. The findings of the 
electrochemical results were confirmed with imaging. The results from the 
scanning electron microscope showed that although the same ink was used for 
the working electrodes there were differences in the surface composition of the 
electrodes after curing them differently. This may have been caused by 
temperature variations and humidity conditions during the curing process (Cui et 
al., 2001a; Grennan et al., 2001). The E-SEM showed a clear difference in both 
the chemical composition and the morphology of the constituent particles on the 
gold surface. The amount of the exposed gold on the infra-red dried sensors 
(65.34%) was less than that from the conventionally dried electrodes (84.8%).  
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This may explain the superior electrochemical behaviour of the conventionally 
dried electrode as shown by the cyclic voltammetry and the immuno assay 
results. Although the IR drying may have commercial advantages on speeding 
the production line, it is evident that this has an impact on the quality.  
 
6.1.3 Development of an Electrochemical Immunosensor for C-
Reactive Protein 
An electrochemical immunosensor based on screen-printed gold electrodes 
was developed for the detection of C reactive protein. CRP has evolved from 
being a postulated marker that can possibly predict cardiovascular events and 
mortality to a proven direct partaker in the pathogenesis of atherosclerotic 
cardiovascular disease (Bisoendial et al., 2010; Nagai et al., 2011). This direct 
relationship makes it a suitable marker for inclusion on as part of a multi marker 
cardiac immunosensor panel. Biomarkers work better as a panel of several 
biomarkers so that they can complement each other in aiding diagnosis (Apple, 
2007) 
 
The electrochemical transduction method adopted for the measurement of the 
immunosensor signal was adopted earlier work done on the same electrodes to 
develop an immunosensor for the detection of salmonella (Salam and Tothill, 
2009). Measurements were performed by adding 100 µL of 4 mM TMB and 
0.06% H2O2 in 0.05 M citrate phosphate buffer plus 0.1 M KCL combined in a 
1:1 ratio, with chronoamperometry methods at -200 mV constant potential. 
Electrochemical noise from the reagents was also investigated and thus the 
parameters prescribed in literature were adopted for use on this immunosensor. 
Electrodes that performed better (JD) in the characterisation, experiments were 
adopted for the development of the immunosensor. Immuno assays were 
developed and optimised on the microplate before being transferred for use on 
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the immunosensor. The direct transfer of plate-based assays on to the screen-
printed electrode presented some challenges. Unlike the microwells that can 
easily accommodate 300 µL, the screen-printed gold working electrode surface 
can hold a maximum of 35 µL before the liquid overspills to other electrodes 
(Kadir and Tothill, 2010).  
The most effective concentration of the coating antibody on the screen-printed 
electrode was 60 µg mL-1, which was exactly ten times the concentration on the 
plate based assay, however less volumes were needed. The highest peak 
response to a standardized antigen concentration was at 60 µg mL-1 coating 
antibody concentration. It was observed that there was a characteristic tailing of 
the curve with concentrations of the coating antibody above 60 µg mL-1. This 
could be attributed to steric hindrance and other factors associated with the 
change in behaviour of highly concentrated antibodies (Law, 1996; Zhu et al., 
2003; Salam and Tothill, 2009). While the prospect of increasing signal with 
increasing the concentration of the antibodies were plausible, trade-offs were 
made to take into account the performance and costs relationship. The 
detection antibody exhibited similar characteristics as shown on the optimisation 
of the capture where there was increasing signal with increasing concentration 
of the antibody. The data showed that the concentration of 30 µg mL-1was the 
optimum for the detection antibody. The investigation of finding out the best 
method for the detecting the antigen showed that there are better results if the 
antigen is premixed with the detection antibody before being exposed to 
immobilised capture antibody. This is because both the antigen and the 
detection antibody are free in solution they have a better chance of binding 
(Law, 1996; D'Orazio, 2003; Zhu et al., 2003). Passive adsorption was used in 
the immobilisation of the capture antibody on the gold working electrode. This 
was because the required sensitivity for the CRP assay was not stringent and 
could easily be achieved using passive adsorption. However, attempts were 
made to covalently immobilise antibodies using self-assembled monolayers 
SAMs. These were made using 11-mercaptoundecanoic acid (11-MUA), and 
3,3-dithiodipropionic acid (DTDPA).  
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The action of thiol groups on metal surfaces results in the formation of  semi 
covalent bods on the electrode surface (Srisombat et al., 2011; Altintas et al., 
2012) . SAMs and have been reported to cause improved antibody performance 
and stability on the sensor surface (Love et al., 2005; Li et al., 2009). However, 
in the development of CRP immunosensor the method of depositing SAMs 
interfered with other electrodes and since the CRP immunosensor had achieved 
its operational parameters this avenue was not pursued further.  
 
The clinical reference ranges for CRP assay are ≥1 µg mL-1 low risk, 1-3 µg mL-
1 is medium risk and ≤ 3 µg mL-1 is high risk (Di Napoli et al., 2005; McBride, 
2008). The performance of the CRP immunosensor was able to achieve 
diagnostically relevant parameters. The developed electrochemical 
immunosensor was highly specific and had a LOD of 2.6 ng mL-1 and spanning 
up to 100 ng mL-1, this translated to a dynamic range of  0.52 µg mL-1 to 20 µg 
mL-1 after compensating for the 200x dilution. This result was comparable to 
other electrochemical immunosensors for CRP that has been reported in 
literature (Zhou et al., 2010; Shaolin et al., 2011) and even had better limit of 
detection when compared to other reported CRP immunosensors assays (Zhu 
et al., 2003). 
 
Performance of the developed immunosensor was compared to that of a in-
housed developed ELISA and a commercial ELISA, using some spiked 
commercial serum samples. The performance of the commercial ELISA was 
superior to both the electrochemical immunosensor and the in-house optimised 
ELISA. This is because the commercial ELISA had the lowest calculated lower 
limit of detection of 1.1 ng mL−1, unlike 1.91 ng mL−1 for the in-house ELISA and 
2.2 ng mL−1 achieved by the immunosensor.  
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A correlation curve was plotted using randomly spiked samples between a 
commercial ELISA kit a correlation with a R2 value of 0.998 was achieved. The 
in-house immunosensor had an R2 value of 0.999 against the commercial 
ELISA. The data for comparing the showed no statistical difference in 
performance, to conclude a CRP immunosensor based on electrochemical 
transduction was developed and it performed comparably to a commercial kit. 
 
6.1.4 The Development of a Gold Nanoparticle Enhanced 
Immunosensor for Cardiac Troponin T 
An electrochemical immunosensor based on gold nanoparticles and self-
assembled monolayers SAMs for enhanced sensitivity was developed for the 
detection of cardiac Troponin T (cTnT) in partly diluted serum samples. Cardiac 
Troponins (T and I) are cardiac isoforms of contractile proteins of the myofibril 
that are very specific for cardiac injury. Due to their great sensitivity and 
specificity for myocardial cell damage, cardiac troponins have been considered 
as the “gold standard” for AMI diagnosis (Alpert et al., 2000; Babuin, 2005). As 
such they would be a suitable biomarker for inclusion in an multi marker panel 
alongside other markers like CRP. 
 
The clinical reference ranges for cTnT are defined by the ability of an assay to 
detect 99% of laboratory baseline values. This equates to lower limit of 
detection levels of around 0.03 ng mL-1. To achieve such high sensitivity a lot of 
development has to be done on the assay that incorporates techniques which 
helps to achieve this. Screen-printed gold electrodes with gold working 
electrodes similar to those used on The CRP immunosensor were modified with 
11-mercaptoundecanoic acid (11-MUA) to make self-assembled monolayers 
(SAMs). This was to facilitate covalent immobilisation of the capture antibody 
using the EDC/NHS chemistry (Van Delden et al., 1996).  
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The covalent coupling enabled higher numbers of correctly orientated coating 
antibodies that helps in increasing the sensitivity of the assay (Law, 1996; Chaki 
and Vijayamohanan, 2002). Incremental development was done in the 
development of the cardiac troponin immunosensor the first assay set up was 
based on the passive adsorption and conjugated detection antibodies and 
resembled that developed for CRP assay described in Chapter 3. This assay 
set up had a lower limit of detection LOD of 2.12 ng mL-1 and a maximum 
Coefficient of variance (CV) of 10.9%.  
 
Further development to the assay setup was done with the use of self-
assembled monolayers on the gold working electrode. As discussed earlier 
SAMs and have been reported to cause improved antibody performance and 
stability on the sensor surface (Love et al., 2005; Li et al., 2009), this was 
particularly useful in the detection of cTnT assay that has small antigen 
concentrations in baseline samples ≤ 0.03 ng mL-1 (Jaffe et al., 2006). A new 
method of generating self-assembled monolayers on the gold working electrode 
using 11-MUA was developed. The method has limited exposure of the 
electrodes to the solvents. Exposure to solvents had been identified to cause 
problems with electrode performance in earlier work done on CRP 
immunosensor. Precautions to prevent rapid evaporation of the 11-MUA 
solution before the monolayer were made with the use of refrigeration and 
moisture tubs. Successful modification of the working electrodes was achieved 
and this was confirmed through cyclic voltammetry and contact angle 
measurements. The EDC/NHS chemistry was used to aid the covalent coupling 
of the coating antibodies in a manner described in previous literature (Van 
Delden et al., 1996). 
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Increased signal were achieved on immunosensors with covalent immobilisation 
and the LOD was significantly lowered 2.12 to1.14 ng mL-1. The next step in the 
development process was incorporating the use of conjugated gold 
nanoparticles on the assay set up to improve on sensitivity. This has been 
reported to have a remarkable effect in improving the sensitivity of the assay 
through signal amplification (Ansari et al., 2010; Suprun et al., 2011; Saha et al., 
2012; Li et al., 2009). Gold nanoparticles were conjugated to HRP and the 
detection antibody 7E7 using passive adsorption method. Gold nanoparticles 
are capable of allowing more quantities of the detection reagents to be localised 
thus increasing the potential for enhanced signal output to occur in low antigen 
concentrations (Ansari et al., 2010; Saha et al., 2012). This has an advantage of 
lowering the limit of detection that is particularly important for the cTnT assay  
 
The use of the gold nanoparticles significantly lowered the limit of detection 
further to 0.51 ng mL-1on buffer and 0.58 in 75% serum standards. This assay 
was comparable to previously reported assays that used screen printed 
electrodes for detecting cTnT (Silva et al., 2010). The interference posed by the 
serum samples was too much that it grossly affected the sensor performance. 
Earlier work by colleagues had proven that a 75% serum dilution with PBS 
Tween and some additives was sufficient in reducing the nonspecific binding 
due to the protein matrix in serum (Uludag and Tothill, 2010) and this was 
adopted for the use on the immunosensor to counteract the matrix effect. A limit 
of detection 0.58 ng mL-1 was achieved which fell short of the new requirements 
for the diagnosis of cardiovascular disease using cTnT. However, the 
immunosensor can have other applications in the screening of suspected 
cardiac events. Other researchers have reported achieving better limits of 
detection with immunosensors that utilise other assay set-ups. The use of  
streptavidin microsphere modified screen printed electrodes managed to 
achieve LOD of 0.2 ng mL-1  (Silva et al., 2010). 
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Other transduction mechanisms like surface Plasmon resonance SPR have 
been reported to detect cTnT to a LOD of 0.05 ng mL-1  (Dutra et al., 2007), and 
the use of QCM has been reported to detect cardiac troponin t to a limit of 
detection of 0.003 ng mL−1 (Fonseca et al., 2011) although some researchers 
reported higher LOD of 5ng mL-1 (Wong-ek et al., 2010). Commercial assays for 
the detection of cardiac Troponin T are based on mostly optical methods and 
have already been summarised in Table 1-3. 
 
Comparisons were made between the developed immunosensor with a hospital 
analyser. The correlation results on 75% spiked commercial serum samples 
show that although the developed immunosensor had more standard error than 
the hospital analyser there was a good correlation(R2 0.991) on the results 
obtained using the two methods. This indicates that despite some calibrations 
differences between the two methods they had similar capabilities in 
distinguishing between different concentrations of cTnT. The development of 
the immunosensor needs further optimisation to reach diagnostic ranges, 
however current performance is sufficient to demonstrate proof of concept and 
screening purposes. The shelf stability of a biosensor is often one of the crucial 
factors on deciding commercial viability of a developed biosensor (Fernandez-
Lafuente et al., 1999). In this Chapter, investigations on to the preservation of 
immobilised antibodies were done using self-assembled monolayers (SAMs) 
and a commercial product Stabiliguard® which contain a combination of 
polyelectrolytes and polyhydroxyl compounds. The use of self-assembled 
monolayers has been demonstrated to have a positive impact on the 
stabilisation of the immobilised proteins (Wink et al., 1997; Altintas et al., 2012). 
Although SAMs were used in the assay for other benefits, including improved 
signals due to controlled antibody orientation, they were evaluated for their role 
in stabilising immobilised reagents to maintain prolonged functionality. The 
results showed that both the use of SAMs and the application of Stabiliguard® 
effectively preserved the functionality of the immunosensor.  
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6.2 Future Work 
There are a lot of interesting areas in immunosensor development that may be 
investigated further in future work. These span the whole spectrum of 
interelated areas including sensor fabrication, to integration of immunosensors 
with compatible microfluidic devices. In the sensor fabrication area, there are 
major restrictions as current sensor compositions, inks and curing methods are 
withhold by manufacturers as either protected intellectual property, or 
commercial secrets aimed at gaining competitive advantage. Should resources 
appear and information barriers be broken, more work could be done on the 
investigating the inclusion of other materials on the electrode. This can help to 
investigate performance of electrodes absent of secret ingrediants and identify 
key parameters for enhanced screen printed electrode performance. 
Investigating the benefits of incorporating other rare metals like platinum may 
have been attempted in this work if time and resources had permitted ,the 
inclusion of masking compounds that prevent electrode degradation during 
rapid curing is also a potential minefield for future studies. On the fabrication 
processes, it may have been worthwhile to look at the effect of other 
environmental conditions like humidity, as well as increasing the array of curing 
temperatures and conditions that were investigated. There is also the possibility 
of investigating different ink thicknesses and and evaluating if there were any 
economic and performance benefits associated with using small ink quantities 
to make microelectrodes. Another interesting area that may need to be explored 
in the future is to compare the screen-printed electrodes against others 
fabricated with other methods including inkjet printed using the same materials. 
The technical set up of the immunosensors can benefit from other non-antibody 
based molecules like aptamers and molecular imprinted polymers. These 
molecules have been demonstrated to provide remarkable interactions with 
antigens with specificities and sensitivities often superior to those of traditional 
antibodies. Although gold nanoparticles were not used in the CRP assay this 
can be explored in future to improve the assay sensitivity. The conjugation of 
the gold nanoparticles in the cardiac Troponin T assay was done passively, this 
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is an uncontrolled process that results in variation and decreases assay 
capability.  
The potential of covalently immobilising the detection antibodies and the HRP 
on the nanoparticles using coupling chemistries like EDC/HNS would help 
standardise the assy. The improvements on the use of EDC/NHS chemistries 
on the immunosensor were demonstrated and thus such improvements can be 
enjoyed if the gold nanoparticles were conjugated in a similar manner. 
The development an integrated sub circuit for both the C-reactive protein and 
cardiac Troponin T capable of simultaneous detection would be a good way 
forward. This is because most clinical results from cardiac markers are more 
useful if they are part of a panel of several markers providing several a set of 
results from a single sample. This helps the doctors to give a more accurate 
diagnosis as well as lowering turnaround times as well as maximising output 
from samples. The integration of the immunosensors to a micro fluidic device 
capable of controlling sample and substrate movement will progress the work 
further towards a becoming a commercial product.  
 
 Final Discussion and Conclusions 
 
 
6.3 Final Conclusions  
The overall results achieved in this study include the development 
immunosensors for the detection of c ardiac markers that can easily be 
integrated to form a multi marker panel. 
Key Achievements of this study are listed below 
• The investigation of the best curing methods and suitable ink 
combinations for the development of screen-printed of electrodes with 
enhanced performance. 
• The development and optimisation of an ELISA assay for C reactive 
protein which can detect diagnostically relevant CRP concentrations in 
serum with comparable measurement to a commercial alternative 
• The development and optimisation of an immunosensor for C reactive 
protein using screen-printed gold electrodes, capable of detecting 
diagnostically relevant ranges of CRP in serum with comparable 
measurement to a commercial alternative 
• The development of an ELISA assay for Cardiac Troponin T 
• The development and optimisation of an immunosensor for cardiac 
Troponin T using screen-printed gold electrodes. 
• The development of a method for modifying the sensor surface with self-
assembled monolayer in a sensor friendly way 
• The optimisation and preservation of the immunosensor performance for 
cardiac Troponin T using self-assembled monolayers. 
• The amplification of the detection signal using gold nanoparticles on the 
cardiac troponin immunosensor 
• The investigation of methods for enhancing immuno sensor shelf life 
The main objective of the development of a multi sensor for the detection of 
biomarkers for cardiovascular disease has been met. 
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